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ABSTRACT 
 Pregnancy is accompanied by a multitude of physical and psychological changes. 
Adaptation to these changes through reduced anxiety and attenuated stress responsiveness 
is necessary across gestation and into the postpartum period for optimal maternal-infant 
health. In contrast, exposure to higher amounts of stressors during pregnancy can disrupt 
neuroendocrine-immune processes required for successful pregnancy outcomes. Evolving 
evidence demonstrates that exposure to adversity early in life has long-lasting effects on 
stress response systems that alter stress reactivity during adulthood. Given this evidence, 
it is posited that women who experience greater pre-pregnancy adversity during their 
childhood are at greater risk for negative maternal-infant health sequelae. Thus, the 
purpose of this study is to investigate the relationship between maternal childhood 
adversity and the psychological-neuroendocrine-immune profile during pregnancy. In 
addition, maternal risk and protective factors posited to moderate this profile were 
examined. Lastly, the relationship among maternal childhood adversity, maternal PNI 
profile during pregnancy, and neonatal outcomes were explored. The findings can 
contribute to improved approaches to identify and stratify risk for adverse maternal-infant 
health outcomes, as well as guide the development of early intervention programs and 
health policy for women who are pregnant or who plan to become pregnant. This is
 xvi 
 
significant because the well-being of mothers and infants determines the health of the 
next generation. Improving maternal-infant well-being can markedly reduce public health 
challenges and ultimately reduce health care costs across the lifespan (U.S. Department 
of Health and Human Services, 2011). 
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CHAPTER ONE 
STATEMENT OF THE PROBLEM 
A successful pregnancy is vital to the health of future generations and thus 
research to improve maternal infant health, including psychological well-being, is a 
national priority (U.S. Department of Health and Human Services, 2011). For most 
women, pregnancy is a profound life experience associated with upheavals of emotions, 
relationships and roles. Lederman (2009) identified seven dimensions of maternal 
emotional health: acceptance of the pregnancy, motivation to take on the role of 
motherhood, relationships with husband/partner, and own mother, preparation for labor, 
self-esteem, and sense of control. All of these have potential to impact delivery, 
postpartum adaptation, infant health, child development, and even adult health 
(Lederman, 2009). Thus, to ensure optimal maternal-newborn outcomes, pregnancy 
requires significant psychological and physiological adaptation. 
Relevant to this proposal, maternal adaptations, such as decreased anxiety and 
attenuated stress responsiveness, are necessary to enable successful pre- and postnatal 
development of the offspring. A review of the chronic stress response, and how this 
influences neurodevelopment and behaviors, is available in Lupien et al. (2009). 
 Evidence demonstrates that maternal stressors negatively impacts pregnancy 
outcomes and subsequent child development (de Weerth & Buitelaar, 2005; Diego et al., 
2006; Van den Bergh, Van Calster, Smits, Van Huffel, & Lagae, 2008). 
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It is possible that psycho-physiological adaptation to the experience of pregnancy 
may be impaired in women who experienced prior life adversity during their childhood. 
This supposition is supported by evidence derived from animal and human studies that 
identify early life adversity as a vulnerability factor that gives rise to an adult phenotype 
characterized by a heightened vulnerability to future stressful life experiences (Danese & 
McEwen, 2012; Heim, Shugart, Craighead, & Nemeroff, 2010). This stress-vulnerability 
has been attributed to alterations in neurobiological processes of the developing brain, 
which persist and shape responses to future life challenges (Danese & McEwen, 2012; 
Heim et al., 2010; Nemeroff, 2004). For example, adults who experienced childhood 
maltreatment or trauma were found to react with greater emotional responsiveness to 
stressful life events (McLaughlin et al., 2010). These individuals also manifested an 
altered physiological response to stressors, including increased autonomic nervous 
system activity and dysregulated hypothalamic-pituitary-adrenocortical (HPA) axis 
reactivity (Heim, Newport, Mletzko, Miller, & Nemeroff, 2008). Further, individuals 
exposed to early life adversity are found to be at greater risk for depression and other 
mood disorders later in life, especially in the context of challenging life circumstances 
(Chen et al., 2010; Heim et al., 2010; Hill et al., 2000; Nemeroff, 2004). Recently, 
childhood adversity was shown to predispose to a proinflammatory phenotype. Lower 
childhood socioeconomic status, and presumably more adverse early life experiences, 
was reported to be associated with higher circulating levels of IL-6 (Carroll, Cohen, & 
Marsland, 2011); while a longitudinal study found that childhood maltreatment predicted 
risk for low-grade inflammation in adults (Danese, Pariante, Caspi, Taylor, & Poulton, 
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2007). Using an acute laboratory social evaluative stress test (Trier Social Stress Test – 
TSST) (Kirchbaum, Pirke, & Hellhammer, 1993), other researchers demonstrated that 
healthy adults exposed to  childhood maltreatment exhibited a greater elevation in plasma 
IL-6, compared to those without a history of childhood maltreatment (Carpenter et al., 
2010). Such a proinflammatory phenotype linked to early life adversity was shown to 
emerge during young adulthood, as peripheral blood mononuclear cells (PBMCs) derived 
from young women raised in a harsh family climate produced more IL-6 in response to in 
vitro challenge with lipopolysaccharide and in response to real-life psychological 
stressors (Chen et al., 2010; Miller & Chen, 2010). 
Little is known about the effect of prior life stressors on psychological, 
neuroendocrine, and inflammatory responses of women who face the adaptive challenges 
inherent to pregnancy, along with the anticipation of impending role change and 
responsibilities associated with parenting. Evidence does support, however, that maternal 
psychological stressors and accompanying emotions—such as depression, anxiety, 
fatigue, and other mood disorders—influence infant short and long term health outcomes 
(Ruiz & Avant, 2005). Although the mechanism as to how this transpires is not clearly 
understood, results of animal and human studies suggest involvement of maternal-fetal 
stress response systems (Sandman, Davis, Buss, & Glynn, 2011a, 2011b). That evidence, 
although not consistent across studies, supports the theory that stress response hormones, 
like cortisol, may mediate the adverse effects of maternal psychosocial stressors on infant 
outcomes and future health (Diego et al., 2009; Field, Diego, Dieter, Hernandez-Reif, 
Schanberg, Kuhn, Yando, & Bendell, 2004). Evidence derived from animal models of 
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prenatal stress response demonstrates prenatal stress exposure affects behavioral and 
biological development through activation of the HPA axis and its end product, the 
adrenal glucocorticoid hormone, cortisol (Coe et al., 2003; Maccari et al., 1996; 
Weinstock, 2005). Maternal stress response is associated with an increase in cortisol and 
corticotropin-releasing hormone (CRH) in the maternal-fetal dyad (Field et al., 2004; 
Weinstock, 2008), and this has been found to be associated with greater risk of preterm 
delivery and low birthweight infants (Diego et al., 2009). In addition, fetal exposure to 
elevations in cortisol is posited to result in impaired neurodevelopment. Compelling 
evidence supports a detrimental effect of cortisol on brain function, as increased cortisol 
exposure was found to change expression of a thousand genes in fetal cultured brain cells 
(Salaria et al., 2006). Also, elevated maternal prenatal cortisol was demonstrated to be 
associated with more negative infant behaviors (Davis et al., 2007). Recently, hair 
cortisol has been shown to be a reliable, non-invasive, retrospective measure of HPA axis 
activity (Russell, Koren, Rieder, & Van Uum, 2011). In a recent article, hair cortisol 
correlated with salivary samples in each trimester of pregnancy (D'Anna-Hernandez, 
2011). Further, hair cortisol and salivary cortisol increased as gestation progressed, 
consistent with the known physiologic increase in cortisol over the latter part of 
pregnancy. While salivary cortisol has been used over the past decade to non-invasively 
measure cortisol, one of its limitations is that it reflects acute stress response, as opposed 
to chronic or cumulative stress response across pregnancy (D'Anna-Hernandez, 2011). 
Evaluation of chronic stress response biomarkers over larger time domains of pregnancy 
will provide critical insight as to the cumulative impact of stressors during pregnancy on 
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maternal-infant outcomes. The proposed study measures hair cortisol as an index of 
(HPA) activation as a retrospective marker, over a three-month time interval, as indicator 
of the stress response, during pregnancy.  
The maintenance of a healthy pregnancy requires a shift in maternal cytokine 
balance toward an anti-inflammatory state (Reinhard, 1998); with more successful 
pregnancies there are higher circulating levels of the anti-inflammatory cytokine IL-10 
(Jenkins, 2000; Lim, 1999). However, near term, in a normal pregnancy, a shift to an 
inflammatory state heralds the onset of labor and infant delivery. Atypical elevations in 
IL-6, IL-8, and TNF alpha, such as that which occurs with maternal infection, are linked 
to preterm birth (Gomez et al., 1995; Zhang, 2000). Important to this proposal, Coussons-
Read and colleagues (2005) reported that women experiencing high levels of stressors 
during pregnancy have increased circulating levels of proinflammatory cytokines late in 
pregnancy compared to women not experiencing high levels of prenatal stressors 
(Coussons-Read, Okun, Schmitt, & Giese, 2005). Specifically, exposure to maternal 
prenatal stressors was associated with higher levels of the proinflammatory cytokines IL-
6 and TNF-alpha and with low levels of the anti-inflammatory cytokine, IL-10 
(Coussons-Read et al., 2005). More recently, this group evaluated associations between 
maternal psychosocial stress and cytokines during early, mid, and late pregnancy 
(Coussons-Read, Okun, & Nettles, 2007). That study showed that during both early and 
late pregnancy, higher levels of maternal stressors was related to elevations in circulating 
IL-6, while elevated CRP levels were associated with stressors during late pregnancy. 
Additionally, more prenatal stressors were related to lower serum IL-10 levels during 
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early pregnancy. In contrast, no associations were observed with stressors and circulating 
cytokines during the second trimester (Coussons-Read et al., 2007). 
Significance  
Prenatal stress-induced dysregulation of stress response hormones and cytokines 
may contribute to short-term and long-term effects on fetal and neonatal development 
(Entringer et al., 2010; Entringer, Buss, & Wadhwa, 2010). Because developing systems 
exhibit considerable plasticity, they are more easily affected by environmental stimuli, 
like maternal prenatal stressors (Hochberg et al., 2010). Disruption of the maternal-fetal 
neuroendocrine-immune milieu can adversely modulate developmental trajectories and 
affect biological, mental, and behavioral processes across the life span of the infant. It is 
anticipated that the results of this investigation will advance understanding of the 
influence of exposure to adverse life experiences during childhood on a woman’s 
psychological, neuroendocrine, and proinflammatory response to her pregnancy. Also, 
results will provide insight as to whether maternal life experiences that occurred during 
her childhood relate to poor neonatal outcomes for her offspring. Such a determination 
has potential to positively impact maternal-infant health, by contributing to better 
identification of antenatal psychosocial risk that portends poor maternal-child health 
outcomes. The fetus is highly sensitive to the environment, and adverse experiences 
during critical periods of fetal development are known to increase life-long risk for 
disease (i.e., risk of cardiovascular, metabolic, and behavioral disorders) (Gluckman & 
Hanson, 2004). Thus the significance is magnified, as maternal prenatal stress response 
and exposure to stressors across pregnancy may result in life-long health issues for the 
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offspring. The findings from this study can provide the foundation for improved 
approaches to identify and stratify risk for adverse maternal-infant health outcomes, as 
well as guide the development of early intervention programs and health policy for 
women who are pregnant or who plan to become pregnant. This is significant because the 
well-being of mothers and infants determines the health of the next generation and is a 
priority of Healthy People 2020. Improving maternal-infant well-being can markedly 
reduce public health challenges and ultimately reduce health care costs over the lifespan 
(U.S. Department of Health and Human Services, 2011). 
Conceptual Model 
 The model as depicted in Figure 1 illustrates potential linkages whereby maternal 
antenatal adverse experiences influence the mother’s psychological well-being, 
neuroendocrine activity, and proinflammatory cytokine levels during pregnancy, 
ultimately affecting neonatal outcomes. For the purposes of this study, life adversity was 
conceptualized as a woman’s pre-pregnancy exposure to adverse experiences, prior to18 
years of age, originating from childhood and family experiences and/or related to low 
SES. Life adversity was measured by asking pregnant women to complete the Child 
Trauma Questionnaire (CTQ), which provides information on the woman’s experience of 
adversity during her childhood. The experience of pregnancy is a normal life event; 
however, it is characterized by marked psychological, social, and physiological changes; 
a life change that for most women results in psychological stressors, requiring adaptation.  
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Figure 1. Life adversity: Impact on PNI profile during pregnancy and on neonatal 
outcomes.  
(Note: Figure 1 describes posited linkages among study variables and is not intended to 
represent a path model.) 
 
The proposed model posits that women who have experienced greater adverse 
experiences during their childhood will respond to their pregnancy, with greater stress 
perception (general distress), greater depressive risk, anxiety, mood disorder, and more 
sleep dysregulation. Additionally, greater childhood adversity will result in elevated 
neuroendocrine (cortisol) and proinflammatory (IL-6 and TNF-alpha) cytokine levels 
during pregnancy. This model is supported by evidence derived from animal and human 
studies that identify early life adversity as a vulnerability factor that gives rise to an adult 
phenotype characterized by a heightened stress reactivity. This heightened stress 
reactivity is characterized by greater psychological, cortisol, and proinflammatory 
responses to stressful life events (Entringer et al., 2008). It is further hypothesized that 
moderating factors (i.e., protective factor) will influence the effect of antenatal adversity. 
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Maternal moderating factors to be evaluated are levels of social support available to a 
woman during her pregnancy. Greater social support during pregnancy is posited to 
lessen (i.e., buffer) the impact of antenatal life adversity on outcomes. Lastly, the 
increased intensity of the woman’s response to stressors across pregnancy (psychological, 
cortisol, TNF-alpha, and IL-6) was posited to result in worse neonatal outcomes 
(Entringer, Buss, Shirtcliff, et al., 2010; Entringer, Buss, & Wadhwa, 2010; Entringer et 
al., 2008). Further, the stress response during pregnancy is evaluated using perceptions of 
stress over a period of weeks to months while plasma blood analysis evaluates a static 
measure of inflammation in cytokines, and hair cortisol evaluates HPA activation across 
the last three months. The neonatal outcomes to be evaluated include birth weight and 
gestational age.  While most studies focus on evaluating each individual stressor 
(perceived stress, depression, anxiety) across pregnancy, this study is unique in its 
innovative approach to create a Distress Composite Score using PCA to evaluate stressors 
during pregnancy—specifically, mid-pregnancy and late-pregnancy.  This allows the 
researcher to better evaluate chronic stress through maternal child adversity, experienced 
in the first 18 years of life, with acute trauma experienced during current pregnancy.   
 10 
 
CHAPTER TWO 
REVIEW OF THE LITERATURE 
 Healthy People 2020 identified maternal-infant health as an important national 
health indicator, and thus a health priority for the nation (U.S. Department of Health and 
Human Services, 2011). Premature delivery, low birth weight (LBW) and infant mortality 
are key benchmarks for maternal-infant health status (U.S. Department of Health and 
Human Services, 2011). Premature and LBW infants have greater risk of negative 
neurodevelopmental outcomes. Additionally, premature as compared to term infants are 
at a greater risk for adverse psychological health, including depressive disorder, bipolar 
affective disorder, and non-affective psychosis (1.3, 2.7, and 1.6 times greater risk, 
respectively) (Nosarti et al., 2012). Adversity during childhood is increasingly recognized 
as a vulnerability factor for poor adult health. Yet, there is very little research 
investigating the psychological, neuroendocrine, and immune impact of childhood 
adversity during pregnancy on either maternal or neonatal outcomes. Adverse life 
experiences are associated with poverty (Hatton & Emerson, 2004), depressive 
symptoms, (Heim & Binder, 2011; Heim et al., 2010), and childhood psychiatric disorder 
(Hatton & Emerson, 2004), with the latter characterized by insecure attachment and 
social processing disorders. Moreover, significant life events prior to or during pregnancy 
enhance the likelihood of delivering a LBW infant (Khashan et al., 2008). Emerging 
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research suggests maternal life experiences may create a sub-optimal environment, 
affecting the fetus and altering development.  
Premature and Low Birthweight Infant 
In 2008 premature delivery accounted for 12.3% of all births in the United States, 
escalating health care costs (Mathews & MacDorman, 2010) (see Appendix A). For 
example, in 2005, premature births alone cost the US government an estimated $26 
billion, with over $50,000 spent per child (Behrman & Butler, 2007). Expenditures 
exponentially increase when the cost associated with long-term care related to 
neurological, cognitive, and behavioral disorders is included (Talge, 2007).  
While rates of premature delivery approach 13% for all women, rates for African 
American women (AAW) are over 17% for 2008 alone; and these rates remained 
virtually unchanged over the past two decades (2008 vital statistic data) (see Appendix 
B). These data suggest that AAW have a 60% greater risk for moderate preterm birth (28-
37 weeks gestation) and a 2.5-times greater risk for extreme preterm birth (<28 weeks 
gestation) (Martin et al., 2009). Additionally, premature infant delivery rates for very low 
birth weight (VLBW) (<1500 grams) and low birth weight (LBW) (<2500 grams) are far 
greater among non-Hispanic Black women (2.5%, 11.6%, respectively) than for White 
(0.8%, 5.3%, respectively) and Hispanic women (1%, 5.7%, respectively) (Martin et al., 
2010) (see Appendix C). This increase represents a 200% and a 120% increase, 
respectively, for VLBW and LBW infants in AAW as compared to White women (Martin 
et al., 2010). While premature birth rates have declined slightly in all races (2006-2008 
data), there remains a gap in understanding why AAW continue to have the highest 
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proportion of premature birth rates despite access and improvements in prenatal health 
care.  
Collins (Collins, Wu, & Davis, 2002) suggests that there is an intergenerational 
effect of poverty and a greater risk of LBW delivery among AAW in Cook County, IL 
(Collins, Rankin, & David, 2011; Collins et al., 2002). Additionally, another study noted 
an intergenerational decrease in birth weight among female descendants of non-US-born 
AAW in contrast to an increase in birth weight among descendants of European-born 
White women (Collins et al., 2002). Meanwhile, in another study, there were differences 
in birth weight when comparing the maternal birth weight to their offspring’s birth 
weight in AAW as compared to Whites (Coutinho, 1997). This evidence suggests that the 
exposure to factors across generations, in addition to throughout gestation and childhood, 
may have a programming effect on the developing infant, resulting in intergenerational 
risk for LBW infants. These health disparities suggest there may be risk factors that are 
mediated by intergenerational or epidemiological links, which increase the incidence of 
premature and low birth weight delivery.  
Biological Embedding 
Adverse childhood experiences may be a risk factor in women during pregnancy 
that contributes to premature and LBW delivery and poor neurodevelopmental infant 
outcomes. This risk may arise from early life biological embedding that results in 
recalibration of stress response systems, which persists into adulthood (Hertzman, 1999). 
For pregnant women, early life adversity may dysregulate the dynamic balance of 
neuroendocrine-immune processes needed for optimal birth outcomes. Thus, it is 
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plausible that poor maternal-infant outcomes may emerge due to a dysregulated maternal 
neuroendocrine-immune profile consequent to exposure to early life adversity. Yet, there 
is little understanding of what psychosocial factors matter most and what underlying bio-
behavioral mechanisms mediate the effects of early life adversity. 
 Compelling evidence suggests that the developing fetus is highly sensitive to 
his/her environment, which in essence is a reflection of the maternal environment. 
Environmental demands, such as that resulting from exposure to maternal stressors, are 
now known to alter malleable physiological systems and predispose not only to poor 
infant outcomes but also to poor health in adulthood. The sensing of the environment by 
the developing fetus results in an adjustment of physiologic set points and this is referred 
to as fetal programming (Davies & Norman, 2002; Welberg & Seckl, 2001). Initially 
adaptive, fetal programming in response to environmental demands imprints developing 
systems in a manner that shapes both the biological and behavioral phenotype; however, 
such phenotypic molding can also be maladaptive and predispose to disease later in life. 
The importance of fetal and infant health to adult health outcomes was first described by 
Dr. David Barker, whose studies demonstrated an association between low birth weight 
and increased systolic blood pressure (Barker, Bull, Osmond, & Simmonds, 1990; 
Barker, Osmond, & Law, 1989). Since that initial work, a multitude of studies have 
confirmed these early findings (Gluckman & Hanson, 2004), culminating in what is 
termed the Developmental Origins of Health and Disease (DOHaD) theory. According to 
DOHaD theory, an adverse intrauterine environment results in an integrated set of 
adaptive responses, which resets the developmental trajectory in anticipation of adverse 
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conditions to be encountered later in life. Mismatch between the anticipated postnatal 
environment and the reality of it exposes the organism to risk of adverse outcomes; the 
greater the mismatch, the greater the risk (Gluckman, Hanson, & Beedle, 2007). 
 The DOHaD offers a framework that emphasizes the importance of early perinatal 
life experiences on life-long risk for disease (i.e., risk of cardiovascular, metabolic, and 
behavioral disorders). Importantly, this applies to the maternal psychological milieu, as 
accruing evidence demonstrates that maternal psychological stressors, accompanied by 
maternal depression, anxiety, fatigue, and mood disorders can influence infant short- and 
long-term health outcomes (Ruiz & Avant, 2005). Although the mechanism is unclear, 
evidence suggests that this may occur as a consequence of activation of maternal-fetal 
stress response systems (Sandman et al., 2011a, 2011b) Maternal-fetal stress response 
activation alters levels of stress hormones that may, in turn, mediate the adverse effects of 
the maternal psychological state on infant outcomes and future health. As well, stress-
induced dysregulation of the immune and inflammatory processes (i.e., proinflammatory 
cytokines) that are key to successful development and postnatal outcomes are also 
potential mediators of maternal stressors on fetal and neonatal development (Entringer, 
Buss, & Wadhwa, 2010; Wadhwa, Entringer, Buss, & Lu, 2011). Developing systems are 
especially vulnerable, as they exhibit considerable plasticity in response to environmental 
demands. Moreover, the window of developmental plasticity extends from preconception 
to early childhood and evolving research suggests that the mechanism likely involves 
epigenetic imprinting in response to environmental stimuli (Hochberg et al., 2010). As a 
result, early life cues set the trajectory for long-term biological, mental, and behavioral 
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responses that can persist across the life span. On the other hand, if effects of adverse 
early life experiences are mediated through epigenetic modifications, the outlook is not 
grim, as increasing evidence shows epigenetic states to be reversible. This opens up the 
opportunity for interventions during critical developmental windows, during both pre- 
and postnatal life (Gluckman, Hanson, & Mitchell, 2010). For instance, emerging 
evidence demonstrates promise for early life environmental enrichment to reverse 
epigenetic modifications consequent to adverse early life experiences (Branchi, Karpova, 
D'Andrea, Castren, & Alleva, 2011). 
Given the important influence of the maternal psychological environment on 
infant and adult health outcomes, the purpose of this review is two-fold: (1) to establish 
the importance of investigating the impact of early maternal prenatal stressors on mother-
infant health; and (2) to discuss potential mechanisms through which prenatal stress 
response impacts mother-infant health. 
Psychoneuroimmunology Kopnisky (Kopnisky, Stoff, & Rausch, 2004) embraces 
an integrated approach to explain the influence of environmental demands on one’s 
biology and behavior and how that impacts health via the immune system. With this 
purpose in mind, PNI theory, as a framework for understanding bio-behavioral processes 
that predict maternal-infant health, is reviewed. Next, key research studies that have 
evaluated the effects of maternal stressors—including anxiety and depression—on 
maternal-infant health are considered. Additionally, a brief identification of the current 
literature on prior life adversity during pregnancy is presented. Issues related to research 
design are addressed and recommendations for future studies are identified. 
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Psychoneuroimmunology: Theoretical Framework 
PNI offers a theoretical framework to understand the integration of psychological 
and physiological factors and how psychosocial context influences maternal-infant health 
outcomes. PNI posits that a person’s adaptive response to the environment involves 
coordinated interactions among the nervous, endocrine, and immune systems. For 
centuries, mind-body philosophy was rooted in anecdotal evidence. Then in 1980, the 
term psychoneuroimmunology was introduced by Robert Ader to denote the study of the 
interactions among behavioral, neural, and endocrine (neuroendocrine) systems with 
immunological processes of adaptation (Ader, 1980). This was in contrast to the 
prevailing view that the immune system operated autonomously from the brain (Maier, 
Watkins, & Fleshner, 1994). In the last 30 years strong evidence has accrued that 
establishes the existence of primary biological pathways linking the brain with the 
immune system (Maier et al., 1994; McEwen et al., 1997). These biological pathways are 
bi-directional, in that the brain not only influences immune function but products of the 
immune system (i.e., cytokines) can also signal the brain and influence the expression of 
behavior and emotions (Witek-Janusek, Tell Cooper, & Mathews, 2010) (see Appendix 
C). The connections among the brain and the cells and tissues of the immune system 
include direct innervation of lymphatic tissue and a shared communication grid in which 
cells of the nervous, endocrine, and immune systems use similar molecules and receptors 
to mutually affect behavior and physiologic function. Thoughts, emotions, and behavior 
are known to activate these pathways and in turn modulate immune function (Mathews & 
Janusek, 2011). This is consistent with the expanding body of evidence that supports the 
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role of emotions in the development and/or progression of disease (Irwin, 2008; Kemeny 
& Schedlowski, 2007; Witek-Janusek, & Mathews, 2012; Witek-Janusek, Tell Cooper, & 
Mathews, 2010; Wrona, 2006). 
Brain and Immune System 
The neuroendocrine system and autonomic nervous system (ANS) are two of the 
major biological pathways connecting behavioral events to the immune system. The 
immune system can be influenced by either the release of catecholamines through 
activation of the sympathetic division of the ANS, or of acetylcholine subsequent to 
activation of the parasympathetic division of the ANS.  Further, sympathetic nerve 
terminals in immune organs connect with lymphocytes and have features much like 
synaptic junctions, suggesting the physical connection to the central nervous system 
(Maier et al., 1994). As a result, ANS stimulation can modulate immune function when 
environmental demands are perceived as a threat that provokes arousal and/or an 
emotional response. Because immune cells have adrenergic and cholinergic receptors, as 
well as receptors for other neurotransmitters, immune function can be altered in response 
to ANS activation. For example, stimulation of these receptors results in functional 
changes in immune response, including cytokine secretion, lymphocyte proliferation, 
natural killer cell cytotoxicity, and antibody production (Elenkov & Chrousos, 2006; 
Wrona, 2006). ANS activation does not solely produce immunosuppression, as originally 
thought.  It is now realized that in response to ANS activation, certain aspects of the 
immune response may be stimulated whereas other responses are suppressed. This has 
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led to the current thinking that stressors produce immune dysregulation, especially if it is 
chronic (Calcagni & Elenkov, 2006; reviewed in (Witek-Janusek, & Mathews, 2012)). 
A new view of the relationship between the immune system and the 
parasympathetic nervous system has recently emerged. Compelling research has 
established that vagal parasympathetic pathways suppress the release of proinflammatory 
cytokines and dampen inflammatory responses (Czura & Tracey, 2005; Thayer & 
Sternberg, 2010). Evidence demonstrates that greater vagal tone is associated with lower 
TNF-alpha and IL-6 (Marsland et al., 2007). It is now believed that this cholinergic anti-
inflammatory pathway is a key adaptive mechanism by which the body reduces excess 
inflammatory responses to stressors (Elenkov, Iessoni, Daly, Harris, & Chrousous, 2005; 
Sternberg, 2006). Little, if any, research has evaluated the cholinergic anti-inflammatory 
pathway during pregnancy or during the postpartum period. 
Neuro-Endocrine-Immune Connection  
The hypothalamic-pituitary-adrenal (HPA) axis serves as an important 
neuroendocrine stress response system. Activation of the HPA axis occurs when a 
stressful event is experienced, causing the release of corticotrophin-releasing hormone 
(CRH) from the hypothalamus and the subsequent release of ACTH from the anterior 
pituitary (Maier et al., 1994). ACTH, in turn, causes the adrenal cortex to release cortisol, 
a glucocorticoid with strong immuno-modulatory effects. Cortisol is an anti-
inflammatory stress response hormone; yet it also influences the overall balance of 
cytokines and is associated with pro-inflammatory effects. Cytokines are protein 
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molecules that regulate the immune response but also can signal the brain and influence 
behavior and emotional state; hence, cytokine balance is key to studies in PNI.  
Lymphocytes that primarily secrete interferon (IFN) gamma, interleukin (IL)-2, 
and tumor necrosis factor (TNF) are classified as Th1 lymphocytes. These cells support 
cellular immunity. In contrast, lymphocytes that predominately secrete IL-4, IL-10, and 
IL-13 are classified as Th2 lymphocytes. These support humoral immunity (Elenkov & 
Chrousos, 1999; Mosmann & Sad, 1996). For the most part, under conditions of stress 
response activation, cortisol and catecholamines shift the cytokine balance toward greater 
levels of Th2 cytokines and reduced levels of Th1 cytokines. For example, 
glucocorticoids (i.e., cortisol), norepinephrine, and epinephrine suppress the production 
of IL-12 by antigen-presenting cells. IL-12 promotes a Th1 response to antigen and in its 
absence, a shift to a Th2 profile of cytokine production results. Furthermore, it is well 
established that stressors are accompanied by elevations in proinflammatory cytokines, 
such as IL-1, IL-6, and TNF-alpha. It is theorized that a key role of cortisol release during 
stress response activation is to attenuate the effects of proinflammatory cytokines and 
thus reduce the potential damage that can result from exaggerated or prolonged release of 
inflammatory molecules (Sternberg, 2006). For example, HPA axis dysregulation can 
occur under conditions of prolonged stress response, and cortisol becomes less effective 
in dampening stress-associated release of inflammatory molecules, like IL-6 (McEwen, 
2000; G.E Miller, Cohen, & Ritchey, 2002). It is clear that the relationship among 
glucocorticoids, catecholamines, inflammation, and the immune system during stress 
response activation is complex, and dysregulation of these relationships can influence 
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health. It has become increasingly clear that when inflammation is not curtailed after a 
stress response, there is increased risk for inflammation-based disease like depressive 
illness or other affective and cognitive disorders (Dantzer & Kelley, 2007). For example, 
individuals with major depression demonstrate HPA axis dysregulation, which may be 
contributory to this affective disorder (Irwin & Miller, 2007). The role of stress-induced 
cytokine dysregulation during pregnancy has received little attention in the literature. 
Cytokine to Brain Signaling  
As noted above, a delicate balance between pro-inflammatory cytokines and anti-
inflammatory cytokines is required to maintain homeostasis of the immune system. 
Cytokines are key molecules that signal the brain and modulate behavior. Moreover, 
extant research indicates that acute stress response modulates many aspects of immunity, 
which may not only contribute to disease but also contribute to behavioral disorders. 
(Cover & Irwin, 1994; M. Irwin, 2002; Irwin & A. Miller, 2007; Miller, 2009). 
Proinflammatory cytokines were first found to induce what was initially termed “sickness 
behavior,” characterized by a constellation of symptoms, such as depressed mood, 
fatigue, lethargy, and disturbed sleep (Miller, 2009). Miller (2009) suggested that 
sickness behavior is an evolutionary protective response, causing the body to protectively 
shut down other activities and shift focus to aid healing. Yet, if excessive, 
proinflammatory cytokines can increase risk for depression (Miller, 2009). Capuron and 
Miller (2004) demonstrated that patients given the cytokine, interferon alpha (IFN-alpha), 
for medical treatment developed significantly higher rates of depression, which subsided 
following its discontinuation (Capuron & Miller, 2004). Cytokines contribute to sickness 
21 
 
 
behaviors like fatigue, sleep disruption, depressed mood, anxiety, impaired memory, and 
anhedonia by signaling the brain to induce central activation of the brain cytokine 
network (Capuron & Miller, 2004). Understanding the physiologic role of cytokines on 
psychological responses is critical to appreciate when caring for women who are 
undergoing prenatal and postnatal stressors; especially in light of the heightened risk for 
depression during the prenatal period. Factors influencing psycho-physiological 
responses may have greater negative effects on health when experienced in the context of 
pregnancy and the unique demands that pregnancy imposes on the mother and the 
developing fetus.  
Maternal Prenatal Stressors and Health Outcomes in the Offspring: Overview 
 While the application of a PNI framework to maternal-child research is relatively 
new, it is highly relevant to an understanding of the impact of prenatal stressors on 
maternal-infant outcomes. For the pregnant woman, many factors can provoke both 
psychological and physiological stress, including unplanned pregnancy, teen pregnancy, 
chronic health conditions like diabetes, domestic violence, financial issues, lack of 
adequate social support, premature delivery, fertility issues, and previous pregnancy loss. 
Understanding how prenatal stress impacts mother-infant and future health is the focus of 
this review.  
 Fetal and neonatal exposure to maternal stressors is posited to exert a major 
(programming) influence on the trajectory of fetal and neonatal development, which has 
potential to alter health across the life span. While maternal exposure to teratogens during 
pregnancy is known to cause lethal defects, less is known about the effects of maternal 
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stress exposure on mother-infant health. Emerging work, however, implicates exposure to 
prenatal stressors as a contributing factor to adverse maternal-infant health outcomes, 
including increased risk for preterm delivery, intrauterine growth restriction, and 
impaired neurological, behavioral, and social-emotional development. The timing of fetal 
exposure to maternal psychological or biological stress is coupled with distinct profiles of 
birth outcomes, fetal/neonatal reactivity, and future health outcomes (Sandman et al., 
2011a, 2011b). Effects of stressors on pregnancy outcomes may be attributed to stress-
induced alterations of stress response activation of hormones and inflammatory 
molecules (i.e., cytokine dysregulation) (Coussons-Read et al., 2007; Ruiz & Avant, 
2005). Given that the developing brain and body systems are more plastic or malleable 
compared to that of adults, the fetus is more vulnerable to the adverse effects of stressors, 
and these effects can imprint long-lasting changes through fetal programming (Bilbo, 
2011). The concept of programming refers to the associations between environmental 
events (internal and external to the organism) and stable alterations in the phenotype of 
the offspring (Meaney, 2007).  
Early life programming primes the fetus for adaptation to the extra-uterine 
environment; however, due to plasticity of developing systems in the early fetal and 
postnatal periods of life, maladaptive programming can also occur. For example, 
maternal exposure to stressors may precipitate maladaptive changes that alter the 
structure, function and biochemistry of the fetal brain and other developing tissues (Bilbo 
& Schwarz, 2009). Animal models establish that adverse early life environments—such 
as exposure to physical or psychological stressors, restricted or unbalanced nutrition, 
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alcohol or tobacco impaired utero-placental perfusion, and exposure to prenatal synthetic 
glucocorticoids—result in programming of developing physiological systems that can 
impair growth and development of the offspring. In particular, the developing HPA axis 
is highly susceptible to programming by early life events and this can alter life-long stress 
reactivity and future physical and mental health (Matthews, 2000; Matthews, Owen, 
Banjanin, & Andrews, 2002; Welberg & Seckl, 2001). Abnormal levels of cortisol 
resulting from maternal prenatal stress exposure during critical periods of development 
may mediate poor birth outcomes. For example, early exposure to prenatal maternal 
stressors with elevated cortisol levels early in gestation was shown to delay mental and 
motor development (Lupien et al., 2005; Field, 2011).  In contrast, late exposure to 
elevated cortisol (with gradual increase of cortisol over time) is associated with enhanced 
mental performance (Davis & Sandman, 2010). Preterm birth is one potential outcome of 
fetal exposure to stressors during gestation; yet, there are other adverse outcomes that 
emerge during adulthood. Early life exposure to stressors can predispose to obesity, 
hypertension, cardiovascular disease, diabetes, and psychiatric disease in the offspring 
(Cottrell & Seckl, 2009). On the other hand, early life programming can have positive 
effects. For instance, maternal-infant interactions that are supportive and nurturing 
provide an environment that can enhance growth and development of the offspring, 
modulate HPA reactivity, reduce the risk for diseases or disorders in adulthood, and 
increase resiliency throughout life (Meaney, Szyf, Seckl, 2007). The biological 
mechanisms, which mediate the effect of early life programming, are under intense 
investigation.  Promising lines of research indicate that this may involve epigenetic 
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processes (Gluckman & Hanson, 2004; Weaver, 2004). (Epigenetics refers to stable 
changes in DNA that occur in response to the environment but do not involve alterations 
to the DNA base pairs (Mathews, 2011).)   
In fact, recent research shows differences in peripheral blood DNA methylation 
patterns in children who were institutionalized versus those raised by parents (Naumova 
et al., 2012). Also, findings recently showed childhood SES was associated more with an 
adult blood DNA methylation pattern than adult (current) SES (Borghol et al., 2012). 
These data translate findings from animal models to human paradigms, demonstrating 
that adverse early life experiences exert epigenetic modification, which persists into 
adulthood. The following discussion reviews the impact of prenatal stressors and the 
emotions (depression and anxiety) it engenders on neonatal and future health outcomes. 
In addition, potential biological pathways posited to mediate the effect of prenatal 
stressors are discussed. 
Maternal Prenatal Stressors: Health Outcomes 
Exposure to maternal prenatal stressors is not without consequence. Several 
prospective studies provide evidence that stressors experienced during pregnancy, 
including maternal anxiety or depression, are associated with adverse neonatal outcomes 
that influence future health, including risk for mental health disorders like attention 
deficit hyperactivity disorder (ADHD), autism, and schizophrenia (O'Donnell, 2009) (see 
Appendix D). The primary outcomes evaluated in studies of prenatal stressors include 
alterations in fetal/infant growth, abnormal social-emotional development, 
neurobehavioral impairments, and delayed cognitive development (Beydoun & Saftlas, 
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2008; Talge, 2007). The following will review major findings, commonalities, and 
inconsistencies among select studies, which have evaluated consequences of prenatal 
stress. This is followed by a consideration of potential psychobiological mechanisms 
proposed to mediate the adverse outcomes of maternal prenatal stressors. 
Neonatal Outcomes: Birthweight and Prematurity 
A body of evidence suggests that maternal prenatal stressors—including daily 
hassles, depression, anxiety, and the experience of negative life events during 
pregnancy—result in earlier delivery and smaller birth weight (Talge, 2007). For 
example, women with scores on the Center for Epidemiological Studies Depression tool 
CES-D (Radloff, 1977) greater than or equal to16 (cut score for depression risk) were 
found to have nearly twice the risk for preterm delivery. Further, this risk escalated with 
increasing severity of depression and was independent of antidepressant medication (Li, 
2009). Prenatal anxiety also increases the incidence of premature delivery and low infant 
birth weight. One study showed that women with prenatal anxiety have higher rates of 
prematurity and lower birth weights, as compared to women with prenatal depression 
(i.e., 10% as compared with 6.5%, respectively) (Field, Diego, Hernandez-Reif, 
Figueiredo, Deeds, Ascencio, Schanberg, & Kuhn, 2010). These results were confirmed 
by a large population-based study (N=3,000), which found that maternal anxiety and 
depression predicted both premature birth (OR=1.16) and low birth weight (OR=1.08) 
(Cooper, Murray, Hooper, & West, 1996). Thus, both prenatal anxiety and depression are 
important psychological factors that influence prematurity and birth weight of offspring.  
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Similarly, pregnancy-specific anxiety was found to result in a two-fold increased 
risk of premature delivery, while perceptions of racial discrimination increased risk for 
premature delivery (RR=1.4) (Dole, 2003). Further, greater negative life events, 
combined with pregnancy-specific anxiety, increased the relative risk of premature birth 
(from OR 2.1 to 2.6) (Dole, 2003); while greater maternal perception of negative life 
events during pregnancy increased the odds (OR 1.8) of preterm birth, independently of 
obstetric complications and maternal substance abuse (Dole, 2003). Acute exposure to 
traumatic events was also shown to reduce infant birth weight and shorten gestation 
(Harville, Xiong, & Buekens, 2010 2010). For instance, pregnant women in the vicinity 
of the Word Trade Center terrorist attack (9/11) delivered infants with a birth weight 
below the 10th percentile (OR=1.90) (Berkowitz et al., 2003). 
More recently, a meta-analysis evaluated psychosocial stressors and perinatal 
outcomes. That analysis evaluated 35 studies (N=31,323 women) which met inclusion 
criteria (based on rigor of design). Findings demonstrated that exposure to psychosocial 
stressors during pregnancy was significantly associated with risk for low birth weight; but 
this association, although significant, was very small. The authors concluded that other 
lifestyle variables and/or risk factors (i.e., vulnerability factors) need to be considered in 
combination with measures of psychosocial stressors to fully address the role of prenatal 
stressors on prematurity and birth weight (Littleton, Bye, Buck, & Amacker, 2010 & 
Amacker, 2010). It is also noteworthy, that a variety of tools are used by investigators to 
evaluate psychosocial stressors; including total number of stressful life events, daily 
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hassles or minor stressful events, perceived stress, and adverse life events (Littleton, Bye, 
Buck, & Amacker, 2010).  
Neuro-Developmental Outcomes  
A large number of studies have demonstrated that exposure to maternal antenatal 
stressors results in a variety of effects that adversely impact the neurobehavioral, social-
emotional, and cognitive function of offspring. Although these human studies do not 
provide causal evidence, the findings are consistent across studies and the effects are 
buttressed by results obtained from experimental animal models that do indeed 
demonstrate causality (see Appendix D). What is remarkable about these studies is that 
they demonstrate that adverse outcomes result from diverse stressor types and intensity, 
ranging from trauma exposure (i.e., natural disasters) to minor stressors, like daily hassles 
(see Appendix D). Collectively, these results indicate that offspring of mothers with 
exposure to antenatal stressors are more likely to be afflicted with emotional disorders, 
including greater risk for attention deficit/hyperactivity, anxiety, delay in language 
development, autism, and schizophrenia (O'Donnell, 2009). Importantly, the magnitude 
of the adverse effects of prenatal stressors are considered to be clinically significant, as 
the attributable development of emotional/behavioral problems is estimated at roughly 
15% (Talge, 2007). Furthermore, collective evaluation of this literature suggests that 
these effects are independent of effects related to maternal postnatal depression and 
anxiety (Talge, 2007).  
The influence of postnatal confounds, like poor mother-child interactions in 
women who suffered from exposure to prenatal stressors, are an important design 
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concern, as many human studies have not controlled for influences of the postnatal 
environment on child development. The vast majority of studies have focused on the 
emotional reaction to the stressors accompanying pregnancy, namely maternal depression 
and anxiety. In light of this, the following provides a review of select studies that have 
evaluated prenatal maternal depression and anxiety. 
Prenatal Depression  
Prenatal major and minor depressive disorders are common during pregnancy. A 
recent review reports the incidence of prenatal depression to range widely, from 6% to 
38% (Field, 2011). This wide range is related to a lack of distinction between clinical 
depression, as compared to depressive symptoms, the latter being more prevalent. For 
example, the incidence of prenatal depressive symptoms in the USA was reported to 
occur in 38% of pregnancies (Records & Rice, 2007). In contrast, a recent evaluation of a 
large sample of community women (N=1997) found that 5.1% of the sample reported 
antenatal clinical depression (clinical depression was defined using the Diagnostic and 
Statistical Manual of Mental Disorders (DSM) criteria) (Gavin et al., 2011). Also, a 
prospective evaluation of an urban sample (N=1888) of pregnant women found that 
antenatal depressive disorders were present in 9.9%, with 5.1% meeting criteria for 
probable major depression and 4.8% meeting criteria for probable minor depression 
(Melville, Galvin, Guo, Fan, & Kanton, 2010). It is even likely that the prevalence of 
maternal prenatal depression is higher, as many cases go unreported. It is estimated that 
over 85% of women with depression and depressive symptoms go untreated. For 
example, in a large study (n=3472), 20% of pregnant women had CES-D scores >13 with 
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nearly 14% of this sample being untreated for depression (Marcus, Flynn, Blow, & Barry, 
2003). This may, in part, be due to the prevailing notion among certain health care 
providers and the general public that depression is a “normal” part of pregnancy. Clearly, 
these statistics highlight not only the magnitude of this problem (Marcus, 2003, Blow, & 
Barry, 2003) but also the need to have conceptual clarity regarding the definition and 
measurement of depression versus depressive symptoms.  
Investigators have identified many factors which influence risk for prenatal 
depression, especially race/ethnicity. One study identified Blacks and Asian/Pacific 
Islanders to be at greater risk for depression during pregnancy, compared to non-Hispanic 
White women; this persisted even after controlling for a number of other risk factors 
(Gavin et al., 2011). Another study confirmed greater risk of prenatal depression for 
African American and Asian women, but also found that Hispanic race independently 
increased risk for any type of depression (Melville et al., 2010). That study, which 
sampled urban women, also found that psychosocial stressors, domestic violence, and 
chronic medical conditions increased the odds for prenatal depression; whereas older age 
decreased depressive risk. Others identified lower education, greater exposure to stressors 
related to fetal well-being and health, and severe marital conflict to be some of the 
strongest predictors of prenatal depression; followed by psychiatric or psychological 
history, stressors related to difficulties at work, and having a previous child with major or 
minor birth defects (Dayan et al., 2010). Further, findings from a recent study showed 
that factors which increased the odds of depression included psychosocial stressors, 
domestic violence, chronic medical health issues, and race; whereas advanced maternal 
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age decreased the odds of depression (Melville et al., 2010). In contrast, supportive 
relationships and marriage are associated with lower risk for maternal prenatal depressive 
symptoms. However, it should be noted that marriage must be qualified, as marital 
dissatisfaction is associated with greater depressive symptoms (Marcus, Flynn, Blow, & 
Barry,, 2003). Different risk factors predict major versus minor depression. Marchesi et 
al. (2009) found that prior depressive episodes and conflicts with husband/partner 
predicted major prenatal depression; whereas minor depression was predicted by being a 
housewife (i.e., no job outside the home), the presence of prior depressive episodes, and 
whether the pregnancy was wanted (Marchesi, Bertoni, & Maggini, 2009). Understanding 
risk factors for prenatal depression can lead to earlier identification and prevention of 
poor neonatal outcomes. 
Investigators identify maternal depression during pregnancy to be associated with 
prematurity and low birth weight infants. This was recently substantiated by findings 
from a multi-international meta-analysis, which documented that antenatal depression 
associated with premature birth and low birth weight delivery (Grote et al., 2010). 
Additionally, when using a categorical measurement for antenatal depression, major 
depression or clinically significant symptoms of depression increased the relative risk of 
premature birth, low birth weight, and IUGR by 39%, 49%, and 45% respectively (Grote 
et al., 2010). Moreover, this meta-analysis identified the following most significant 
variables to control: smoking or substance abuse, race or SES, history of preterm 
delivery, and antidepressant treatment with a serotonin uptake inhibitor (SSRI).  
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 Substantial evidence demonstrates that maternal prenatal depression negatively 
impacts the neurobehavioral outcomes for the offspring. In general, prenatal depression is 
linked to excessive infant activity, fetal growth delay, prematurity, low birth weight, 
disorganized sleep, and neonatal reduced responsiveness to stimuli (Field, 2011). Effects 
of prenatal depression can be initially observed in the fetus, as prenatal depression 
together with prenatal anxiety was shown to result in greater fetal activity, explaining 
39% of the variance in infant activity (Dieter et al., 2001). In response to vestibular 
stimuli, however, the fetuses of prenatal depressed women showed less total movement 
and an increase in heart rate, as opposed to a decrease in heart rate (a decrease in heart 
rate is normally associated with attention to stimuli) (Emory & Dieter, 2006). 
In the early neonatal period prenatal depression may interfere with maternal-
infant interactions. Mothers with prenatal depression more often perceive their infant’s 
temperament as difficult, as compared to non-depressed mothers (McGrath, Records, & 
Rice, 2008). In a large study investigating term infants, mothers with prenatal depression 
in the third trimester had greater perceptions of negative infant behaviors and higher 
levels of cortisol, even when maternal psychological measures were controlled. In that 
study, perceived stress did not predict maternal perceptions of infant temperament (Davis 
et al., 2007). In contrast, however, Pesonen and colleagues (2005) did find that prenatal 
maternal stressors predicted a greater maternal perception of negative infant temperament 
(Pesonen, Raikkonen, Strandberg, & Jarvenpaa, 2005). Of note, maternal subjective 
report of infant temperament should be complemented with objective measures or 
observations of the infant in order to increase measurement validity. This is particularly 
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important, as maternal postnatal affect will likely influence the mother’s perception of 
her infant’s behavior; albeit maternal perception is recognized as an important adjunct to 
objective observations of neonatal behavior. 
The effects of prenatal depression extend beyond infant temperament, as these 
infants show attention, emotional, and behavioral problems that extend into childhood 
and influence future health (Field, 2011). Regarding attention, infants of depressed 
mothers exhibit greater arousal and less attentiveness to face/voice stimuli, as assessed by 
the Brazelton Neonatal Behavioral Assessment Scale (NBAS) (Hernandez-Reif, Field, 
Diego, & Ruddock, 2006 & Ruddock, 2006). This is attributed to delayed attention 
and/or slower processing (Field, 2011). Also, older infants (3-6 months of age) were 
found to exhibit less negative responses to viewing their mother’s non-contingent and 
still-face behavior. The authors interpreted this to indicate that these infants were more 
accustomed to this behavior in their mothers, suggesting that prenatal depressed mothers 
exhibit inferior interaction styles with their infants (Field, Diego & Hernandez-Reif, 
2009). This was confirmed by other studies showing that these mothers spent less time 
smiling, touching, and imitating their infants (Field, Diego & Hernandez-Reif, 2009). 
Such findings emphasize the fact that postnatal maternal-infant interactions contribute to 
or synergize with the effects attributed to prenatal depression; certainly postnatal mother-
infant interactions need to be controlled in studies evaluating the outcomes of prenatal 
stress exposure. 
Mothers who have experienced prenatal depression more often have infants with 
sleep problems (Diego, Field, & Hernandez-Reif, 2005), manifested by their infants 
33 
 
 
spending less time in deep sleep and more time in disorganized sleep (Field et al., 2007). 
These infants are often perceived as being fussier and spending more time crying. This 
adds to maternal postpartum sleep inadequacy and exacerbates stressors experienced, 
such as fatigue and negative affect; all of which may further disturb maternal-infant 
interactions. Thus, a cycle that intensifies maternal negative affect results from infant 
sleep disturbance. Moreover, sleep disturbance often continues into childhood, as 
manifested by refusal to go to bed, waking up early, experiencing nightmares, and 
sleeping only for short intervals (O’Connor et al., 2007). Sleep problems are not benign, 
as infant sleep problems have been associated with childhood behavioral depression 
(O’Connor et al., 2007) and ADHD (Wiggs & Stores, 2005; Gruber, 2000 #1945;Stores, 
2001 #2615)(Glover, 2011) This continues to be consistent in more recent literature with 
the exploration of maternal cortisol and cortisol levels in amniotic fluid during pregnancy 
is strongly correlated between the fetus and mother, particularly in those women with 
greater anxiety (Glover, Bergman, Sarkar, & O'Connor, 2009).  
Many studies have established that male infants are at greater risk for poor neuro-
developmental outcomes due to exposure to antenatal stressors. For example, a recent 
prospective case-control study evaluated the effect of prenatal depression (DSM-IV 
criteria) on neuro-development in one-year-old infants using the NBAS, and social 
emotional development using the Infant-Toddler Social and Emotional Assessment Scale. 
Prenatal depression was identified in 34 women and infant outcomes were compared to a 
non-depressed group (N=79). Findings revealed prenatal depression to be highly 
correlated with anxiety and stress response scores, suggesting that these affective states 
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accompany one another. Interestingly, the results demonstrated that male newborns of 
mothers with prenatal depression had lower scores than control infants on the motor skills 
and regulation of states based on the NBAS. Moreover, at one year of age, infants of 
antenatal depressed mothers exhibited more generalized anxiety, which again was more 
marked in males. Also the infants of prenatal depressed mothers scored higher on 
activity/impulsivity and had more sleep problems than infants of non-depressed mothers 
(Gerardin et al., 2011). 
Prenatal Anxiety  
Anxiety can be conceptualized as an emotional reaction to real or imagined 
stressor (Austin & Leader, 2000). Evidence suggests that prenatal anxiety has unique 
influences on fetal development and infant/childhood outcomes. This is especially the 
case when the anxiety is “pregnancy-specific anxiety”—that is, anxiety associated with 
worry about delivery or worry about fetal health, including infant disability (Beijers, 
Jansen, Riksen-Walraven, & de Weerth, 2010). A meta-analysis found that pregnancy-
specific anxiety symptoms were associated with a lower infant gestational age. However, 
the effect size was small and the variance was large (Littleton, Breitkopf, & Berenson, 
2007). Possible reasons for this variation in results may relate to other correlates of 
anxiety, including depressive symptoms, social support, negative life events (recent), 
perceived stress, optimism, and self-esteem (Littleton, Breitkopf, & Berenson, 2007). In 
another review of ten studies, gestational age and small for gestational age were not 
found to be associated with higher levels of anxiety (Andersgaard et al., 2008). In 
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contrast, when comparing second trimester high versus low anxiety, Field (Field et al., 
2003) found high anxiety resulted in significant differences in birth weight.  
Findings from a study of prenatal anxiety and infant outcomes suggest that 
maternal sensitivity to infant distress moderates the relationship between maternal 
prenatal anxiety and infant cognitive development. However, it failed to moderate the 
relationship between prenatal anxiety and infant psychomotor development when the 
infants were evaluated at seven months of age. These findings were independent of 
prenatal depression or combined postnatal depression and anxiety (Grant, McMahon, 
Reilly, & Austin, 2010 & Austin, 2010). Research also indicates that timing of exposure 
to anxiety may produce unique effects on fetal development (Grant et al., 2010). For 
example, early exposure to prenatal anxiety was independently associated with reduced 
scores on the Bayley Scales of Infant Development (BSID) at one year of age (Davis & 
Sandman, 2010). In contrast, late exposure to prenatal anxiety was associated with 
behavioral and emotional problems in boys and girls and hyperactivity with inattention in 
boys (O’Connor, Heron, Golding, Beveridge, & Glover, 2002 Beveridge, & Glover, 
2002). Differences in developmental and behavioral outcomes based on timing of 
exposure likely occur because different brain regions develop at specific times during 
gestation, resulting in different windows of vulnerability. 
 Previous research shows that prenatal anxiety results in physiological effects on 
the infant. For example, infants of mothers who experienced prenatal anxiety appear to 
have impaired immune function, as they experience more infectious illness and require 
more frequent use of antibiotics throughout their first year (Beijers et al., 2010). Also, 
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infants born of mothers with anxiety during pregnancy have greater sleep disturbance. 
The effect on sleep was long lasting, as prenatal anxiety and depression each predicted 
greater sleep disturbance in infants at 1.5 and 2.5 years old (O’Connor et al., 2007). 
Infant sleep disturbance is posited to predict future behavioral problems or altered stress 
reactivity later in life. In support of this concept, it has been shown that infants born to 
mothers with prenatal anxiety exhibit elevated cortisol levels during childhood 
(O’Connor, Ben-Shlomo, Heron, Golding, Adams, Glover, 2005). 
Prenatal Combined Depression and Anxiety  
Anxiety often accompanies prenatal depression. Research by Field (Field, Diego, 
Hernandez-Reif, Figueiredo, Deeds, Ascencio, Schanberg, & Kuhn, 2010) identified 
greater developmental and socio-emotional problems in infants born to women who 
experienced both depression and anxiety during the prenatal period. For example, infants 
of mothers with combined prenatal anxiety and depression were found to spend less time 
in awake and alert states than infants of mothers without depression or anxiety (Diego et 
al., 2005). This may interfere with mother-infant bonding. Others show the combined 
presence of prenatal anxiety and depression predicted 27% and 20% of the variance in 
infant behavioral reactivity measured at four and nine months, respectively (Davis et al., 
2004). The detrimental effects of combined prenatal anxiety and depression extend to 
childhood, as manifested by an association with greater symptoms of ADHD in children 
eight and nine years old (Van den Bergh & Marcoen, 2004), behavioral problems at four 
and seven years of age (O’Connor, Heron, Golding, Glover, & ALSPAC Study Team, 
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2003 Glover, & Team, 2003), and childhood anxiety and depression at 10 years of age 
(Leech, 2006 & Day, 2006). 
 Because anxiety and depression are highly correlated and produce similar effects 
(Davis, Glynn, Waffarn, & Sandman, 2011), it makes it difficult to disentangle the 
independent effects of depression versus anxiety (Field et al., 2011). Nevertheless, it is 
clear that mothers with both prenatal depression and prenatal anxiety represent a highly 
vulnerable group (T. Field, Diego, M., Hernandez-Reif, M., Figueiredo, B., Deeds, O., 
Ascencio, A., Schanberg, S., & Kuhn, C., 2010). Furthermore, the effects of and the 
linkages between prenatal anxiety and depression emphasize the importance of measuring 
not only perceived stress, but the emotional response to stressors, including both anxiety 
and depression. 
Sleep Disturbance  
Sleep disturbance is common during pregnancy and may escalate in response to 
maternal stress; yet sleep disturbance may also be a symptom of maternal depression. 
Either way, sleep disturbance is associated with psychological distress, including 
depression, anxiety, and mood disturbance (O’Connor et al., 2007). For example, prenatal 
sleep disruption in the second and third trimester is greater in women with depression or 
anxiety, or the combination of both depression and anxiety, as compared to women 
without depression (Field, Diego, & Hernandez-Reif, 2010; Field, Diego, Hernandez-
Reif, Figueiredo, Deeds, Ascencio, Schanberg, & Kuhn, 2010). Further, prenatal sleep 
disruption in low SES AAW is greater in women with depression as compared to women 
without depression (Field et al., 2009). Hence, sleep disturbance is a key factor that can 
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moderate and possibly compound the adverse effects of prenatal stressors and negative 
mood states. 
 Sleep disruption is also known to alter immune function, HPA axis regulation, 
cortisol, and stress reactivity (Vera et al., 2009). During pregnancy, sleep disturbance 
may adversely alter critical aspects of immune function, such as cytokine regulation, 
leading to poor pregnancy outcomes (Okun, Hall, & Coussons-Read, 2007). Prior 
research shows that third trimester sleep disruption is associated with increased levels of 
the pro-inflammatory cytokine, IL-6 (Okun & Coussons-Read, 2007; Okun et al., 2007). 
In contrast, others report no effects of third trimester sleep disruption on IL-6 levels 
(Okun et al., 2007). The authors attribute this discrepancy to the wide variability in time 
that the samples were drawn from, the lack of consideration of the diurnal IL-6 rhythm 
(Dimitrov et al., 2006), and the lack of control for body mass index (BMI) (i.e., adipose 
tissue is a source of circulating IL-6) (Mohamed-Ali et al., 1997). 
Maternal Prenatal Stressors: Biological Mechanisms 
 Activation of the maternal HPA axis and the resultant increase in circulating 
cortisol has been identified as a key biological pathway contributing to the detrimental 
effects of prenatal stressors on the developing fetus. Strong evidence for this proposition 
has been obtained from animal studies (O'Donnell, 2009 #1963;Talge, 2007 #1599). Yet 
the design and interpretation of studies in humans, which evaluate maternal HPA axis 
activation and cortisol as a mediating pathway for the effects of prenatal stress, is fraught 
with many complexities. Namely, the maternal HPA axis behaves differently as gestation 
progresses. Also, the placenta controls transfer of circulating products from mother to 
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fetus, and, furthermore, the fetal adrenal contributes to cortisol secretion. In the next 
section the evidence for cortisol as a mediating hormone for adverse effects of maternal 
prenatal stress on infant outcomes is considered. 
Pregnancy and the HPA Stress Response System  
During pregnancy, stress response systems undergo remarkable change to 
accommodate the developing fetus (Davis & Sandman, 2010). Overall, there is an 
increased secretion of the maternal and placental stress hormones that are necessary for 
maternal adaptation and fetal development. The placenta is central to the variations in 
stress hormones across pregnancy, as it expresses the genes for CRH and 
proopiomelanocortin, the precursor for ACTH and beta-endorphin; and all of these stress 
hormones gradually increase as pregnancy proceeds. Most dramatic, however, is the 
marked increase in CRH in maternal plasma, which attains levels comparable to that 
observed in the hypothalamic portal system during physical stress. As a result, some 
consider pregnancy itself to be a stressor (Lowry, 1993). During pregnancy, the elevated 
CRH levels are maintained by a positive feedback loop in which cortisol stimulates CRH 
production by the placenta. This results in elevations in ACTH, beta endorphin, and 
cortisol as pregnancy advances (Petraglia, Fiorio, Nappi, & Gennazzani, 1996; Robinson, 
Emanuel, Frim, & Majzoub, 1988). Yet by term, this positive feedback loop is blunted 
because maternal receptors for stress hormones become down-regulated. As a result, 
during late gestation environmental stress is less effective in triggering the HPA axis; 
thus, women become less responsive to stressors (Glenn, 2010; Glenn, Wadhwa, Dunkel-
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Schetter, Chicz-Demet, & Sandman, 2001; Schuetze & Das Eiden, 2005) (see Appendix 
G).  
Due to the influence of estrogen, maternal plasma corticosteroid binding globulin 
(CBG) levels increase progressively with advancing gestation until 36 gestational weeks 
when the CBG levels diminish (Ho, Lewis, & O’Loughlin, 2007). Changes in CBG 
influence the levels of biologically active cortisol during pregnancy. When cortisol is 
bound by CBG it is inactive, yet uncoupling of circulating cortisol from CBG provides a 
ready source for biologically active cortisol, if needed. Variations in CBG may be a 
factor in poor infant outcomes because lower levels of maternal prenatal CBG (i.e., 
greater biologically active cortisol) associate with fetal growth restriction (Ho et al., 
2007).  
In animal models during pregnancy, stress exposure, glucocorticoid exposure, and 
the blocking of placental enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) 
cause lower birthweight, greater blood pressure, and greater glucose levels (Seckl & 
Holmes, 2007). Further, the placental enzyme 11β-hydroxysteroid dehydrogenase type 2 
(11β-HSD2) changes cortisol to its inactive form. Of importance to the fetus, maternal 
stress is known to also down-regulate placental 11β-HSD2, allowing for a greater 
proportion of maternal cortisol to cross the placenta and influence fetal development in 
adverse ways (Mairesse et al., 2007). This may alter fetal programming of developing 
tissues and could account for adverse effects of prenatal stress on maternal-infant health. 
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Maternal Prenatal Stressors: Neuroendocrine Mechanisms 
Ample evidence derived from animal models of prenatal stress demonstrate that 
prenatal stress exposure affects behavioral and biological development through activation 
of the HPA axis, and in particular its end product, the adrenal glucocorticoid hormone 
(i.e., cortisol in humans and primates) (Coe et al., 2003; Maccari et al., 1996; Weinstock, 
2005). It is clear that in response to maternal stress the fetal hormonal environment is 
altered. Maternal stress is associated with an increase in cortisol and CRH in the 
maternal-infant dyad (Field, Diego, Dieter, Hernandez-Reif, Schanberg, Kuhn, Yando, & 
Bendell, 2004; Weinstock, 2008), increasing risk for adverse infant outcomes.  
The work of Field has shown that the fetuses of depressed women with increased 
prenatal cortisol exhibit growth retardation and these women deliver more preterm and 
low birth weight infants (Diego et al., 2009).  Elevated evening cortisol and flattened 
diurnal rhythm of cortisol in the later part of pregnancy has also been associated with 
more infant illness (Beijers et al., 2010). Moreover, fetal exposure to elevations in 
cortisol is posited to result in impaired neurodevelopment. Compelling findings 
demonstrate increased cortisol exposure results in a change in expression of a thousand 
genes in fetal cultured brain cells (Salaria et al., 2006). Also supportive of cortisol’s 
effect on fetal brain development are studies of infant neuro-behavioral outcomes that 
find elevated maternal prenatal cortisol to be associated with maternal reports of infant 
negative behaviors (Davis et al., 2007). This outcome was confirmed with investigator-
observed negative infant behaviors at five months of age (de Weerth, van Hees, & 
Buitelaar, 2003). Additionally, elevated cortisol levels in later pregnancy were shown to 
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result in greater motor activity in infants, with boys being more vulnerable than girls 
(DiPietro, Kivlighan, Costigan, & Laudenslager, 2009). Others also showed that in an 
evaluation of 17 mother-infant pairs, 4 of 15 behaviors of young infants during everyday 
routines were correlated with maternal saliva cortisol during pregnancy (de Weerth, van 
Hees, & Buitelaar, 2003). Moreover, higher levels of maternal cortisol in the third 
trimester were found to be associated with more infant crying, fussiness, and negative 
facial expressions (Pfeifer, 2002). Long-term associations of prenatal cortisol are also 
linked to emotional disorders in childhood (depression and anxiety) and attention 
deficits/hyperactivity and delayed language development (Talge, 2007).   
  Prenatal stress has been shown to result in greater neonatal cortisol levels and this 
may also contribute to poor outcomes. Field and colleagues reported that maternal 
prenatal depression is directly correlated to cortisol levels in the infant (Field, 2011; 
Field, Diego, & Hernandez-Reif, 2010). Moreover, the combined effects of prenatal 
depression and anxiety resulted in greater levels of neonatal cortisol (as well as increased 
epinephrine and lower levels of dopamine and serotonin) compared to neonates of 
mothers with prenatal anxiety alone or to control women (Field, Diego, Hernandez-Reif, 
Figueiredo, Deeds, Ascencio, Schanberg, & Kuhn, 2010). Mothers with prenatal 
depression that exhibit higher cortisol, lower dopamine, and lower serotonin levels also 
showed alterations in biochemical markers in their neonates (Field et al., 2004; Field, 
Diego, Dieter, Hernandez-Reif, Schanberg, Kuhn, Yando, & Bendell, 2004). Further, in a 
path analysis, prenatal cortisol mediated the relationship between antenatal depression 
and neonatal outcomes including prematurity; while prenatal norepinephrine mediated 
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the relationship between antenatal depression and infant low birth-weight (Field et al., 
2004; Field, Diego, Dieter, Hernandez-Reif, Schanberg, Kuhn, Yando, & Bendell, 2004). 
Additionally, in a later study, antenatal depression was associated with increased 
incidence of premature delivery and LBW (OR 2.6, 4.75, respectively) (Diego et al., 
2009). Further, maternal CESD scores during pregnancy mediated the relationship among 
maternal antenatal second trimester cortisol levels, gestational age, and fetal growth rate, 
predicting 30% and 14% of the variance, respectively (Diego et al., 2009). 
 Yet the relationship of maternal stress-induced elevations in cortisol to fetal 
elevations in cortisol is complex and many unresolved issues remain. For example, as 
noted earlier, maternal cortisol responses to stress decline over the course of gestation, 
and earlier in pregnancy, the association between maternal and fetal cortisol is less 
robust. In contrast to studies linking maternal prenatal stress and cortisol to infant 
outcomes, others find no such relationships. For example, a study of women awaiting 
amniocentesis found no relationship between cortisol and trait anxiety and only a modest 
relationship was observed with state anxiety, in spite of these women reporting high 
anxiety levels (Bergman, Sarkar, Glover, & O'Connor, 2010). This same group also 
found no association between state anxiety and amniotic fluid cortisol (measured at one 
time point) and fear reactivity in infants at 17 months of age. Yet this study is limited by 
sampling women only at one point in time during pregnancy, examining them during an 
acute situational stress, and determining cortisol in amniotic fluid. Of note, the linkage of 
amniotic fluid cortisol to circulating (maternal and fetal) cortisol is not clear. 
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Nevertheless, these authors suggest that an HPA-mediated link between maternal and 
fetal cortisol is weaker or more complex than has been assumed.  
This complexity is confirmed by other human studies, which do not support a 
simple relationship among prenatal maternal stress, cortisol, and child outcomes. For 
example, Davis et al. (Davis et al., 2007) found that maternal prenatal salivary cortisol 
predicted maternal reported infant temperament independently of prenatal stress. Also, a 
more recent evaluation of 81 women with normal pregnancies showed that prenatal 
general distress did not impact maternal cortisol levels after awakening (area under the 
curve) nor did maternal prenatal perceived stress correlate with infant size at birth. 
However, that study did find that newborns of mothers with higher prenatal salivary 
cortisol levels upon awakening (cortisol awakening response) had lower birth weights 
and were shorter at birth. In that study, maternal prenatal cortisol levels explained 19.8% 
of the variance in newborn birth weight and 9% of the variance in their body length, even 
after controlling for gestational age, parity, pre-pregnancy BMI, smoking, and infant sex. 
The authors concluded that maternal cortisol levels in pregnancy influence intrauterine 
growth and may be a better predictor for birth outcome than prenatal perceived stress 
(Bolten et al., 2011).  
 It is also possible that chronic stress might be more important than acute 
situational stress in elevating maternal/fetal cortisol and in producing untoward birth 
outcomes. It is known that chronic stress disturbs diurnal cortisol rhythms; yet few 
studies have evaluated diurnal cortisol in women with prenatal stress, depression, or 
anxiety. One study did find that women who had experienced a major life event or who 
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had high levels of pregnancy-specific anxiety exhibited higher evening cortisol, late in 
pregnancy (Obel et al., 2005). Another study also evaluated women during late 
pregnancy and found that those with high-trait anxiety had a flattened afternoon decline 
in cortisol, consistent with elevated afternoon levels (Kivlighan, DiPietro, Costigan, & 
Laudenslager, 2008). Others also evaluated maternal trait anxiety and found that maternal 
trait anxiety was associated with all stress-related psychological measures and that high-
trait anxiety predicted low baseline cortisol awakening levels in early pregnancy. Thus, 
these results suggest that in addition to more thoroughly evaluating the HPA axis across 
the day, maternal prenatal trait psychological constructs also need to be considered 
together with state specific measures of stress, mood, and anxiety (Entringer, Kumsta, 
Hellhammer, Wadhwa, & Wust, 2009; Pluess, 2010). 
In humans, however, elevations in maternal glucocorticoids are largely prevented 
from reaching the fetus through inactivation by placental 11β-HSD or by binding to 
CBG. Thus, some are skeptical as to whether maternal glucocorticoids mediate the effects 
of stress on the fetus. Yet there is evidence that prolonged or chronic maternal stress 
impairs feedback regulation of the HPA axis, resulting in elevations in cortisol. It is thus 
hypothesized that chronic stress-induced elevations in cortisol then increase the release of 
CRH from the placenta (via positive feedback). CRF can pass through the placenta and 
normally CRH initiates labor by stimulating the release of prostaglandins and oxytocin 
from the placenta (Florio et al., 2002). Studies show that increased plasma CRH predicts 
risk for preterm birth and low birth weight. Moreover, CRF has been implicated in 
preterm labor, reduced birth weight, and slow growth rate in prenatally stressed infants 
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(Inder et al., 2001; Ruiz, Fullerton, Brown, & Dudley, 2002; Wadhwa, Dunkel-Schetter, 
Chicz-DeMet, Porto, Sandman, 1996). For example, the incidence of preterm births was 
found to increase with a doubling of plasma levels of CRH (Weinstock, 2005). Greater 
levels of maternal CRH can stimulate the fetal adrenal and excess fetal cortisol is 
believed to disturb brain development and predispose to cognitive and behavioral 
disorders (Weinstock, 2005). These findings emphasize that chronic or enduring stress 
during pregnancy is more important than acute episodic stress (O’Connor et al., 2002; 
Stott, 1973; Wadhwa, Sandman, Garite, 2001).  
Maternal Prenatal Stressors: Cytokine Balance 
Adaptive changes in maternal immunity are vital for the support of pregnancy and 
the sustenance of the fetus (Elenkov & Chrousos, 1999). Mor (Mor & Cardenas, 2010) 
identifies a review of immune function during pregnancy, suggesting immune function is 
not suppressed but rather modulated across pregnancy. Further, the pregnancy is 
identified immunologically as three distinct phases to shift and accommodate the needs of 
the developing fetus. While the first phase or early pregnancy is a proinflammatory state 
to allow for successful implantation, mid-pregnancy is an anti-inflammatory state to 
allow for rapid fetal growth, and late-pregnancy returns to a proinflammatory state to 
allow for parturition and delivery of the fetus (Mor & Cardenas, 2010). Alterations in 
maternal cell mediated immunity permit the growing fetus to be immunologically 
privileged. Maintenance of a healthy pregnancy requires this shift in maternal cytokine 
balance toward an anti-inflammatory state (Mor & Cardenas, 2010; Reinhard, 1998). This 
assertion is supported by observational studies that conclude that women with more 
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successful pregnancies exhibit higher circulating levels of the anti-inflammatory cytokine 
IL-10, while women who experience miscarriages have lower levels of IL-10 (Jenkins, 
2000; Lim, 1999). Near term in normal pregnancies, a shift to an inflammatory state 
heralds the onset of labor and delivery of the infant. An increase in proinflammatory 
cytokines ripens the cervix prior to delivery. Atypical elevations in IL-6, IL-8, and TNF 
alpha, such as due to infection, are linked to premature birth (Gomez et al., 1995; Zhang, 
2000).  
 It is well-established that psychological stress results in an elevation of 
proinflammatory cytokines (Witek-Janusek, & Mathews, 2012). Less is known about 
whether stress-induced overproduction or untimely production of maternal 
proinflammatory cytokines serves as a possible mechanism whereby maternal stress 
results in adverse infant outcomes. The work of Ruiz and Coussons-Read, however, 
demonstrated that women experiencing high levels of stress during pregnancy have 
increased circulating levels of proinflammatory cytokines late in pregnancy compared to 
women not experiencing high levels of prenatal stress; (Coussons-Read et al., 2005). 
Specifically, maternal prenatal stress was associated with higher levels of the 
proinflammatory cytokines IL-6 and TNF-alpha and with low levels of the anti-
inflammatory cytokine IL-10 (Coussons-Read et al., 2005). More recently, Coussons-
Read evaluated associations between maternal psychological stress and cytokines during 
early, mid, and late pregnancy (Coussons-Read et al., 2007). That study showed that 
during both early and late pregnancy, higher levels of maternal stress was related to 
elevations in circulating IL-6, while C-reactive protein (CRP) levels were associated with 
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stress during late pregnancy. Also, elevated prenatal stress was related to lower IL-10 
serum levels during early pregnancy. In contrast, no associations were observed with 
stress and circulating cytokines during the second trimester. The authors conjecture that 
the lack of associations of stress and cytokines during the second trimester is because this 
phase of pregnancy reflects a more quiescent time, as the early physical disturbances (i.e., 
morning sickness, sleep disturbance) that accompany pregnancy have dissipated. In 
contrast, the third trimester is characterized by stress and anxiety linked to the impending 
birth. Furthermore, that study also found that elevated levels of maternal stress across 
pregnancy predicted greater production of IL-1 beta and IL-6 by ex vivo LPS-stimulated 
lymphocytes derived from maternal blood during the third trimester. Thus, these findings 
provide evidence that elevations in maternal stress during pregnancy can indeed shift 
cytokine production to a more inflammatory (Th1) state and are consistent with potential 
mechanisms whereby stress can negatively impact birth outcomes.  
Findings from a recent study showed that depressive symptoms were associated 
with inflammatory biomarkers in pregnant African American women evaluated during 
the second trimester of pregnancy. That study demonstrated that more depressive 
symptoms (measured by the CES-D) were associated with greater levels of IL-1beta. 
Depressive symptoms were also related to IL-6 and IL-10 but these associations were 
mediated by body mass index (BMI). For leaner women, depressive symptoms were 
associated with higher IL-6 and IL-10 levels. In contrast, for heavier women depressive 
symptoms were associated with lower levels of IL-10 (Cassidy-Bushrow, Peters, 
Johnson, & Templin, 2012). This study did not evaluate whether depression-associated 
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dysregulation of inflammatory biomarkers affected pregnancy outcomes. It is possible 
that the disparity in birth outcomes (i.e., lower birth weight, increased preterm delivery, 
and neonatal neurodevelopmental impairment) observed in African American women 
may be related to greater depressive symptoms accompanied by excess inflammation. 
 It is also possible that maternal psychological factors can affect immune 
development in the infant. There is some evidence that maternal negative mood, such as 
depression, might alter cytokine balance in the infant (Mattes et al., 2009). Findings show 
that mild to moderate maternal depression is associated with increased neonatal levels of 
IL-6 and IL-10, along with increased levels of stimulated cytokine response to bacterial 
antigens and allergens (Mattes et al., 2009). These results provide suggestive evidence 
that maternal depression mediates neonatal immune responses, even when depression 
levels are low to moderate. It is clear that studies investigating maternal stress should 
include assessments of mood or other emotional states, and that outcome indicators 
should include maternal as well as infant evaluations.   
Effect of Maternal Prenatal Stressors on Adult/Offspring HPA-Immune Activation  
Maternal prenatal stress not only results in neonatal adverse effects but also can 
alter adult stress reactivity. For example, healthy young adults whose mothers 
experienced severe prenatal stressful events (e.g., death of someone close) were found to 
exhibit lower cortisol levels prior to being subjected to the Trier Social Stress Test 
(TSST) and greater increases in cortisol in response to the TSST compared to individuals 
whose mothers did not experience stressful events during pregnancy. Also the offspring 
of mothers who experienced more prenatal stressful events produced less cortisol in 
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response to ACTH but had normal basal diurnal cortisol levels. The results of this study 
demonstrate that prenatal psychosocial stress exposure in humans predisposes to long-
term alterations in the regulation of the HPA axis of adult offspring (Entringer et al., 
2009).  
Maternal prenatal stress was also shown to influence the immune response of their 
offspring during adulthood. Ex vivo stimulation of peripheral blood mononuclear cells 
(derived from adult women whose mothers experienced major life stressors during their 
pregnancy) exhibited a greater IL-2 production relative to interferon gamma as well as 
increased IL-6 and IL-10 compared to women whose mothers did not experience prenatal 
stressful events. These findings demonstrate that maternal prenatal stress exposure results 
in long-lasting effects on immune function of their adult children (Entringer et al., 2008).  
Methodological and Design Considerations: Stress Biomarkers 
There are many methodological issues to be considered when evaluating whether 
either cortisol or proinflammatory cytokines mediate the effects of prenatal stress on 
infant outcomes. For example, many previous studies relied on single assessments during 
pregnancy. Clearly, there is a need for longitudinal assessment of stress that takes into 
account the normal changes in the prenatal HPA axis and cytokine balance, as well as 
changes in maternal psychological state that fluctuate with stage of pregnancy. With 
respect to cortisol, evidence shows a strong relationship between maternal and fetal 
cortisol levels; yet the maternal HPA axis fluctuates and changes as a result of maternal 
response to stress over the course of pregnancy (Talge, 2007). With advancing 
pregnancy, maternal cortisol steadily increases; while at term gestation, cortisol levels are 
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increased from the fetus, placenta, and uterus (Benfield, Newton, Tanner, & Heitkemper, 
2014). Further, there is a reduction in the ACTH responsiveness to CRH at late-
pregnancy (Benfield et al., 2014). Consequently, closer to term there is a reduced 
maternal capacity to respond to psychosocial stressors or emotional states. It is unknown 
when the maternal HPA loses responsiveness and how much inter-individual variation 
there is in HPA responsiveness over pregnancy (O'Donnell, 2009). As noted above, 
investigators should evaluate diurnal cortisol rhythm to determine its association with 
indicators of maternal psychosocial stress, anxiety, and/or depression. Also, the placenta 
“buffers” the fetus from the full effects of maternal cortisol. The placental enzyme, 11β-
HSD2, converts much of the maternal cortisol to an inactive metabolite (i.e., cortisone), 
with only about 10-20% of maternal cortisol crossing over to affect to the fetus (Challis 
et al., 2001). However, animal models show differential effect of acute versus chronic 
stress, with chronic stress down-regulating (11β-HSD2) and thus favoring transfer of 
maternal cortisol to the fetus (Mairesse et al., 2007; Welberg, Thrivikraman, & Plotsky, 
2005). Moreover, other evidence suggests that the activity of placental 11β-HSD2 is 
dependent upon the genetic vulnerability of the mother adding to inter-individual 
variation (O'Donnell, 2009).  
The biological matrix in which cortisol is measured is critical. Currently cortisol 
can be measured in blood, saliva, urine, amniotic fluid, feces, and, more recently, hair 
samples. Each of these forms of cortisol assessment has measurement issues. In 
particular, the procurement of amniotic fluid produces anxiety and may reflect episodic 
stress and not the specific stress associated with pregnancy or overall life events stress. 
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Furthermore, the sample source requires different interpretations regarding the timing of 
the stressor. For example, blood and saliva reflect acute cortisol responses, while cortisol 
measurement from hair samples reflect cumulative HPA activity over the past few 
months (D'Anna-Hernandez, Ross, Natvig, & Laudenslager, 2011). Regarding cytokines, 
studies have relied on plasma or serum levels as well as stimulated production of 
cytokines. Each of these must be interpreted differently as stimulated cytokines reflect 
the immune cell’s capacity to respond to an artificial (i.e., laboratory) stimulus; whereas 
circulating cytokines reflect what is available to target cells in vivo (albeit, at the time of 
blood collection).  
Given the complex changes in maternal HPA function and maternal-fetal cytokine 
balance across gestation, the timing of stress and biomarker assessment and 
corresponding neurobehavioral or physiological outcomes is critical. This is important as 
different physiological systems develop at specific times and thus there are critical 
windows of vulnerability to prenatal stress. For example, exposure to prenatal elevated 
cortisol levels early in gestation was found to be associated with delayed cognitive 
development over the first year (Davis & Sandman, 2010); whereas, exposure to elevated 
cortisol levels during late gestation contributed to prematurity (Field, Diego & 
Hernandez-Reif, 2009; Field, Diego, Dieter, Hernandez-Reif, Schanberg, Kuhn, Yando, 
& Bendell, 2004). Not only is timing of prenatal stress exposure important to consider, it 
is also crucial to consider whether the stress exposure was acute or chronic. Chronic 
stress exposure results in allostatic load or overload and dysregulates HPA function 
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(McEwen, 2004). In summary, there are many conceptual and methodological issues to 
consider when evaluating maternal prenatal stress biomarkers. 
Other Biological Indicators 
 Field has proposed that activation of the sympathetic nervous system subsequent 
to maternal perception of stress during pregnancy might also contribute to poor infant 
outcomes. Although norepinephrine does not cross the placenta, it can increase uterine 
artery resistance and decrease placental blood flow; this, in turn, will reduce delivery of 
oxygen and nutrients to the developing fetus (Field, 2011). Supporting a role for such a 
possibility is a report which demonstrated that prenatal depression was associated with 
elevations in both prenatal cortisol and norepinephrine levels, and that furthermore, 
elevations in norepinephrine were positively associated with low birth weight infants 
(Field, Diego, Dieter, Hernandez-Reif, Schanberg, Kuhn, Yando, & Bendell, 2004).  
 Fetal heart rate variability (HRV) is an index of sympathetic/parasympathetic 
balance and is also a well-established marker of fetal well-being. HRV indicates vagal 
tone and serves as a marker of an organism’s vulnerability to stress (McEwen, 2003, 
Porges, 1992 #1524). Studies show that more vulnerable infants, such as those with 
intrauterine growth retardation, as compared to a normal growing healthy fetus, have less 
HRV and have more difficulty adapting to the extra-uterine environment (Kikuchi et al., 
2006). Maternal psychological factors also influence fetal HRV. In particular, compared 
to pregnant women with low stress levels, the fetus of pregnant women with high stress 
levels were shown to exhibit lower HRV. Moreover, the fetus of depressed pregnant 
women showed higher baseline and delayed heart rate responses to stimulus (Kinsella & 
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Monk, 2009). Older infants (14 months of age) from prenatal depressed mothers were 
also shown to exhibit a higher mean heart rate and a lower high frequency component of 
heart rate variability, indicating lower vagal tone (Dierckx et al., 2009). Others have also 
shown that infants of mothers with prenatal depression have lower vagal tone, which is 
associated with reduced attentiveness. These infants exhibit increased right frontal EEG 
activation, which has been linked to withdrawal behavior; interestingly this was also 
observed in the depressed mothers, suggesting that the infant mirrored the mother’s 
neurological status (Field, 2011). 
Methodological and Design Considerations: Psychosocial Factors 
According to the DOHaD or fetal programming model, early exposures to 
prenatal stress can have long-term consequences that result in harmful outcomes for 
health across the lifespan. Yet there remain many methodological issues that need to be 
considered in order to improve the design and advance research in this area. The 
following addresses issues that pertain to the measurement of maternal psychosocial 
constructs. 
Measurement of Prenatal Psychosocial Stressors 
The investigation of stressors during pregnancy is hampered by similar concepts 
along with measurement issues that are common to stress research in general. A 
pervasive limitation is the lack of uniformity in the approaches used to measure prenatal 
stress. Table 1 illustrates a summary of measurement approaches used in previous 
investigations. A large number of studies evaluating stress during pregnancy utilized 
instruments that measure perceived stress (such as Cohen’s Perceived Stressor Scale—
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PSS). These instruments quantify general stress perception by asking respondents how 
controllable or manageable they perceive events in their life to be. In contrast, other 
studies evaluate emotions that occur in response to stress, especially maternal prenatal 
anxiety and depression. Several studies have evaluated stressful life events (i.e., 
stressors) that have occurred either during pregnancy or within a designated time 
preceding the pregnancy. This approach often relies on a checklist of life events and 
respondents are asked to recall whether these events occurred and also the meaning of 
such events. A few studies took advantage of natural disasters as exemplars of a stressful 
or traumatic life event. Those studies are strengthened by a clear delineation of the timing 
of occurrence and duration of the event or stressor with respect to gestation. Pre-
conceptual stressors have also been examined to determine their relationship to birth 
outcomes. Examples include measurement of socioeconomic status and racial 
discrimination in studies evaluating disparity in birth outcomes (Kramer, Hogue, Dunlop, 
& Menon, 2011). Few studies have used qualitative approaches or interview methods. 
These approaches have the advantage of providing a richer understanding of the nature 
and meaning of stress within the context of the pregnancy. 
The variety of approaches used to measure stress attest to differences in how the 
term “stress” was conceptualized by the investigators. For some studies, stress was 
conceptualized as a stimulus or event (i.e., stressor). On the other hand, others measure 
the perception of that event (i.e., perceived stress) or the response to that event 
(emotional and/or biological). Unfortunately, the lack of conceptual clarity and 
uniformity among studies adds to the difficulty in interpreting the results, as well as 
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comparing results across studies. Yet, few studies have acknowledged the complexity 
associated with measuring stress. Lazarus and Folkman’s theory of stress and coping 
(Lazarus & Folkman, 1984) emphasizes the role of cognitive appraisal in shaping the 
psychological and physiological response to negative events or stressors. According to 
this theory, stress occurs only when an event (i.e., a stressor) is perceived as a threat that 
outstrips an individual’s adaptive capacity or resources to cope or deal with that stressor 
(Lazarus & Folkman, 1984). When perception of a stressor occurs it triggers an 
emotional response (i.e., anxiety and depression) and also activates the brain, leading to 
sympathetic nervous system arousal, neuroendocrine activation, and immune system 
dysregulation. Thus, dependent upon the conceptualization of stress, an investigator may 
choose to measure the event (i.e., stressor), an individual’s perception of the stressor, 
and/or an individual’s response to the stressor (i.e., emotional and/or physiological). This 
needs to be considered within the context of the research question and the outcomes of 
interest. 
Pregnancy-Specific Stressors 
The vast majority of studies investigating prenatal stress have assessed general 
life stress, as opposed to pregnancy-specific stress. Failure to measure pregnancy-
specific stress can underestimate the source and intensity of stress in pregnant women, as 
general stress-measurement tools do not include items that reflect the unique experience 
of pregnancy. This is important because pregnancy-specific stress was shown to be 
associated with worse poor birth outcomes than was general stress (DiPietro, Ghera, 
Costigan, & Hawkins, 2004). This emphasizes the importance of measuring the unique 
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fears and concerns that pregnant women face. Examples of items designed to capture 
pregnancy-specific stress include: “I am fearful regarding the health of my baby; I am 
concerned or worried about losing my baby; I am concerned or worried about developing 
medical problems during my pregnancy” (Sandman et al., 2011a, 2011b). 
Positive Emotions during Pregnancy  
Pregnancy represents a time of tremendous physiologic and psychological 
adaptation that occurs in response to the demands of the growing fetus and the 
anticipation of the infant’s birth. Yet, for many women pregnancy is a time of fulfillment 
and is associated with positive emotions, even in women with low income and few 
resources (Hawkins, DiPietro, & Costigan, 1999). The assessment of positive emotions 
during pregnancy has received little attention. Positive emotions are now recognized as 
distinct constructs and not a polar opposite of negative emotions. In women with high-
risk pregnancies, positive emotions were shown to buffer both the emotional distress and 
adverse birth outcomes associated with these conditions (Lobel, DeVincent, Kaminer, & 
Meyer, 2000). Moreover, others have identified the ratio of pregnancy-associated “daily 
hassles” to “uplifts” to be the most important measure of pregnancy-related stress 
(DiPietro, Ghera, Costigan, Hawkins, 2004). Measurement of both positive and negative 
responses to the experience of pregnancy will provide a more balanced evaluation of 
stress during pregnancy. 
Timing of Stress Exposure  
The vast majority of studies have assessed prenatal stress at one time point during 
gestation. Yet, it is clear that the time of stress exposure is important from both the 
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maternal as well as the fetal perspective. That is, as pregnancy progresses there are 
dramatic psychological and physiological adaptive responses that can either increase or 
attenuate the perception and response to a stressor. Moreover, the maturation of fetal 
systems follows an orderly developmental pattern with certain organs and tissues 
exhibiting precise windows of vulnerability to environmental stimuli. Thus, the 
detrimental outcomes of stress exposure are highly dependent upon the timing of 
exposure with respect to the period of gestation. Duration of the stressor is also critical, 
as acute stress exposure may have quite a different effect on birth outcomes than a more 
enduring or chronic stressor. Studies, which incorporate repeated measures of evaluating 
the stress response across time, will yield more valid and complete assessments of 
stressors impacting pregnancy. Also, the timing of stress measurement should be 
logically linked to the developmental time-frame of the system, organ, or tissue of 
interest. Finally, the influence of past life events or childhood trauma could have an 
additive negative insult on the individual. 
Postnatal Environment  
It is clear that infant/child health outcomes are influenced by interactions between 
mother and child during the postnatal period. Mothers who experience prenatal stressors 
are also more likely to have postpartum depression or other mood disorders and, thus, 
will have poor interactions with their infants and poor parenting styles with their children. 
As a result, these infants and children are subjected to double jeopardy (i.e., pre- and 
postnatal stressor exposure) and are most vulnerable. Yet for most studies, the influence 
of the postnatal environment, especially mother-infant interactions, are not considered or 
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controlled for. However, some propose a contrasting view. That is, fetuses that 
experience a harsh prenatal environment, such as that resulting from maternal stress 
response signals, may undergo adaptive changes that better equip them to respond to a 
hostile postnatal environment (i.e., poor maternal care). Thus, these infants may, in fact, 
be more resilient throughout life. Understanding resilience and vulnerability factors is an 
intriguing area of future research in the field of understanding prenatal stressors and 
impact on mother-infant health.  
Confounding and Moderating Variables  
 There are a variety of potential confounders that need to be considered when 
designing a study to determine the effects of prenatal stressors on birth/infant outcomes 
(Grote et al., 2010; Littleton, Bye, Buck, & Amacker, 2010). Important maternal factors 
include the following:  
• maternal age,  
• race,  
• education,  
• marital status,  
• employment,  
• SES,  
• parity (primparous or multiparous),  
• drug use (prescription, over-the-counter, illicit drug use),  
• smoking,  
• alcohol and caffeine intake,  
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• obstetric complications,  
• co-morbidities (prior depression, and psychological disorders),  
• early life stressors 
• prenatal care compliance, and  
• general health behavior (diet, exercise, weight gain in pregnancy).  
 Fetal or infant factors to consider in designing research to address birth outcomes 
include:  
• sex  
• gestational age,  
• birth weight,  
• intrauterine growth record,  
• birth anomalies,  
• genetic-based disease,  
• severity of illness,  
• length of time in the neonatal intensive care (NICU), and  
• complications related to an NICU stay.  
 As well, there are many potential moderators, which may positively or negatively 
influence the relationship between maternal perception of and mother-infant health 
outcomes. Examples of important moderating variables include: life events, marital 
satisfaction, social support, prior pregnancy experiences, domestic violence, and prenatal 
care access or compliance with prenatal care recommendations (Grote et al., 2010; 
Littleton, Bye, Buck, & Amacker, 2010).  
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In review, experience of prenatal stressors is an important modifiable risk 
factor. In order to develop and test interventions to reduce prenatal stressors, there is a 
need to conduct more rigorous observational studies to understand the impact of 
prenatal stressors on birth outcomes and the psycho-biological mechanism(s) that 
mediate these adverse effects. As noted by Beydoun and Saftlas (2008), an ideal 
observational study should have a prospective design, enrollment across pregnancy, 
with clear assessments of prenatal stress exposure, along with multiple maternal stress 
assessments, assessment of prenatal and postnatal confounds, and assessments of stress 
response biomarkers such as CRH, pCRH and cortisol.  
Implications and Future Direction 
Research examining the impact of maternal prenatal stressors has received 
considerable attention over many years. Yet despite the wealth of research in this area, 
additional studies are needed to further advance the state of the science. Examples of 
future directions for research in this area include the following: 
• Studies that link the timing of exposure to stressors during pregnancy with specific 
maternal-infant outcomes. 
• Longitudinal multivariate evaluations of maternal stressors. 
• Consideration of gene-environment interactions (single nucleotide polymorphisms for 
biomarkers, epigenetic markers). 
• Expanded incorporation of biomarkers (sympathetic biomarkers, immune biomarkers, 
epigenetic biomarkers). 
• Studies that use mixed methods (i.e., quantitative and qualitative approaches). 
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• Studies that address what types of stressors are most detrimental. 
• Consideration of resilience versus vulnerability factors (i.e., role of marital status, 
social support, etc.). 
• Racial disparity/ health disparity and prenatal stressors. 
• Consideration of infant gender (i.e., male infants are more vulnerable). 
• Assessment of antecedent variables (i.e., prior life adversity, recent loss/trauma, prior 
depression or illness). 
Prenatal Distress, Epigenetics, and Early Life Programming  
 
 The etiology of unfavorable birth outcomes remains unknown and the evidence, 
as reviewed here, suggests a role for maternal distress and negative mood (e.g., 
depression). The vast majority of the investigations evaluated prenatal situational 
stressors and anxiety and show that these factors contribute to birth complications, poor 
infant health, and increase the risk for long-term adverse health outcomes across the life 
span. These results are consistent with fetal programming of physiologic systems (e.g., 
neuroendocrine stress reactivity, immune function), which can contribute to maladaptive 
responses later in life and risk for adult onset disease. 
An area that has received little attention, however, is the relationship between 
maternal preconceptional psychosocial stressors and/or maternal early life adversity 
with birth outcomes. It is possible that maternal preconceptional stressors or adversity, 
perhaps during early life, might epigenetically program the neuroendocrine and/or 
immune systems of a woman. As a result, during pregnancy she is potentially incapable 
of providing a favorable maternal physiologic milieu conducive to optimum birth 
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outcomes. The capacity of prenatal mood to influence fetal outcomes through epigenetic 
modification is a new concept that is based on evidence obtained in animal models. 
Those models show that prenatal and early neonatal stress and/or maltreatment produce 
long-lasting epigenetic modifications of genes that regulate stress response systems, 
including the immune system (Mathews & Janusek, 2011). In humans, maternal 
prenatal depressed mood was reported to be associated with epigenetic modification of 
the glucocorticoid receptor (GR) in leukocytes obtained from umbilical cord blood. 
These cord blood leukocytes exhibited increased methylation of DNA at the binding site 
for transcription factors required to transcribe mRNA that codes for GR. Moreover, the 
increased DNA methylation was associated with an increase in infant salivary cortisol 
response. The authors suggest that infants of mothers with prenatal depression are at 
risk for developing disturbed central regulation of the HPA axis, possibly through an 
epigenetic process (Oberlander et al., 2008). This is one of few studies in humans that 
bridge epigenetic modification to GR expression, psychological state (i.e., prenatal 
depressive mood), and infant cortisol secretion. It is possible that depression 
dysregulates maternal hormones and results in epigenetic modifications in the neonate. 
Understanding the role of epigenetics in fetal/neonatal programming that occurs in 
response to environmental signals (i.e., from the maternal environment) is one of the 
most intriguing future directions of research in maternal-child health. 
Summary 
Prenatal psychosocial stressor leads to adverse effects on the newborn that 
predispose to future mental and physical health problems across the lifespan. To alleviate 
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these negative outcomes, it is crucial to understand the nature of the stressor that is most 
devastating, the factors that confer vulnerability versus resilience, and the mechanism(s) 
explaining how these effects occur. Such understanding can guide approaches for early 
identification of risk and for the development of interventions to reduce prenatal stressors 
and subsequently improve the health and well-being of mother, infant and family. The 
results of such research can offer healthcare providers (particularly nurses) evidence-
based practice approaches that ultimately reduce the human and economic costs of the 
experience of prenatal stressors on mother-infant health. Attaining this goal can exert 
tremendous benefit, as early life adversity sets up a trajectory for life-long health 
problems. 
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CHAPTER THREE 
DISCUSSION OF PROPOSED RESEARCH METHODOLOGY 
Life Adversity and the Psycho-Neuroendocrine-Immune Profile during Pregnancy 
Given the discussion in Chapters One and Two, the overarching objective of this 
project is to evaluate the influence of a woman’s life adversity prior to her pregnancy on 
her psychological, neuroendocrine, and proinflammatory profile during her pregnancy. In 
addition, the effect of maternal antenatal life adversity on infant outcomes is evaluated. 
The central hypothesis of this proposal is that adverse experiences prior to pregnancy 
prime stress response systems and lead to increased psychological distress, 
neuroendocrine activation, and dysregulated proinflammatory cytokine levels. Such 
alterations in maternal stress-response systems may contribute to poor infant outcomes.  
Specific Aims and Hypotheses 
Women were enrolled in this study during the second trimester of their pregnancy 
to evaluate the specific aims and hypotheses, as listed below: 
Aim 1. Examine the relationship between maternal childhood adversity and maternal 
psycho-neuroendocrine-inflammatory (Kopnisky) profile during pregnancy. 
Hypothesis 1. Maternal childhood adversity will be related to maternal 
psychosocial profile, higher levels of hair cortisol, and higher levels of plasma  
IL-6 and TNF alpha during pregnancy. 
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Hypothesis 2. Maternal psychosocial profile during pregnancy will be related to 
higher levels of maternal hair cortisol plasma IL-6 and TNF-alpha. 
Aim 2. Evaluate maternal risk and protective factors as moderators of maternal PNI 
profile during pregnancy. 
Hypothesis 3. Maternal risk (income) and protective (social support) factors will 
moderate the relationship between maternal childhood adversity and:  
a. maternal PNI profile during pregnancy; and 
b. neonatal outcomes. 
Aim 3. Explore the relationship among maternal childhood adversity, maternal PNI 
profile during pregnancy, and neonatal outcomes.  
Hypothesis 4. Worse neonatal outcomes (lower birthweight and earlier gestational 
age) will be related to: 
 a. greater maternal childhood adversity and altered PNI profile 
during pregnancy; and 
 b. higher maternal hair cortisol, IL-6 and TNF-alpha levels during 
pregnancy. 
Research Design and Methods 
For this study, pregnant women were enrolled and evaluated at three time points 
(2
nd
 trimester, 3
rd
 trimester and postpartum) to determine the effect of maternal childhood 
adversity on maternal psychological, neuroendocrine, and inflammatory outcomes. In 
addition, the effect of maternal prenatal stressors on neonatal outcomes was investigated. 
This study used a prospective correlational design to evaluate each hypothesis. Sample, 
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design, measures, and data analysis are described below.  
Sample  
Pregnant women (18-39 years of age) experiencing uncomplicated singleton 
pregnancy were recruited from outpatient obstetric health clinics during their first and/or 
second trimester of pregnancy. Participants were fluent in English, without history of 
medical or psychiatric disorders requiring hospitalization, major immune-based disease, 
drug or alcohol abuse, and not taking psychotropic or immune-altering medications.  
Recruitment  
Pregnant women were recruited from obstetric clinics of a large academic medical 
center located within the near west suburbs of the major metropolitan area of Chicago 
(i.e., Loyola University Medical Center and its affiliate, Gottlieb Hospital). Loyola 
University Medical Center reported 886 live births in 2010; race characteristics were 62% 
White, 24% Black, 1% Asian, and 12% unknown. Gottlieb Hospital is a community 
hospital with 742 live births in 2010; race characteristics were 80% White and 18% Black 
(of these, 20% were Hispanic/Latino and 20% non-Hispanic/Latino).  
Overview of Design  
Pregnant women were evaluated at three time points during pregnancy. Pregnancy 
has four trimesters: 1
st
 trimester is 1-12 weeks, 2
nd
 trimester is 13-26 weeks, 3
rd
 trimester 
is 27-42 weeks gestation, and 4
th
 trimester, postpartum 6 weeks after delivery.  
Recruitment identified participants early in gestation but data collection did not begin 
until their 2
nd
 trimester. Initial data collection, Time 1 (T1), took place during the second 
trimester (16-24 weeks gestation), while Time 2 (T2) occurred during the third trimester 
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(28-32 weeks gestation), and Time 3 occurred during the 4th trimester (after delivery in 
postpartum period).  See Table 1. tools and data collection time-points. 
Table 1. Tools and Data Collection Time-points. 
  
T1:  
16-24 
WEEKS 
GESTA
TION  
T2:  
28-32 
WEEKS 
GESTA
TION 
AFTER 
DELIVERY 
1-14 days 
BACKGROUND INFORMATION       
Demographic Information X     
Health History Survey X X   
PRIOR LIFE ADVERSITY       
Childhood Trauma Questionnaire X     
Household Dysfunction X     
MacArthur Subjective Social Status Scale 
(MSS) X     
MODERATING VARIABLES       
Social Provisions Scale (SPA) X X   
PSYCHOLOGICAL DATA       
Perceived Stress Scale (PSS) X X   
Pregnancy-Related Anxiety (PA) X X   
State Trait Anxiety (STAI) X X   
Edinburgh Depression Scale (EDS) X X   
Depressive Symptoms (CES-D) X X   
Mood Disturbance (POMS-65) X X   
Pregnancy Experience Scale (PES-Brief) X X   
Tilburg Pregnancy Distress Scale (TPDS) X X   
The Pittsburg Sleep Quality Index (PSQI) X X   
NEUROENDOCRINE DATA       
Hair cortisol (cutting hair) X X   
IMMUNE DATA        
IL-6 (blood draw) X X   
TNF Alpha (blood draw) X X  
NEONATAL OUTCOMES       
Birth Weight (grams)     X 
Gestational Age (weeks gestation)     X 
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Pregnant women will complete self-report instruments to evaluate prior life 
adversity, which includes the Childhood Trauma Questionnaire, Socio-Economic Status 
(Trettin, Moses-Kolko, & Wisner, 2006), and the MacArthur Subjective Social Status 
Scale. It is hypothesized that prior life adversity factors will result in greater 
psychological distress during pregnancy. The experience of psychological stressors 
across gestation including perceived stress, pregnancy-related anxiety, depressive 
symptoms, and mood disturbance was assessed through self-reported questionnaires. 
HPA activity during pregnancy was evaluated indirectly by measuring cortisol in hair 
samples. Hair cortisol provides a cumulative index of HPA activity over the preceding 
three months. Hair cortisol was measured at both second and third trimester (T1 and T2 
respectively). Proinflammatory immune activation was determined by measuring plasma 
IL-6 in blood samples during both the second (T1) and third trimesters (T2) of 
pregnancy. Neonatal outcomes were assessed to provide exploratory data to evaluate the 
association between prenatal distress and neonatal development. Birth data (birth weight 
and gestational age) was obtained from medical records.  
Study Variables 
Table 2 (see below) lists study variables. Each instrument is included in Appendix 
E. This list of study variables identifies the independent variables, dependent variables, 
moderating variables and covariates in this study.  
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Table 2. Study Variables 
 
Independent 
Variables 
Dependent Variables 
Moderating 
Variables 
Covariates 
Prior Life 
Adversity 
Psychological Neuro- 
Endo-
crine 
Immune Neonatal  
Outcomes 
  
CTQ Perceived 
Stress (PSS) 
Hair 
Cortisol 
IL-6 
TNF-
alpha 
Birth 
weight 
Social 
Support 
Social 
Provisions 
Scale (SPA) 
Prenatal 
Care 
Independent 
Variables 
Dependent Variables 
Moderating 
Variables 
Covariates 
Household 
Dysfunction 
Pregnancy- 
Related 
Anxiety (PA) 
 
Pregnancy 
Experience 
Scale (PES-
Brief) 
Tilburg 
Pregnancy 
Distress Scale 
(TPDS)  
   
Gestational age Income 
 
Prenatal 
Compli-
cations 
SES 
 
Anxiety 
(STAI) 
    Health 
Behaviors 
MacArthur 
Scale  
 
Depression 
(EDS) 
    Medication
s 
 Depression 
(CES-D) 
    Demograph
ics 
 Mood 
Disturbance 
(POMS-65) 
     
 Sleep 
Disturbance 
(PSQI) 
     
 
CTQ=Childhood Trauma Questionnaire; SES=Socioeconomic status; EDS=Edinburgh 
Depression Scale; CES-D=Center for Epidemiologic Studies–Depression; STAI=State and Trait 
Anxiety Inventory; PSQI=Pittsburg Sleep Quality Index 
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Childhood Adversity  
Early life adversity is conceptualized as exposure to adverse experiences prior to 
18 years of age, which may originate from the family and/or community. Prior life 
adversity was measured using the Child Trauma Questionnaire (CTQ). Place of residence 
is strongly shaped by social position and ethnicity and consequently community 
characteristics are important contributors to inequities in health. Strong evidence 
demonstrates that social stressors, like violence, are a clear source of community 
adversity (Ranjit et al., 2009). Thus, community violence was assessed. Each of the 
instruments was administered once and is described below.  
Child Trauma Questionnaire (CTQ)  
The CTQ (Version 3) is a shortened version of the original CTQ, which has 
improved the reliability among all scales. CTQ is a screening tool that evaluates 
childhood trauma in five domains: emotional, physical, and sexual abuse, along with 
emotional and physical neglect. It also includes one scale, made up of three items that 
evaluate minimization or denial to help identify the under-reporting of traumatic events.  
In total, it has 28-items and uses a 5-point scale (never true-very often true) to assess 
frequency of each item. It takes 5-10 minutes to complete and for this study, the time-
frame requested is in their first eighteen years of life. CTQ has good internal consistency 
(range among the five scales, α= 0.69-0.91) and good test-retest reliability. It also has 
good convergent and discriminate validity when compared with interview-based tools 
(Bernstein, & Fink, 1997; Bernstein et al., 1994). 
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Household Dysfunction  
This was measured using the scale adapted from the Adverse Child Experience 
(ACE) study (Felitti et al., 1998), which assesses exposure to substance abuse, mental 
illness, violent treatment of mother or stepmother, parental separation or divorce, and 
criminal behavior in the household. Previous research demonstrated a strong graded 
relationship between exposures to household dysfunction during childhood and multiple 
risk factors for several leading causes of death in adults (Dube et al., 2009; Felitti et al., 
1998). This tool is not a validated tool. 
Socio-Economic Status 
SES was evaluated for both childhood and current status (Trettin et al., 2006). 
Childhood SES was assessed by parental occupation, education, childhood place of 
residence matched with census data, and whether the participant’s parents were 
homeowners. Home ownership correlates with, but is distinct from, traditional measures 
such as income, and can be more reliably assessed than such measures when assessed 
retrospectively (Adler, Boyce, Chesney, Folkman, & Smye, 1993). Home ownership has 
been identified as an independent predictor of improved quality of children’s physical 
and emotional environment, decreased distress, and increased stability (Haurin, 2002). It 
has been linked to later health, immune function, and inflammation (Chen, 2010; 
Monroe, 1995; Miller, 2007). Additional SES variables include maternal age, marital 
status, race, years of education (maternal), and annual household income (ordinal ranking 
of 1= <10,000 to 10=>90,000).  
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MacArthur Subjective Social Status Scale (MSS) 
This scale uses a ladder metric to determine a person’s sense of their place in the 
social ladder. Respondents view a “social ladder” with 10 rungs, representing where 
people “stand” in society. The top rung represents those who are best off (most money, 
most education, best jobs) while the bottom rung represents those who are worst off (least 
money, least education, worst jobs). Respondents select the rung that best represents their 
social status (Adler, Epel, Casellazzo, & Ickovics, 2000). 
Psychological Stress Measures 
Psychological distress measures will use tools to evaluate perceived stress 
(Perceived Stress Scale), anxiety symptoms (State and Trait Anxiety Index), depressive 
symptoms (CES-D and EDS), and mood disturbance (Profile of Mood State). Pregnancy 
specific distress measures were evaluated to determine concurrent validity with more 
generalized measures of distress including pregnancy-specific anxiety (Pregnancy-
Related Anxiety and Pregnancy Experience Scale-Brief), and pregnancy-specific distress 
(Tilburg Pregnancy Distress Scale). 
Perceived Stress Scale (PSS)  
Not all stressful events are perceived as stressful. Thus, for the purposes of this 
study maternal stress perception was measured at T1 and at T2 using the PSS. PSS 
measures global or overall stress, as opposed to a specific event in the environment, 
which evokes a stress response. PSS has 10 items, which measure the degree to which 
experiences are appraised as uncontrollable (S. Cohen & Williamson, 1988). Responses 
are made using a 5-point Likert scale (0=never, to 4= very often). Scores range from 0-40 
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with higher scores representing greater stress perception; the time-frame for responses on 
the PSS represent feelings over the last week. The PSS is a widely used measure of 
perceived stress (Cohen, 1983, & Mermelstein, 1983; Cohen, 1988 #1275). Cronbach 
alpha reliability for the total scale ranges from 0.75 to 0.86 (S. Cohen & Williamson, 
1988). This scale takes approximately three minutes to complete. 
Pregnancy-Related Anxiety (PA)  
This is a 10-item questionnaire using a 4-point Likert scale (1= never or almost 
never, to 4= a lot of the time or very much) to evaluate pregnancy-specific anxiety. The 
respondent is asked about her feelings regarding health (both self and baby) and about 
labor and delivery. Scores range from 10-40. Greater scores suggest greater pregnancy-
related anxiety symptoms. This tool has good reliability (α=0.78) (Glynn, Schetter, 
Hobel, & Sandman, 2008; Rini, Dunkel-Schetter, Wadhwa, & Sandman, 1999). 
State and Trait Anxiety Inventory (STAI) 
This tool identifies a temporal state of anxiety as compared to a long-standing 
trait of anxiety. It is a 40-item instrument and the respondent rate items using a 4-point 
Likert scale (1=not at all, 2=somewhat, 3=moderately so, 4=very much so). Scores range 
from 20-80 with higher scores representing greater anxiety. It has good reliability and 
good concurrent validity when compared to other anxiety scales. This scale takes 
approximately ten minutes to complete; the time-frame for responses on this scale is how 
they feel generally, without a specific time requested. STAI has been used during 
pregnancy to evaluate anxiety. However there is a parabolic, U-shaped curve for 
occurrence of anxiety symptoms across the three trimesters of pregnancy (Teixeira, 2009 
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Pacheco, & Costa, 2009), with greater maternal anxiety in the first and third trimester. 
Further there is support for stability of both the state and trait anxiety scores during 
pregnancy, six weeks after birth, and 24 months after birth (J. A. DiPietro, Costigan, K. 
A., & Sipsma, H. L., 2008 2008). This support also extends further into development 
linking pregnancy state and trait anxiety with ADHD in children 8-9 years old (Van den 
Bergh & Marcoen, 2004).  
Profile of Mood States (POM-65)  
The POMS consists of 65 items in this scale, which assesses mood state in six 
domains:  tension, anger, confusion, fatigue, vigor, and depression. Respondents use a 4-
point Likert scale (0= not at all to 4= extremely) to rate their feelings “right now” or 
“over the past month” (this study asked specifically their feelings over the past month).  
Cronbach alpha for internal reliability for the total score ranges from 0.75 to 0.92 
(McNair, 1987). 
Pregnancy Experience Scale-Brief (PES-Brief)  
This tool evaluates both positive and negative stressors across pregnancy. The 
PES-Brief has ten items identified as pregnancy hassles and ten items as pregnancy 
uplifts. These items are evaluated on a 4-point Likert scale (0=not at all to 3= a great 
deal). Time frame for the PES is not specified, but directed as generalized feelings. 
Cronbach alpha for internal reliability was previously reported to be 0.82 and 0.83 for 
uplifts and hassles, respectively (DiPietro, Christensen, & Costigan, 2008). 
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Tilburg Pregnancy Distress Scale (TPDS)  
This tool evaluates both pregnancy negative affect and perceived partner 
involvement. The tool was developed as a pregnancy-specific psychological functioning 
scale. The TPDS has 16 items with two subscales; negative affect with 11 items and 
partner involvement with five items. The time-frame for reporting feelings is specified as 
in the last week. This tool has good internal reliability for the entire scale (0.78) and for 
each of the subscales (0.80) (Pop, 2011). 
Social Provisions Scale (SPA)  
This is a 24 item tool evaluates a person’s perception of social support that is 
received from their social relationships. Respondents use a 4-point Likert scale (1= 
strongly disagree to 4= strongly agree) to indicate either the presence or absence of 
support. The time-frame for feelings on this tool is not specified as a concrete time but 
rather a generalized feeling. Cronbach alpha for internal reliability of the total scale was 
previously reported to be 0.92 (Cultrona, 1987). 
Edinburgh Depression Scale (EDS)  
This is a 10-item instrument used to evaluate both prenatal and postnatal 
depression symptoms. Respondents rank each item on a 4-point Likert scale (0=never or 
rarely, to 3= often or usually).  The time-frame for responses on the EDS is for feelings 
over the last week. The scores range from 0-16 and scores >13 indicate depression risk, 
warranting further clinical intervention. Negatively worded items are reverse scored 
(items 3, 5, 6, 7, 8, 9, 10) (Cox, Holden, & Sagovsky, 1987; Murray & Cox, 1990). 
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Center for Epidemiologic Studies Depression Scale (CES-D)  
This tool is widely used to evaluate self-reported generalized depressive 
symptoms in a general population. It is a 20-item instrument that asks respondents how 
they felt or behaved over the last week, using a 4-point Likert scale (0=rarely to none of 
the time, less than 1 day, to 3=most or all of the time, 5-7 days). Scores range from 0-60 
with greater scores suggesting greater depressive symptoms (with scores >16 suggesting 
clinical depression). It has good reliability (α= 0.85-0.90) in healthy and patient subjects. 
Also, the scale demonstrates good test-retest reliability with high internal consistency and 
very good concurrent validity by both clinical and self-reported criteria. This scale takes 
approximately three minutes to complete. (Radloff, 1977). 
The Pittsburg Sleep Quality Index (PSQI)  
This includes 19 self-rated items as a sleep quality measurement tool.  The tool 
also includes partner-rated items that are not included in the scoring of the tool. PSQI 
evaluates sleep over the last week. In a sample of pregnant women, Cronbach alpha for 
internal consistency was reported to range from 0.72 to 0.78 in pregnant women which 
has been evaluated during the second and third trimesters (0.72 to 0.78 respectively) 
 (Skouteris, Wertheim, Germano, Paxton, & Milgrom, 2009).  
Maternal Biological Outcomes 
Hair Cortisol Rationale  
Cortisol becomes incorporated in the hair shaft and recently hair cortisol has been 
shown to be a reliable measure of HPA activity in humans. Hair cortisol provides an 
integrated measure of cortisol over a longer time frame and thus is useful for study 
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designs that require a long-term evaluation of cortisol (D'Anna-Hernandez, 2011; Natvig, 
& Laudenslager, 2011).  
Hair Cortisol Measurement  
For the measurement of hair cortisol, hair was collected from the posterior vertex 
region of the head during the second and third trimester of pregnancy. Thinning shears 
(scissors) were used to cut a 1-cm
2
 patch of hair, as close to the scalp as possible and as 
recommended by the Society of Hair Testing (approximately 50 hair strands) (Stalder & 
Kirschbaum, 2012; Testing, 1997). After cutting, the proximal end of the hair sample was 
secured with tape onto aluminum foil and wrapped for shipment to the laboratory of Dr. 
Mark Laudenslager, at the University of Colorado Denver, Anschutz Medical Campus. 
Hair was analyzed for cortisol in Dr. Laudenslager’s laboratory, where he has developed 
a reliable measurement technique for evaluating hair cortisol and is a leading expert in 
this procedure.  
The methods for processing hair samples were consistent with an earlier study 
process and briefly described below (Hoffman, Karban, Benitez, Goodteacher, & 
Laudenslager, 2014). Hair was cut, collected, and secured with light adhesive tape onto 
aluminum foil, then labeled with study participant identification number and date in a 
consistent pattern with the cut portion of the hair sample for analysis, above the taped 
portion of hair.  Hair was sent in batches and processed collectively with both time-points 
for each respective participant, at the same time.  Hair was collected stored and processed 
in the lab of Dr. Laudenslager.  Hair was washed three times in isopropanol alcohol and 
dried for four days. After this process was complete, hair was weighed, then ground and 
79 
 
 
 
processed as described by Hoffman and colleagues (Hoffman et al., 2014).  Then, after 
drying, extracts were reconstituted with 133μl of buffer and commercial high-sensitivity 
EIA kits used to determine cortisol levels (Salimetrics, LLC, State College, PA, USA). 
To determine a control sample, an inter-assay coefficient of variation (CV) was used 
from a previous ground hair sample, and processed on the same plate with new samples.  
Intra-assay coefficient of variation (CV) for the control sample was 4.1%, while the intra-
assay CV was 11%. 
Cytokine IL-6 Rationale  
Of the three classic proinflammatory cytokines, IL-6 is the key inflammatory 
response mediator (Hirano, Akira, Taga, & Kishimoto, 1990; Kishimoto, 2005; Ohzato et 
al., 1992). IL-6 is chosen as representative of an exemplary proinflammatory cytokine, as 
it is more dependably detected and evaluated than the other classic proinflammatory 
cytokines (TNF alpha and IL-1 beta) (Fernandez-Botran, Miller, Burns, & Newton, 
2010). Also, adults exposed to childhood maltreatment exhibit an exaggerated IL-6 
response (Carpenter et al., 2010) when subjected to acute laboratory stressors and exhibit 
elevations in circulating IL-6 when under chronic stress (Kiecolt-Glaser et al., 2010). 
Coussons-Read and colleagues evaluated associations between maternal psychosocial 
stress and cytokines during early, mid and late pregnancy (Coussons-Read et al., 2007). 
That study showed that during both early and late pregnancy, a greater exposure to 
maternal stressors was related to elevations in circulating IL-6. 
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Cytokine IL-6 Measurement  
Blood (20 ml) was obtained in the early afternoon (1-3 PM) in a uniform manner 
(Nagabhushan, 2001; Witek-Janusek, Albuquerque, Chroniak, Chroniak, Durazo-Arvizu, 
& Mathews, 2008; Witek-Janusek, Gabram, & Mathews, 2007). Plasma IL-6, was 
determined as described previously (Witek-Janusek, Albuquerque, Chroniak, Chroniak, 
Durazo-Arvizu, & Mathews, 2008; Witek-Janusek, Gabram, & Mathews, 2007), using 
commercial ELISA kits (R&D Systems, Minneapolis, MS). Intra- and inter-assay 
coefficients of variation were previously reported to be 9.2% and 2.8%, respectively. 
Cytokine TNF Alpha Rationale  
Of the 3 classic proinflammatory cytokines, TNF alpha is another key 
inflammatory response mediator (Sedger & McDermott, 2014) and is frequently 
evaluated during pregnancy.  It has both anti-viral and anti-bacterial effects. TNF alpha is 
associated with bacteria in amniotic fluid during pregnancy.  When comparing premature 
delivery to term delivery, elevations in cytokine TNF alpha was predictive of earlier 
gestational age (Coussons-Read, Lobel, Carey, Kreither, D'Anna, Argys, Ross, Brandt, 
Cole, 2012).   
Cytokine TNF Alpha Measurement  
Blood (20 ml) was obtained in the early afternoon (1-3 PM) in a uniform manner 
(Nagabhushan, 2001; Witek-Janusek, Albuquerque, Chroniak, Chroniak, Durazo-Arvizu, 
& Mathews, 2008; Witek-Janusek, Gabram, & Mathews, 2007). Plasma TNF-Alpha, was 
determined as described previously (Witek-Janusek, Albuquerque, Chroniak, Chroniak, 
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Durazo-Arvizu, & Mathews, 2008; Witek-Janusek, Gabram, & Mathews, 2007), using 
ELISA commercial ELISA kits (R&D Systems, Minneapolis, MS).  
Neonatal Outcomes 
Neonatal outcomes will include infant birth weight and gestational age. Birth data 
was obtained from the medical record after delivery. The birth weight was recorded in 
grams, while the head circumference and length was recorded in centimeters.  
Gestational Age  
This was an estimate obtained from the medical record based on the mother’s last 
menstrual period and/or by ultrasound measurement, if available.  
Covariates 
Several potential covariates were included in the model based on previous 
research indicating they may be related to study outcome variables while others were 
conceptually identified including week prenatal care started. Maternal covariates that 
were controlled for in the statistical analysis included the following: prenatal care, 
pregnancy complications, pre-pregnancy BMI (Christian, Franco, Glaser, & Iams, 2009), 
and demographics (age, education, income (Ronald, Pennell, and Whitehouse, 2011), 
etc.).  Inclusion of covariates were determined from previous research investigating 
stressors during pregnancy and maternal infant outcomes.  The covariates included the 
following: maternal age, parity, BMI pre-pregnancy (Bolten et al., 2011), income, race 
(bivariate), and education. 
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Statistical Analysis 
The independent variables to be evaluated for this study include measures of 
childhood adversity, as well as maternal psychosocial stressors. Dependent variables will 
include hair cortisol, plasma IL-6, plasma TNF alpha, and neonatal outcomes 
(birthweight and gestational age). Each variable was evaluated for distribution and 
residuals for normality, linearity, homoscedasticity, homogeneity, and multicollinearity. 
Analysis was performed using IBM SPSS Statistics Standard GradPack 23 for Mac. 
A series of regression models were used to evaluate study hypotheses. For Aims 1 
and 2, regression models will evaluate the contribution of childhood adversity factors on 
each of the psychological, neuroendocrine, TNF-alpha, and IL-6 variables for each time 
point (i.e., second and third trimesters of pregnancy).  Each adversity factor including 
income, and position in community and society using rungs on a ladder, using the 
MacArthur Subjective Status Scale was evaluated as a predictor of outcomes. Also a 
single factor, as a composite score to represent childhood adversity using Principal 
Component Analysis (PCA), was unable to be created because variables were 
uncorrelated. The childhood adversity composite score was composed of measures of 
childhood trauma, income, and social status. Moderators (i.e., risk and protective factors) 
for each model were evaluated to determine their contribution and/or interaction with 
childhood adversity factors (Aim 2). Covariates (health behaviors and demographics) 
were initially evaluated (Stage 1) to determine associations with outcome variables. Only 
those covariates found to have significant associations (p<0.05) were retained in the final 
models. 
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Each distress factor was evaluated as a predictor of outcomes. Also a single factor 
was created as a composite score to represent stress, using PCA. The “Distress 
Composite Score” was composed of measures of generalized depression, generalized 
anxiety, perceived stress, mood dysfunction, and sleep disturbance. A composite score 
was established given the ability to compress into a single composite score, to establish a 
single construct.   
For exploratory Aim 3, correlations was determined between measures of 
neonatal outcome and (a) maternal childhood adversity factors, (b) maternal prenatal 
distress, (c) maternal hair cortisol, (d) maternal TNF-alpha, and (e) maternal IL-6. These 
correlations were determined at each time point (T1 and T2). Exploratory regression 
models were also evaluated to determine which of the maternal variables best-predicted 
neonatal outcomes. 
Power Analysis 
 There are seven predictors in the proposed model: prior life adversity 
(independent variable), income and social support (moderating variables), the interaction 
between prior life adversity and each of the moderating variables, and health risk factors 
and age (covariates). Using a G* power 3.1 analysis to determine the sample size, using a 
medium effect size (0.2),  error probability 0.05, power 0.80, with seven predictors in 
the model, an estimate of 80 pregnant women would be needed to have sufficient power 
to run a multiple linear regression. A smaller sample would be needed to accomplish the 
bivariate correlations. 
  
84 
 
 
 
Protection of Human Subjects 
Participants signed an informed consent prior to enrollment into the study. The 
informed consent for Loyola University Medical Center and Gottleib Hospital was 
submitted to the IRB at Loyola University. The informed consent included a description 
of the purpose of the research project, procedures involved including two blood draws for 
evaluation of immune function, cutting of two samples of hair to evaluate hair cortisol as 
a physiologic measurement of HPA activity over the past three months, and risks and 
benefits. Participants were told that participation was voluntary and that they could 
withdraw at any time by notifying the investigator. Further, clarification of the distinction 
between research and clinical care for the participant and their newborn was provided. 
Potential participants were given the opportunity to ask questions. 
 While there are minimal risks to this research study, there is some risk related to 
the blood draws, including pain, discomfort, or possible bruising from the procedure. A 
trained phlebotomist or Registered Nurse to ensure consistent procedures was done on all 
blood draw procedures. The blood sampling was necessary to evaluate immune function 
during pregnancy and compare these findings to psychological data and hair cortisol. The 
investigator obtained all hair samples, as instructed by Dr. Mark Laudenslager. Hair 
cortisol provided information regarding HPA of participant’s activation over the last 
three months. Hair was cut as close to the scalp as possible, in the posterior vertex region, 
as described earlier (see “Hair Cortisol Measurement”). Thinning shears were used to 
collect approximately 50 strands of hair to minimize the visual impact.  Participants were 
compensated $50.00 at study completion for providing the two blood collection 
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procedures.  They were still compensated regardless of whether or not they provided all 
questionnaires or hair sample, but provided a blood sample.
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CHAPTER FOUR 
RESULTS 
Enrollment and Data Collection 
This study was approved by Loyola University Medical Center, Institutional 
Review Board.  Data were collected from November 2012 to November 2014.  Ninety-
five healthy low-risk pregnant women were enrolled during their first or second trimester 
of pregnancy.  Women were recruited from Loyola University Medical Center, Women’s 
Health Clinic, as well as from associated satellite clinics of Loyola University.  Of the 95 
women enrolled, fourteen women withdrew from the study for the following reasons: 
Five did not respond to follow-up phone calls, one electively terminated pregnancy for 
congenital anomalies, one thought questionnaires were too personal, one withdrew 
because it required too much effort for her to provide blood and to complete study 
questionnaires, two were too busy, and three women were electively withdrawn because 
of medical reasons (prior hemorrhage with last pregnancy, thrombocytopenia with 
current pregnancy, and Hashimoto’s thyroiditis). Lastly, the investigator withdrew one 
woman after she fainted in clinic during the study blood draw. [Note: This was reported 
to her physician and the Institutional Review Board as an adverse event.]  
Women were assessed at Time 1 (between 16-24 weeks gestation, second 
trimester) and at Time 2 (between 28-32 weeks gestation, third trimester). Of the 95 
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women enrolled, only a portion completed all measures for each time point.  For Time 1, 
a total of 64 women provided data for all biologic variables and all questionnaires.For 
Time 2, only 44 women provided data for these measures.  For hair cortisol assessment, 
66 and 52 women agreed to hair collection at Time 1 and Time 2, respectively.  
Data for depression, anxiety (STAI trait), maternal childhood adversity before 18 
years of age (CTQ), maternal hardship before 18 years of age (Blackmore et al., 2006), 
maternal medical complications, infant complications, APGAR scores, birthweight and 
gestational age were also collected after delivery.  
Demographic Description of the Sample 
A description of the sample demographics is illustrated in Table 3.  The mean age 
of those enrolled (N=95) was 27.7 years (SD= 5.6, range 18-39 years).  The ethnic and 
racial characteristics of the enrolled sample were as follows: 27.7% identified as 
Hispanic/Latino and 28.3% White, 23.4% African American, 2.1% Asian, 3.2% more 
than one race, and 5.3% other race or did not specify.  Women were primarily married 
(43%), single (20%), and divorced or separated (1%).   The highest educational degree 
earned was an Associates or Bachelor’s degree (41%), followed by a high school diploma 
or GED (27%), with 22% reporting some graduate training (22%).   Nearly 22% of the 
sample reported a household income less than $9,999; 11% reported an income between 
$10,000 to $29,000; another 11% reported an income between $30,000 to $49,000; 16% 
reported an income between $50,000 to $69,000; and about 40% reported a household 
income equal to or greater than $70,000. About half of the women had home ownership 
(or someone in household owned the home), while the remainder lived in a rented home.  
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Using Federal poverty guidelines, based on income and family size, it was determined 
that 23% of the sample were living in poverty.  Most women (64%) worked full-time 
during their pregnancy, 15% worked part-time, 8% were unemployed/laid off or looking 
for work, and 2% were students.  In addition, 13% percent of the women replied that they 
were “homemakers”. 
Table 3. Demographics 
Race/Ethnicity Frequency Percent 
White 36 38.3 
African American 22 23.4 
Other 5 5.3 
Asian 2 2.1 
More than one race 3 3.2 
Hispanic/Latino 26 27.7 
Age at Consent Frequency Percent 
18-20 12 14.1 
21-30 43 50.6 
31-39 30 35.3 
Marital Status Frequency Percent 
Single 20 31.3 
Married 43 67.2 
Divorced/Separated 1 1.6 
Employment Status Frequency Percent 
Full-time 39 62.9 
Part-time 9 14.5 
Homemaker 8 12.9 
Unemployed 5 8.1 
Student 1 1.6 
Household Income Frequency Percent 
Less than $9,999 14 22.2 
$10,000-$19,000 3 4.8 
$20,000-$29,000 4 6.3 
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Table 3. Demographics (cont.)   
   
$30,000-$39,000 5 7.9 
$40,000-$49,000 2 3.2 
$50,000-$59,000 3 4.8 
$60,000-$69,000 7 11.1 
$70,000-higher 25 39.7 
Education Level Frequency Percent 
High School Incomplete 7 11.1 
High School Diploma or GED 17 27.0 
Associates Degree 6 9.5 
Bachelor's Degree 18 28.6 
Master's Degree 9 14.3 
Professional (MD, JD, DDS, etc) 3 4.8 
Other 4 6.4 
 
Pregnancy and Health Descriptive Data 
Sample characteristics of the women enrolled in this study are illustrated in Table 
4.  In this sample of women, 49% reported this pregnancy as a planned pregnancy. This 
pregnancy was confirmed at six weeks or earlier in 87% of the sample.  Most women 
were multiparas (86%).  Among multiparas women, 20.9% had one or more miscarriages, 
as compared to national average in the PRAMS nationwide database of 14.9 % (Robbins 
et al., 2014). Nearly all women (92%) had regular health care before pregnancy. Most 
women reported both good to excellent physical and mental health prior to pregnancy 
(93% and 96%, respectively). Both tobacco and alcohol use pose considerable adverse 
health consequences to mother-infant health. In the sample, 5% percent reported 
smoking, and 6% used alcohol during this pregnancy. As a comparison, national averages 
for smoking are 18%, while alcohol use is reported as 54% in women prior to pregnancy 
(Robbins et al., 2014).  
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About 80% of the sample expressed happy feelings about their pregnancy, while 
19% of women reported feeling unhappy or having ambivalent feelings about their 
pregnancy. Those feeling unhappy during mid-pregnancy is particularly concerning given 
that this time of pregnancy is a relatively quiescent time of pregnancy (Sandman, & 
Davis, E. P., 2012).   
Co-morbidities prior to pregnancy were also assessed. None of the women 
reported hypertension, diabetes, or eating disorder, while 8% reported anemia, 5% 
thyroid problems, 8% asthma, 5% depression, and 14% anxiety disorder. These rates are 
lower than the national averages for pre-pregnancy diabetes at 2.1% and hypertension at 
3.0% (Robbins et al., 2014). Some women experienced complications by the end of their 
pregnancy (40%).  This was most often pregnancy-induced hypertension (11%), followed 
by gestational diabetes (9%).  Women with these risk factors either before pregnancy or 
during pregnancy pose additional health concerns to mother-infant health.  These 
pregnancy complications are listed in Table 5. 
Fifty percent of women in this study reported their pregnancy as unplanned, in 
comparison to national average (43%) reported by the PRAMS study in 2009. In the U.S., 
approximately half of all pregnancies are unintended (Finer & Zolna, 2011). Women 
most likely to have an unintended pregnancy are low-income women, and this is 
inversely related to education level.  Further, there continues to be ethnic and racial 
disparities; low-income Hispanic women have the highest rate of unplanned pregnancy 
while African American women in both low-income and high-income had the highest 
rate of unplanned pregnancy (Finer & Zolna, 2011). 
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Table 4. Sample Characteristics   
   
 Frequency Percent 
Primaparas 9 14.3 
Miscarriages 1 or 2 13 20.9 
WIC before this pregnancy 18 28.6 
Regular health care before this 
pregnancy 
58 92.1 
Fertility treatment for this pregnancy 3 4.8 
Daily Prenatal Vitamins before 
pregnancy 
18 28.6 
Daily Prenatal vitamins (in the last 
month) during pregnancy 
49 77.8 
Using birth control when got pregnant 10 16.1 
Unplanned pregnancy 32 50.8 
Rate Physical Health Before 
Pregnancy 
Frequency Percent 
Excellent 19 30.2 
Good 40 63.5 
Fair 18 6.3 
Rate Mental Health Before 
Pregnancy 
Frequency Percent 
Excellent 32 51.6 
Good 27 43.5 
Fair 3 4.8 
Week of gestation when pregnancy 
confirmed 
Frequency Percent 
6 or less weeks 53 86.9 
7 or greater 8 13.1 
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Table 4. Sample Characteristics (cont.) 
  
   
When pregnancy confirmed, how did 
you feel? 
Frequency Percent 
Very happy 38 61.3 
Somewhat happy 12 19.4 
Somewhat unhappy 5 8.1 
Very unhappy 3 4.8 
Unsure how I felt 4 6.5 
Describe pregnancy overall Frequency Percent 
One of the happiest times of my life 14 24.1 
Happy time without many problems 32 55.2 
Moderately hard time 8 13.8 
Very hard time 4 6.9 
 
Table 5. Pregnancy Complications 
 
 Frequency Percent 
Pregnancy Complications (any) 39 39.8 
Gestational Diabetes 9 9.2 
Hypertension/ Pregnancy Induced 
Hypertension (PIH) 
11 11.2 
Anemia 1 1.0 
Infection-chorio-amnionitis 1 1.0 
 
Prenatal vitamins were taken less frequently before conceiving (51% took 
prenatal vitamins), while a majority (78%) took them daily in the second trimester.  In 
comparison, prenatal or before conception vitamin use is lower than the national rates 
(29.7%) (Robbins et al., 2014).  Regarding health care insurance prior to this pregnancy, 
10% reported no health insurance coverage, 66% reported private health insurance (Blue 
Cross and Blue Shield, HMO), and 24% had public health insurance.  In comparison to 
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national averages of 75% reporting health insurance coverage prior to pregnancy, this 
study has 15 % higher rates of insurance coverage than the national average (Robbins et 
al., 2014). Additionally, 29% reported receiving WIC prior to this pregnancy. Most 
women conceived naturally without fertility treatment.   
Most women delivered vaginally, with 43% undergoing a cesarean delivery.  As a 
comparison, the national average for cesarean delivery is 33%.  All women delivered live 
infants, and 40% delivered a female infant. The mean infant birthweight was 3229.4 
grams (SD= 547.3, range 950-4180 grams), and mean gestational age was 38.4 (SD= 
1.99, range 27-41 completed weeks). See Table 6 for descriptive information on infant 
birthweight and gestational age. Delivery information is listed in Table 7 and Table 10. 
Only 9% of women delivered a premature infant (i.e., less than 37 weeks gestation).  
Also, 9% of the women delivered a low birthweight infant (< 2500 grams), while 1% 
delivered a very low birthweight infant (<1500 grams), and 1% delivered an extremely 
low birthweight infant (<1,000 grams). As expected, most of the women delivering 
prematurely also delivered a low birthweight infant. As a comparison, birth data from the 
2013 National Vital Statistics Report report premature delivery accounting for 11.4%, 
low birthweight delivery accounting for 8.0%, and very low birthweight delivery 
accounting for 1.4%, of all births. Additionally, for comparison, national averages for 
low birthweight rates are 8.0% for all women.  The low birthweight rates continue to be 
greatest in African American women at 13.1% followed by Hispanic women at 7.1% and 
White women at 7.0%. Illinois state average for premature birth was 12.2% in 2013, 
which is slightly higher than the national average. In light of these national and state data, 
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as a comparison, the current study sample had lower averages for premature infant 
delivery and for low birthweight delivery (Martin, Hamilton, Curtin, & Mathews, 2015).  
The Apgar score is a simple standardized evaluation tool used to evaluate all 
newborns in the hospital setting.  APGAR is an acronym for Appearance, Pulse, 
Grimace, Activity and Respiration, which are the tools five categories.  See Table 9 for a 
visual description and scoring system of the tool.  This quick evaluation is done at one, 
five, and ten minutes of age. Infants are rated on a scale of 0-2 for each of the five 
categories. It is used to evaluate the infant’s transition to the extra-uterine environment, 
but is not predictive of long-term outcomes. APGAR scores are impacted by prematurity, 
medications during delivery, resuscitation, cardio-respiratory compromise, and 
neurologic issues (Practice, 2015). Infants with scores of 0-3 are severely depressed, 4-6 
moderately depressed, and 7-10 in normal condition (Newborn, 2006).  See Table 8 for 
APGAR scores in this sample, and Table 9 for a diagram of the Apgar scoring system. At 
one minute of age, 3.9% of the infants were severely depressed, 3.9% were moderately 
depressed, while at five minutes none of the infants were severely depressed and 1.3% 
were moderately depressed.  At ten minutes of age all of the infants were in the normal 
range.  
Table 6. Infant Descriptive Statistics: Birthweight and Gestational Age 
 
 N Min Max Mean SD 
Birthweight 81 950.00 4180 3229.42 547.33 
Gestational Age 80 27.00 41.00 38.43 1.99 
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Table 7. Infant Descriptive Statistics: Delivery 
 
 N Percent 
Term Delivery 37-42 weeks 73 91 
Premature Delivery <37 weeks 7 9 
Average Weight Delivery (AGA) >2500 grams-4200 grams 74 91.4 
Low Birthweight Delivery (LBW)  <2500 grams-1500 grams 5 6.2 
Very Low Birthweight Delivery (VLBW) <1500 grams-1000 
grams 
1 1.2 
Extremely Low Birthweight Delivery (ELBW) <1000grams 1 1.2 
AGA: 2500-4200gm (5lb 8oz - 9lb 4oz), LBW: 2500 grams (5lb 8oz), VLBW: <1500 
grams, (3lb 5oz). ELBW: <1000gms, (2lb 3oz) 
 
Table 8. Infant Descriptive Statistics: APGAR Scores 
 
 APGAR 1 Minute APGAR 5 Minute APGAR 10 Minute 
Score Frequency Percent Frequency Percent Frequency Percent 
Range 1-3 3 3.9 0 0 0 0 
Range 4-6 3 3.9 1 1.3 0 0 
Range 7-10 72 92.3 77 98.7 62 100 
Note: Scores 0-3: Severely depressed; Scores 4-6: Moderately depressed; Scores 7-10: 
Normal condition 
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Table 9. Apgar Scoring System 
 
 0 Points 1 Point 2 Points 1 
Min. 
Total 
5 Min. 
Total 
10 Min. 
Total 
Activity Absent Arms and 
legs flexed 
Active 
movement 
   
Pulse Absent Below 100 
BPM 
Above 100 
BPM 
   
Grimace, 
reflex 
irritability 
Flaccid Some flexion 
of 
extremities 
Active motion 
(cough, 
sneeze, pull 
away 
   
Appearance 
(skin color) 
Blue, 
pale 
Body pink 
extremities 
blue 
Body and 
extremities 
pink 
   
Respiration Absent Slow, 
irregular 
Vigorous cry    
Totals       
BPM= beats per minute.  
Note: scores 0-3: severely depressed; scores 4-6: moderately depressed; scores 7-10: 
normal condition.  
 
Table 10. Delivery Method 
 
Delivery Type Frequency               Percent 
Normal Vaginal 
Delivery 
46 57.5 
Caesarean Delivery 34 42.5 
 
Table 11. Anticipated Feeding Choice at Mid-Pregnancy 
 
Feeding Method        Frequency Percent 
Breastfeeding 36 46.8 
Formula 23 29.9 
Combination 18 23.4 
 
Breastfeeding is the optimal nutrition for infants; The World Health Organization 
(Organization, 2001; Phillips et al., 2000) and the American Academy of Pediatrics 
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(AAP) recommends exclusive breastfeeding for the first six months of life for optimal 
growth, nutrition, and development (Section on, 2012 2001). Despite these 
recommendations, women are influenced by personal, physical, social, environmental 
(Cunningham, 2009), and medical reasons (Section on, 2012).  Rates of breastfeeding 
remain low in women with lower education (without college education), women living in 
poverty, African American women, and younger women (Center for Disease Control and 
Prevention, 2013). Healthy People 2020 include specific aims to increase breastfeeding 
rates in women at initiation, and to sustain exclusive breastfeeding through the first six 
months, and beyond through the first 12 months of age (U.S. Department of Health and 
Human Services, 2011). In this study, 47% of the women evaluated during the second 
trimester anticipated breastfeeding, 30% formula feeding, and 23% a combination of both 
breast and bottle feeding (see Table 11). Additionally, 44% mothers reported being 
breastfeed as an infant, while 49% reported not being breastfeed as an infant.  In 71% of 
the sample, they reported that their friends breastfed their own infants, while 24% said 
their friends did not breastfeed. These personal and social factors influence the rates of 
breastfeeding initiation and duration for mothers in this study. 
Weight and height were used to calculate BMI.  Mean BMI for pre-pregnancy 
weight was 28.4kg (N=60, SD=6.5, range 16.8-46.2 kg), and mean BMI in second 
trimester of pregnancy was 26.5kg (N=62, SD= 6.5, range 17.7-47.5).  Weights for 
participants came from self-report. About 3% of women had pre-pregnancy weights 
categorized as underweight, 50.8% normal weight, 18.6% overweight, and 27.6% obese. 
At mid-pregnancy, those who were underweight were 1.6%, normal weight was 34.4%, 
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overweight was 27.9%, and obese was 36.1%.   In comparison, National and local Illinois 
rates of obesity (BMI 30 or greater) before pregnancy, through the 2009 PRAMS self-
report, were 22.1% and 20.2%, respectively (Robbins et al., 2014; Farr, et al., 2014).  
Descriptive Statistics: Psychosocial and Behavioral Measures 
Women completed self-report instruments that assessed general and pregnancy 
specific measures of depression (CES-D, EDS), anxiety (STAI, PAS), fatigue/distress 
(TPDS), pregnancy experience (PES), and sleep quality (PSQI).  Women also completed 
instruments measuring mood (POMS-65), perceived stress (PSS), social support (SPA), 
and maternal childhood trauma (CTQ) (prior to 18 years of age). Additionally, 
demographic information was obtained and a health history was completed.  
Key Variables 
 Each key variable is discussed in the following sections.  Tables 23 and 24 
identify the descriptive statistics of the psychological variables for T1 and T2 including; 
sample size, range of scores, mean, standard deviation, and percent above standard cut 
score for each measurement tool. Additionally, internal consistency of the tools is 
presented. The key variables are: perceived stress, depression, anxiety, mood disorder, 
social support, sleep, and maternal childhood trauma (trauma before 18 years of age). 
Additionally, nurse/scientist-derived tools to investigate pregnancy specific measures 
were evaluated for concurrent validity to evaluate stressors experienced during 
pregnancy. Each of these tools are used less commonly in the literature, but may be 
useful to administer in the clinical setting.  These include the following: the Tilburg 
Pregnancy Distress Scale (TPDS) to evaluate pregnancy distress, Pregnancy Anxiety 
99 
 
 
Scale (PAS) to evaluate pregnancy specific anxiety, and the Pregnancy Experience Scale 
(PES) to evaluate pregnancy experience.   
Perceived stress. The Perceived Stress Scale (PSS) was used to measure 
generalized perception of stress in the last month of the second and third trimester of 
pregnancy. Scores for T1 ranged from 5-36 (N=64, m=16.1, SD= 7.3), with 63% above 
the population mean of healthy women, score of greater or equal to 13 (listed as a cut 
score in the graph); while scores for T2 ranged from 1-36 (N= 44, m=12.9, SD= 6.9), 
with 52% above population mean.  A cut score of 13 was determined based on normative 
sample mean (Sheldon Cohen & Janicki-Deverts, 2012). Internal consistency for PSS in 
this sample was strong (= 0.89).  Descriptive statistics are listed in Table 12.  
Table 12. Descriptive Statistics: Perceived Stress Scale (PSS) 
 
 N Min Max Mean SD % Cut 
score
1
 
Perceived Stress T1 64 5.00 36.00 16.08 7.33 63 
Perceived Stress T2 44 1.00 31.00 12.89 6.92 52 
1= Percentage of sample above cut score (based on population mean of healthy adult 
women) for each measure 
Perceived Stress (PSS) cut score: >13 
 
Depression.  Screening for depression during pregnancy and the postpartum 
period is currently recommended by the American College of Obstetrics and 
Gynecologists (ACOG) (Practice, 2015), while the American Academy of Pediatrics 
(AAP) recommends depressive risk screening in the postpartum period (Earls & 
Committee on Psychosocial Aspects of Child Family Health, 2010). ACOG recommends 
all women be screened at least once during their pregnancy.  Only the American 
Psychological Association (APA) recommends universal screening of all women for 
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postpartum depression, but this screening has not been accepted as a standard of care. 
[Note: There is an Act to provide funding in 2015 for universal screening of all women 
through the Melanie Blocker Stokes MOTHERS Act, but it has not been funded and 
accepted as a standard of care by Congress to this date. While there is no mandate 
requiring universal screening in all women, some states are moving toward this initiative, 
such as the state of New Jersey.]   
While both the EDS and CES-D are depressive risk tools, the EDS is a pregnancy 
specific measure of depressive risk (the CES-D is a generalized measure of depressive 
risk). Both are used in research studies; however, the CES-D is used much more 
frequently.  The EDS is currently being used on all pregnant women at several times 
across pregnancy and into postpartum. 
The Center for Epidemiological Studies Depression Scale (CES-D) was used to 
measure generalized depressive symptoms in the second and third trimester of pregnancy. 
Scores for T1 ranged from 0-53 (N=64, m=12.9, SD= 11.9) with 28% above the cut score 
(>16); while scores for T2 ranged from 4-29 (N= 44, m=7.8, SD= 4.88), with 7% above 
the cut score (see Table 13 for descriptive information on CES-D). Internal consistency 
for CES-D in this sample was strong (= 0.94).  
Table 13. Descriptive Statistics: Center for Epidemiological Studies Depression Scale 
(CES-D) 
 N Min Max Mean SD % Cut 
score
1
 
Depression CES-D T1 64 .00 53.00 12.91 11.93 28 
Depression CES-D T2 44 4.00 29.00 7.75 4.88 7 
1= Percentage of sample above cut score for each measure 
Depression cut score  (CES-D) cut score: >16 
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The Edinburgh Depressive Scale (EDS) was used to measure pregnancy specific 
depressive symptoms in the second and third trimesters and after delivery (Cox, 
Chapman, Murray, & Jones, 1996; Cox, Holden, & Sagovsky, 1987). Original authors 
suggest cut scores could range from 9-13 (Cox, Holden, & Sagovsky, 1987). More 
current literature suggests clinical depressive risk cut score of 13 or greater, while the 
American Academy of Pediatrics suggests a cut score of ten or greater for probable 
depressive risk screening (Earls & Committee on Psychosocial Aspects of Child Family 
Health, 2010).  For consistency in this analysis, a cut score of 13 or greater was used.  
Scores for T1 ranged from 0-24 (N=64, m=6.7, SD= 6) with 10% above the cut score 
score at or above 13; while scores for T2 ranged from 0-16 (N= 44, m=4.5, SD= 4.0) with 
7% above the cut score; see Table 14 for descriptive information on EDS. Internal 
consistency for EDS in this sample was strong (= 0.86).  Use of the EDS and EPDS has 
been validated for use across pregnancy and into the postpartum. EDS is used to 
represent Edinburgh Depression Scale before delivery while the EPDS is used to 
represent Edinburgh Depression Scale after delivery (postpartum). The EDS and EPDS 
are the exact same assessment tool with the same questions, but represent different time 
frames of administration; either during pregnancy, or postpartum, respectively.  Table 14 
below identifies both the EDS and EPDS for comparison purposes. The EDS at Time 1 
had greater mean scores than any other time-point.  Further, EDS mean at Time 2 
measured at 24-32 weeks identified via study questionnaire, and EDS mean at 
approximately 28 weeks gestation during routine medical appointment and obtained from 
the medical record was consistent. Lowest mean values for EPDS were in the postpartum 
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period either soon after delivery or at the six-week check per medical record report. In a 
large meta-analysis there were differences in cut scores across multiple studies based on 
determining the best trade-off based on sensitivity and specificity; it is believed that 
cultural differences could contribute to higher or lower cut scores (Kozinszky & Dudas, 
2015).  Findings from a validation study measuring depressive symptoms across 
pregnancy (based on 845 White women) suggest a cut score of 10 to provide adequate 
sensitivity and specificity, and positive predictive value (Bergink et al., 2011).  In this 
research, a predetermined cut score was based on cut scores determined a priori, by initial 
tool development. Additionally, it was protocol for any identified person scoring 1, 2, or 
3 on question 10, which addresses suicidal thoughts of harming themselves or their baby, 
to be referred for additional screening. In this study, three participants (5%) listed some 
thoughts of harming themselves in the second trimester of screening, necessitating 
immediate primary care physician, nurse practitioner notification: One had a history of 
depression, one had pregnancy complications (gestational diabetes), and one had no 
documented preexisting conditions.   
 
Table 14. Descriptive Statistics: Edinburgh Depression Scale (EDS) 
 
 N Min Max Mean SD % Cut 
score
1
 
Edinburgh Depression Scale T1 64 0 24.00 6.746 6.00 25/11 
Edinburgh Depression Scale T2 44 0.00 16.00 4.50 4.01 14/7 
1= cut scores >10/>13; Edinburgh Depression (EDS) cut score: >13 (clinical depressive 
risk).  (AAP recommends EDS >10 should get referral however in this paper, cut scores 
of > 13 is used) 
 
Table 15. Descriptive Statistics: Edinburgh Depression Scale (EDS) and Edinburgh 
Postpartum Depression Scale (EPDS) 
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 N Min Max Mean SD 
EDS T1 63 0.00 24.00 6.75 4.86 
EDS T2 44 0.00 16.00 4.50 4.01 
EDS 28 69 0.00 18.00 4.72 4.02 
EPDS PP 78 0.00 12.00 2.88 2.99 
EPDS 6 Weeks PP 57 0.00 16.00 2.56 3.21  
Note: EDS is used to represent Edinburgh Depression Scale before delivery 
EPDS is used to represent Edinburgh Depression Scale after delivery (postpartum). 
The EDS and EPDS are the exact same assessment tool with the same questions, but 
represent different time frames of administration; either not postpartum, or postpartum, 
respectively. 
 
 Anxiety.  The State Anxiety Inventory (STAI) was used to measure generalized 
anxiety symptoms in the second and third trimesters of pregnancy. Scores for T1 ranged 
from 20-70 (N=64, m=36.5, SD= 13.1), while scores for T2 ranged from 20-78 (N= 44, 
m=34.4, SD= 12.2). Internal consistency for STAI in this sample was strong (= 0.96).  
Normative data is based on a sample of non-pregnant women (N= 210, M= 36.17, SD= 
10.96, = .92) (Speilberger, 1983).  STAI range of scores in this study is consistent with 
normative ranges of non-pregnant women at Time 1 and slightly lower than normative 
ranges at T2 or T3.  Women scoring above the cut score for STAI of greater than thirty-
six at mid-pregnancy (41%), late-pregnancy (24%), and remaining elevated at post-
pregnancy (22%), are displayed in Table 16 below.   
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Table 16. Descriptive Statistics: State Anxiety Scale (STAI) 
  
 N Min Max Mean SD >36
a
 
STAI T1 64 20 70.00 36.47 13.05 41% 
STAI T2 42 20 78.00 34.40 12.20 24% 
STAI T3 18 20 69.00 30.78 13.34 22% 
a= mean score for STAI measure, normative sample in women 19-39 years old was 36.17 
(SD=10.96). 
 
The Pregnancy Anxiety Scale (PAS) was used to measure pregnancy specific 
anxiety symptoms in the second and third trimester of pregnancy.  Scores for T1 ranged 
from 11-34 (N=63, m=18.1, SD= 4.9); while scores for T2 ranged from 10-27 (N= 43, 
m=16.7, SD= 4.3); see Table 17 below for descriptive statistics on PAS. Internal 
consistency for PAS in this sample was strong (= 0.78).  Elevated pregnancy-specific 
anxiety using the PAS is associated with a negative long-term impact on the incidence 
of anxiety in 6-9 year-old children.  Further, PAS and not STAI-State anxiety scale in 
mid-gestation (25 weeks as compared to 20 or 30 weeks gestation) was the single 
greatest predictor of childhood anxiety. A study by Davis and Sandman (2012) showed 
a 10% elevated risk for pre-adolescent anxiety for every 1-point increase on PAS, 
consistent with an earlier large study using the PAS (mean scores at 20, 25, 30 weeks 
gestation M= 18.8, SD 4.6) (Buss, Poggi Davis, Pruessner, Head, and Sandman, 2012).  
The PAS in mid-pregnancy is correlated with perceived stress (PSS), depression 
(CES-D and EDS), anxiety (STAI state), and low social support (SPA) and poor sleep 
(PSQI global). See Tables 18 and 19 below for correlations on the PAS at Time 1 and 
Time 2 with key distress variables.  This tool was only used to establish concurrent 
validity of the tool with other more generalized measures of stressors across pregnancy 
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therefore, these correlations were not corrected for a Type 1 error using a Bonferroni 
correction.  This supports fair concurrent validity of this tool to evaluate pregnancy 
specific anxiety during mid-pregnancy.  PAS in late-pregnancy was approaching 
significance for the same tools mentioned above with mid-pregnancy.  
Table 17. Descriptive Statistics: Pregnancy Anxiety Scale (PAS) 
 
 N Min Max Mean SD 
PAS T1 63 11 34.00 18.06 4.87 
PAS T2 43 10 27.00 16.70 4.33 
 
Table 18. Correlations: Key Stress Variables with PAS Time 1 
 
** Correlation is significant at the 0.01 level (2-tailed).  
* Correlation is significant at the 0.05 level (2-tailed). 
 
Mood disturbance.  Profile of Mood Scale (POMS-65) was used to measure 
generalized mood symptoms in the second and third trimesters of pregnancy. Scores for 
total mood disturbance scores for T1 ranged from 11.0-114.0 (N=53, m=20.3, SD= 25.3); 
while scores for T2 ranged from -11 -105 (N= 35, m=17.7, SD= 28.3). Internal 
consistency for POMS-65 in this sample was strong (= 0.94). Range of scores for 
POMS-65 subscales tension-anxiety, depression-dejection, anger-hostility, vigor-activity, 
 PSST1 EDST1 CESDT
1 
POMST
1 
STAIT1 SPAT1 PSQI 
GlobalT
1 
PAS T1 r .289
*
 .286
*
 .287
*
 .162 .338
**
 -.397
**
 .04 
Table 19. Correlations: Key Distress Variables with PAS Time 2 
 
 PSST2 EDST2 CESDT
2 
POMST
2 
STAIT2 SPAT2 PSQI 
GlobalT2 
PAS T2 r .266 .289 .322
*
 .307 .303 -.287 .243 
** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed).  
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fatigue-inertia, confusion-bewilderment (9 items, range 0-36, 15 items, range 0-60, 12 
items, range 0-48, 8 items, range 0-32, 7 items, range 0-28 respectively); normal range of 
scores for POMS-65, Total Mood Disturbance is 0-200 (Curran, 1995; McNair, Lorr, & 
Droppleman, 1992). For women scoring above cut scores based on normative mean, see 
Table 20 for descriptive statistics, while Tables 21 and 22 show the subscales for Time 1 
and Time 2.  Approximately 11-13% of the sample scored above the cut scores for 
tension, depression, anger, confusion subscales, while 21% scored above the cut scores 
for fatigue, and 61% scored above the cut scores for vigor. It is important to note that the 
sample varies among the subscales because not all women responded to every question 
on the tool; therefore, there is a variation in the sample size for the subscales. 
Table 20. Descriptive Statistics: POMS-65 
 N Min Max Mean SD 
Total Mood Disturbance T1 53 -11.00 114.00 20.28 25.25 
Total Mood Disturbance T2 35 -11.00 105.00 17.66 28.28 
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Table 21. Descriptive Statistics: POMS-65 Subscales T1 
  
 N Min Max Mean SD >Cut Score
3
 
Mood Disturbance 
Tension-Anxiety 
55 2.00 27.00 8.63 5.53 12.2% 
Mood Disturbance 
Depression-Dejection 
60 .00 41.00 7.43 9.59 12.2% 
Mood Disturbance 
Anger-Hostility 
58 .00 33.00 7.21 7.11 9.8% 
Mood Disturbance 
Vigor-Activity 
59 3.00 27.00 15.00 4.99 64.9% 
Mood Disturbance 
Fatigue-Inertia 
56 1.00 24.00 8.46 4.89 17.5% 
Mood Disturbance 
Confusion-Bewilderment 
57 .00 19.00 6.33 3.79 10.3% 
       
a= mean score for POMS-65, subscale cut scores: Tension-Anxiety M= 16, SD= 8.9, = 
.92, Depression-Dejection M= 20, SD= 14.5, = .95, Anger-Hostility M= 16, SD= 10.7, 
= .92, Vigor-Activity M= 12, SD=7.5, = .93, Fatigue-Inertia, Confusion-Bewilderment 
M= 12, SD= 6.4 = .86.  
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Table 22. Descriptive Statistics: POMS-65 Subscales T2 
  
 
                  
N Min Max Mean 
                
SD 
 
> Cut Score
a
 
Mood Disturbance 
Tension-Anxiety 
41 .00 25.00 8.32 5.49 10.9% 
Mood Disturbance 
Depression-Dejection 
41 .00 38.00 5.73 8.73 13.3% 
Mood Disturbance 
Anger-Hostility 
41 .00 33.00 6.46 7.13 12.1% 
Mood Disturbance 
Vigor-Activity 
37 2.00 25.00 16.00 5.59 61.0% 
Mood Disturbance 
Fatigue-Inertia 
40 1.00 19.00 7.38 4.43 21.4% 
Mood Disturbance 
Confusion-Bewilderment 
39 1.00 17.00 6.13 3.67 12.3% 
       
a= mean score for POMS-65, subscale cut scores: Tension-Anxiety M= 16, SD= 8.9, = 
.92, Depression-Dejection M= 20, SD= 14.5, = .95, Anger-Hostility M= 16, SD= 10.7, 
= .92, Vigor-Activity M= 12, SD=7.5, = .93, Fatigue-Inertia, Confusion-Bewilderment 
M= 12, SD= 6.4 = .86. 
 
Sleep.  Sleep quality during the second and third trimester of pregnancy was 
assessed using the Pittsburgh Sleep Quality Index (PSQI).  Global Sleep for T1 ranged 
from 0-18 (N=64, m= 6.84, SD= 3.51, with 59.4% above the cut score; while scores for 
T2 ranged from 0-16 (N=45, m= 6.89, SD=3.32), with 55.6% above the cut score. 
Descriptive statistics for the PSQI are listed below in Table 23.  Internal consistency for 
PSQI in this sample was strong (= .79). A global PSQI cut score of > 5 represents poor 
sleep quality.  Women in this sample scoring above the cut scores were (n=38) 59.4% 
and (N=25) 55.6% for T1 and T2, respectively.  In comparison, in a similar study 
investigating sleep in women during late pregnancy, 69% of the sample scored above the  
cut score (Okun, Hanusa, Hall, & Wisner, 2009).  
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Table 23. Descriptive Statistics: Pittsburgh Sleep Quality Index Global Sleep (PSQI) 
  
 N Min Max Mean SD % Cut 
Score
1
 
Global Sleep T1 64 1 18 6.84 3.51 
59.4 
(n=38) 
Global Sleep T2 45 2 16 6.89 3.32 
55.6 
(n=25) 
1= cut off scores > 5 Global Sleep (poor sleep quality)  
Social support.  Social Provisions Scale (SPA) was used to measure social 
support in the second and third trimester of pregnancy.  Social support for T1 ranged 
from 51-96 (N=64, m=84.5, SD= 10.3); while T2 ranged from 52-95 (N=44, m=87.1, 
SD= 9.4). Descriptive statistics are listed in Table 24 for total scores while Tables 25 and 
26 list descriptive information on the subscales for Time 1 and Time 2, respectively. 
Internal consistency for SPA in this sample was strong (= 0.92).   
Table 24. Descriptive Statistics: Social Provisions Scale (SPA) 
 
 N Min Max Mean SD % Cut 
Score
1
 
Social Support T1 64 51.00 96.00 84.47 10.34 81.3% 
Social Support T2 44 52.00 95.00 87.05 9.42 86.4% 
a= mean score for Social Provisions Scale (SPA) measure, normative sample based on 
N=1036 adults, was 78.85 (SD=10.37). 
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Table 25. Descriptive Statistics: Social Provisions Scale (SPA) Subscale T1 
 
 N Min Max Mean SD % Cut 
Score
1
 
Social Support Total T1 64 51.0 96.0 84.47 10.34 81.3% 
Attach Support T1 64 8.0 16.0 14.45 2.21 82.8% 
Social Integration Support T1 64 6.0 16.0 13.50 2.20 73.4% 
Reassurance of Worth Support T1 64 8.0 26.0 14.00 2.61 76.6% 
Reliable Alliance Support T1 64 6.0 16.0 14.75 2.13 76.6% 
Guidance Support T1 64 6.0 16.0 14.44 2.47 82.8% 
Opportunity for Nurturance Support T1 64 5.0 16.0 13.33 2.44 67.2% 
1= Percentage of sample above cut score for each measure 
 Normative range Social Provisions Scale Total (N= 1036, M= 78.85, SD= 10.37, = 
.93), cut scores >79, Attach >13, Social >13, Reassure >13, Reliable >14, Guidance >13, 
Opportunity >13 (Cutrona & Russell, 1987).   
 
Table 26. Descriptive Statistics: Social Provisions Scale (SPA) Subscales Time 2 
 
 N Min Max Mean SD % Cut 
Score
1
 
Social Support Total T2 44 52.0 95.0 87.05 9.42 86.4% 
Attach Support T2 44 8.0 16.0 14.86 1.88 86.4% 
Social Integration Support T2 44 8.0 16.0 14.00 2.00 77.3% 
Reassurance of Worth Support T2 44 5.0 16.0 14.23 2.23 81.8% 
Reliable Alliance Support T2 44 7.0 16.0 14.95 1.88 79.5% 
Guidance Support T2 44 9.0 16.0 15.00 1.76 88.6% 
Opportunity for Nurturance Support T2 44 8.0 16.0 13.93 2.14 67.2% 
1= Percentage of sample above cut score for each measure 
 Normative range Social Provisions Scale Total (N= 1036, M= 78.85, SD= 10.37, = 
.93), cut scores >79, Attach >13, Social >13, Reassure >13, Reliable >14, Guidance >13, 
Opportunity >13 (Cutrona & Russell, 1987). 
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Table 27. Descriptive Statistics: Psychological Variables Time 1 
 N Min Max Mean SD % Cut 
Score
1
 
Perceived Stress (PSS) Time 1 64 5.00 36.00 16.08 7.33 63 
       
General Depression CES-D) T1 64 .00 53.00 12.91 11.93 28 
Edinburgh Depression (EDS) T1 64 0 24.00 6.746 6.00 25/11 
Social Support (SPA) T1 64 51.00 96.00 84.47 10.34 81 
Total Mood (POMS-65) T1 53 -11.00 114.00 20.28 25.25 Na 
General Anxiety (STAI) T1 64 20.00 70.00 36.47 13.05 41 
Sleep Quality (PSQI Global) T1 64 1.00 18.00 6.84 3.51 59 
1
= Percentage of sample above cut score for each measure 
Perceived Stress (PSS) cut score: >13 
Depression cut score  (CES-D) cut score: >16 
Edinburgh Depression (EDS) cut score: >13 (clinical depressive risk) 
(AAP recommends EDS >10 should get referral) 
Global Sleep (PSQI) cut score: >5 
PSS based on normative mean. 
STAI based on normative mean. 
SPA based on normative mean. 
na = not applicable; no established cut score for the total mood disturbance. 
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Table 28. Descriptive Statistics: Psychological Variables Time 2 
 
 N Min Max Mean SD % Cut 
Score
1
 
Perceived Stress (PSS) T2 44 1.00 31.00 12.89 6.92 52 
General Depression (CES-D) T2 44 4.00 29.00 7.75 4.88 7 
Edinburgh Depression (EDS) T2 44 0.00 16.00 4.50 4.01 14/7 
Edinburgh Depression (EDS)  
28 weeks from EMR 
69 0.00 18.00 4.72 4.02 
4 
Social Support (SPA) T2 44 52.00 95.00 87.05 9.42 86 
Total Mood (POMS-65) T2 35 -11.00 105.00 17.66 28.28 na 
General Anxiety (STAI) T2 42 20.00 78.00 34.40 12.20 24 
Sleep Global (PSQI Global) T2 45 3.00 16.00 7.11 3.34 62 
1= Percentage of sample above cut score for each measure 
Perceived Stress (PSS) cut score: >13 
Depression cut score  (CES-D) cut score: >16 
Edinburgh Depression (EDS) cut score: >13 (clinical depressive risk) 
(AAP recommends EDS >10 should get referral) 
Global Sleep (PSQI) cut score: >5 
PSS based on normative mean. 
STAI based on normative mean. 
SPA based on normative mean. 
na = not applicable; no established cut score for the total mood disturbance. 
 
Pregnancy Distress (Negative Affect and Partner Involvement) 
The Tilburg Pregnancy Distress Scale (TPDS) is a pregnancy distress scale (Pop, 
2011).  It also has subscales to evaluate pregnancy affect and perceived partner 
involvement in the second and third trimester of pregnancy.  Pregnancy distress (TPDS 
total scale, with 16 items) T1 ranged from 1-39 (N=62, M=12.89, SD= 8.16) and T2 
ranged from 0-35 (N=44, M=11.59, SD= 8.57); descriptive information on the total 
scales and subscales are listed below in Table 29.  The subscales for the TPDS are 
Negative Affect and Partner Involvement.  TPDS Negative Affect for T1 ranged from 1-
31 (N=12, M=7.98, SD= 8.86), and TPDS Partner Involvement for T1 ranged from 1-14 
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(N=62, M=3.19, SD= 3.60); while TPDS Negative Affect for T2 ranged from 1-24 
(N=10, m=6.78, SD= 9.38) and TPDS partner involvement for T2 ranged from 1-13 
(N=44, m=2.86, SD= 3.27). Internal consistency for TPDS total scale and each subscale 
(Negative Affect and Partner Involvement) was strong (= 0.87, 0.86, .086, 
respectively). As a comparison, this data is consistent with normative values of the 
TPDS total scale with sixteen items (N= 304, Range 0-37, M= 10.67, SD= 5.81, = 
.78). Normative values on the subscales Negative Affect (NA) with five items and 
Partner Involvement (PI) with eleven items is consistent with study values (N= 304, 
Range 0-14, M= 4.20, SD= 2.90, = .80, N= 304, Range 0-23, M= 6.46, SD= 4.70, = 
.81, respectively) (Pop, 2011).  
The TPDS in mid-pregnancy and late-pregnancy is highly correlated with 
perceived stress (PSS), depression (CES-D and EDS), anxiety (STAI state), mood 
disturbance, and low social support (SPA); further, it is also correlated with poor sleep 
(PSQI global) See Tables 29 and 30 below (note, these correlations were not corrected 
for a Type 1 error using a Bonferroni correction). This supports concurrent validity of 
TPDS to evaluate pregnancy distress during both mid-pregnancy and late-pregnancy.  
Table 29. Descriptive Statistics: Tilburg Pregnancy Distress Scale (TPDS) 
 
 N Min Max Mean SD 
Pregnancy Distress T1 62 1 37 12.89 8.16 
Pregnancy Distress T2 44 0 35 11.59 8.57 
      
TPDS Subscales:      
TPDS Negative Affect T1 61 0 29.00 9.66 6.22 
TPDS Partner Involvement T1 62 0 14.00 3.19 3.60 
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Table 29. Descriptive Statistics: Tilburg Pregnancy Distress Scale (TPDS) (cont.)      
      
TPDS Negative Affect T2 10 0 24.00 6.78 9.38 
TPDS Partner Involvement T2 44 0 13.00 2.86 3.27 
 
Table 30. Correlations: Key Distress Variables with TPDS Time 1 
 
 
Table 31. Correlations: Key Distress Variables with TPDS Time 2 
 
 
* Correlation is significant at the 0.05 level (2-tailed).  
 
Pregnancy Experience 
The Pregnancy Experience Scale (PES) was used to evaluate positive and 
negative stressors across pregnancy.  Further, positive and negative stressors are 
conceptualized by the original authors as pregnancy uplifts and hassles in the second and 
third trimester of pregnancy (DiPietro, Christensen, & Costigan, 2008). This is illustrated 
in Table 32. Internal consistency for PES in this sample was strong (= 0.79). 
The Pregnancy Experience Scale (PES) subscales measure pregnancy affective 
valance frequency and pregnancy affective valance intensity. Pregnancy affective 
valance frequency at mid-pregnancy is highly correlated with perceived stress (PSS), 
 
TPDST
1 
PSST1 EDST1 CESD
T1 
POMS
T1 
STAIT
1 
SPAT1 PSQI 
GlobalT
1 
TPDS T1 r 1 .582
**
 .624
**
 .593
**
 .443
**
 .719
**
 -.618
**
 .262
*
 
**Correlation is significant at the 0.01 level (2-tailed).  
*Correlation is significant at the 0.05 level (2-tailed).  
 
TPDST
2 
PSST2 EDST2 CESD
T2 
POMS
T2 
STAIT
2 
SPAT2 PSQI 
GlobalT
2 
TPDS T2 r 1 .428
**
 .580
**
 .490
**
 .442
**
 .472
**
 -502
**
 .293
*
 
** Correlation is significant at the 0.01 level (2-tailed).  
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depression (CES-D and EDS), anxiety (STAI state), mood disturbance (POMS), poor 
sleep (PSQI global) and low social support (SPA); while at late pregnancy it is 
correlated with STAI (state) and approaching significance with low social support.  See 
Tables 33 and 34 below for correlation tables; note, these correlations were not 
corrected for a Type 1 error using a Bonferroni correction, given that this tool was used 
to establish concurrent validity with generalized measures of stressors across pregnancy. 
Pregnancy affective valance intensity at mid-pregnancy and late-pregnancy is highly 
correlated with perceived stress (PSS), depression (CES-D and EDS), anxiety (STAI 
state), mood disturbance (POMS), and poor sleep (PSQI global), and low social support 
(SPA).  This supports concurrent validity of the PES to evaluate pregnancy experience 
during both mid-pregnancy and late-pregnancy.   
Table 32. Descriptive Statistics: Pregnancy Experience Scale (PES) 
 
 N Min Max Mean SD 
Pregnancy Uplifts Frequency T1 63 5.00 10.00 9.08 1.29 
Pregnancy Hassles Frequency T1 63 1.00 10.00 6.59 2.56 
Pregnancy Uplifts Intensity T1 63 1.00 3.00 2.28 0.47 
Pregnancy Hassles Intensity T1 63 1.00 2.78 1.49 0.50 
      
Pregnancy Uplifts Frequency T2 44 6.00 10.00 9.43 0.97 
Pregnancy Hassles Frequency T2 44 2.00 10.00 6.89 2.35 
Pregnancy Uplifts Intensity T2 44 1.20 3.00 2.41 0.45 
Pregnancy Hassles Intensity T2 44 1.00 2.63 1.47 0.39 
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Table 33. Correlations: Key Distress Variables with PES Time 1 
 
 
** Correlation is significant at the 0.01 level (2-tailed).  
* Correlation is significant at the 0.05 level (2-tailed). 
 
Childhood Trauma 
The Childhood Trauma Questionnaire (CTQ) was used to measure maternal 
childhood adversity before 18 years of age in the pregnant mother.  This was assessed in 
women after delivery.  The maternal childhood adversity (CTQ) cut score determines 
frequency and intensity of abuse and neglect.  These range in four categories (none, low, 
moderate, severe) for each of the five subscales on the CTQ. Subscales on the CTQ 
 
PES 
Freq 
T1 
PES 
Inten 
T1 
PSS 
T1 
EDS 
T1 
CESD
T1 
POMS
T1 
STAI
T1 
SPA 
T1 
PSQI 
Global
T1 
PES Freq 
T1 
 1 
.571
**
 
.457
**
 .359
**
 .329
**
 .420
**
 .361
**
 -.198 
.346
**
 
PES Inten 
T1 
r  
1 
.583
**
 .574
**
 .607
**
 .451
**
 .571
**
 -.459
**
 
.449
**
 
Table 34. Correlations: Key Distress Variables with PES Time 2 
 
 
PES 
Freq 
T2 
PES 
Inten 
T2 
PSS 
T2 
EDS 
T2 
CESD 
T2 
POMS 
T2 
STAI 
T2 
SPA 
T2 
 
PSQI 
Global 
T2 
PES Freq 
T2 
 1 
.557
**
 
.217 .242 .219 .248 .359
*
 -.291 
.250 
PES Inten 
T2 
r  
1 
.520
**
 .590
**
 .673
**
 .610
**
 .649
**
 -.579
**
 
.463
**
 
** Correlation is significant at the 0.01 level (2-tailed).  
* Correlation is significant at the 0.05 level (2-tailed).  
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include emotional neglect and abuse, physical neglect and abuse, and sexual abuse. The 
CTQ total score ranged from 25-89 (N=53, M=33.4, SD= 12.7).  Table 35 identifies 
descriptive statistics for the CTQ.  Internal consistency for CTQ in this sample was 
strong (= 0.93).  The study results on the CTQ subscales included, emotional neglect 
with scores ranging from 5-24 (N=53, M=7.8, SD= 4.3), emotional abuse with scores 
ranging from 5-25 (N=53, M=7.3, SD= 4.0), physical neglect with scores ranging from 5-
15 (N=53, M=6.36, SD= 2.9), physical abuse with scores ranging from 5-23 (N=53, 
M=6.3, SD= 2.8), and sexual abuse with scores ranging from 5-15 (N=53, M=5.7, SD= 
2.0).  
As a comparison, the normative values for the total scores on the CTQ in a 
community sample of women between 25-44 (N=511)= 32.48 (11.58) (Scher, Stein, 
Asmundson, McCreary, & Forde, 2001) Additionally, subscales on the CTQ, in a large 
HMO sample of women shows good internal consistency (N=1225, = 0.83.4) 
(Bernstein, & Fink, 1997) which is consistent with the findings in this study and are 
presented below.  The observations in this study are likely consistent with the large 
sample size in the HMO study, based on its large size and the greater likelihood of having 
cases of less severe childhood trauma.  Further, for comparison, normative values include 
emotional neglect and abuse (M=10.5, SD= 5.0, = 0.92 and M=9.2, SD= 4.8, = 0.85, 
respectively) physical neglect and abuse (M=6.6, SD= 2.7, = 0.63, and M= 6.9, SD= 
3.4, = 0.92, respectively) and sexual abuse (M=6.8, SD= 4.2, = 0.93) (Bernstein, & 
Fink, 1997). The use of these cut scores for the subscales are based on normative values 
and provides consistency when comparing values across different studies. While the CTQ 
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total does not have an established cut score yet as identified above, a cut score was 
established based on a community sample mean of 32.48 (Scher et al., 2001).  Pregnant 
women scoring above cut score for CTQ total is 34% (n=18). For this study, Table 36 
below lists the percentage and number of participants that fall within the cut scores for 
each of the four levels of maltreatment on the CTQ. The four levels of maltreatment are 
none (minimal), low, moderate, and severe.  Women reporting moderate to severe 
childhood trauma from emotional neglect were 9.5% (n=5), emotional abuse 5.7% (n=3), 
physical neglect 13.2% (n=7), physical abuse 5.7% (n=3), and sexual abuse 11.3% (n=6).   
Table 35. Descriptive Statistics: Childhood Adversity 
  
 N Min Max Mean SD % Cut 
Score
1
 
Maternal Childhood Trauma 53 25.00 89.00 33.38 12.67 
34.0 
(n=18) 
CTQ Emotional Neglect 53 5.00 24.00 7.81 4.28 
9.5 
n=5 
CTQ Emotional Abuse 53 5.00 25.00 7.25 3.95 
5.7 
n=3 
CTQ Physical Neglect 53 5.00 15.00 6.36 2.91 
13.2 
n=7 
CTQ Physical Abuse 53 5.00 23.00 6.25 2.81 
5.7 
n=3 
CTQ Sexual Abuse 53 5.00 15.00 5.72 2.01 
11.3 
n=6 
1= Percentage of sample above Cut score for each measure total scale mean 32.48 (Scher 
et al., 2001) and subscales emotional neglect 10, emotional abuse 9, physical neglect 8, 
physical abuse, 8, sexual abuse 6  (Bernstein, & Fink, 1997; Bernstein et al., 1994). 
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Table 36. Descriptive Statistics: Maternal Childhood Adversity Cut Scores 
 
       None
1
 Low
1
        Moderate
1
 Severe
1
 
N             % N       % N     % N     % 
Emotional Neglect 
Cut Score 
41 77.4% 7 13.2% 3 5.7% 2 3.8% 
Emotional Abuse 
Cut Score 
43 81.1% 7 13.2% 0 0.0% 3 5.7% 
Physical Neglect 
Cut Score 
44 83.0% 2 3.8% 1 1.9% 6 
11.3
% 
Physical Abuse 
Cut Score 
45 84.9% 5 9.4% 2 3.8% 1 1.9% 
Sexual Abuse  
Cut Score 
45 84.9% 2 3.8% 4 7.5% 2 3.8% 
1= Cut scores for each subscale and each of the four levels of maltreatment.   
Emotional Neglect: None (or minimal) 5-9, Low 10-14, Moderate 15-17, Severe >18 
Emotional Abuse: None (or minimal) 5-8, Low 9-12, Moderate 13-15, Severe >16 
Physical Neglect: None (or minimal) 5-7, Low 8-9, Moderate 9-12, Severe >13 
Physical Abuse: None (or minimal) 5-7, Low 8-9, Moderate 10-12, Severe >13 
Sexual Abuse: None (or minimal) 5, Low 6-7, Moderate 8-12, Severe >13 
(Bernstein, & Fink, 1997; Bernstein et al., 1994). 
 
MacArthur Subjective Status Scale 
This scale identifies the self-perceived standing of the pregnant mother on an 
illustrated social ladder.  The internal consistency in this scale is good (= 0.74) based on 
the two items—rungs on the ladder. Rungs on the ladder are ranked as the following: 1 is 
the lowest rung on the ladder, the lowest subjective placement in community (or U.S.A.); 
whereas 10 is the highest rung on the ladder, the highest subjective placement in the 
community (or USA).  Table 37, listed below, illustrates responses on the MacArthur 
Subjective Status Scale.  Study data regarding responses to rungs on a ladder in a 
community (N=60, Range 2-10, M= 6.02, SD= 2.00), and rungs on a ladder in the USA 
(N=59, range 1-10, M= 5.46, SD= 2.24). This is consistent with normative data from a 
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large sample (N=1294, range 1-10, M=5.85, SD=1.78, age 18-60+, 55% women and 76% 
White).  Further, the study participants ranked where they placed in a community—steps 
1-3, 4-7, 8-10 (13.3%, 63.3%, 23.3%, respectively)—while the normative sample ranked 
steps 1-3, 4-7, 8-10 (10%, 74%, and17%, respectively).  Both the normative data and the 
study sample are both slightly above the midpoint for the mean scores (Operario, Adler, 
& Williams, 2004).  
 The study sample participants were well-educated, with a majority (60.4%) 
having some college education.  Women reported their educational level as less than high 
school diploma 9.5%, high school diploma or GED 27%, Associates or Bachelor’s degree 
38.1%, and Master’s or Doctorate degree 22.3%.  In comparison, the educational level is 
much higher than normative ranges from a large, national, multi-ethnic sample where the 
participants reported less than high school 9%; high school diploma 53%; or some 
college, college degree, or graduate education 39% (Operario et al., 2004). Many of the 
women worked full-time 63.5%, followed by raising children or keeping house 15.9%, 
working part-Time 14.8%, unemployed/laid off 4.8%, and looking for work 1.6%. The 
greatest percentage of women (67.1%) earned less than $50,000 annually. Household 
size, based on how many were in the household including self, was three or more for 63% 
of the sample. Additionally, 72.6% had one child while 27.4% had two to five children in 
the household.  Further, 82% had two to three adults living in the home.  In this sample, 
50% had home ownership, while 45% rented their home.  When participants were asked 
about the availability of emergency funds, 75% reported that they had enough money to 
last 12 months or less at the same standard of living. When subtracting all debt from 
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credit cards, loans, etc., most women (35.5%) had less than $5,000 on reserve in 
accounts.  However, a third of the sample (29%) did not answer this specific question.  
Table 37. Descriptive Statistics: MacArthur Subjective Status Scale  
 
Rungs on a Ladder: Place Yourself in Community N=60 Frequency Percent 
Rungs 1-3  8 13.3 
Rungs 4-7  38 63.3 
Rungs 8-10  14 23.3 
Rung 1 Lowest Placement, Rung 10 Highest Placement    
Rungs on a Ladder: Place Yourself in USA N=59   
Rungs 1-3  13 22.0 
Rungs 4-7  34 57.7 
Rungs 8-10  12 20.4 
Rung 1 Lowest Placement, Rung 10 Highest Placement    
Highest grade (years in school) N=63   
8-12 grade  18 28.7 
13-16  24 36.2 
17-20  19 28.6 
Highest Degree Earned N=63   
Incomplete High School  6 9.5 
High School Diploma/GED  17 27 
Associates Degree/Bachelor’s Degree  24 38.1 
Master’s Degree/Doctorate/Professional MD/JD/DDS, etc.  14 22.3 
Other  2 3.2 
Daily Activities and Responsibilities N=63   
Working Full-time  40.0 63.5 
Working Part-time  14.3 14.3 
Unemployed or Laid Off  3.0 4.8 
Looking for Work  1.0 1.6 
Keeping House or Raising Children  10.0 15.9 
How Much Do You Earn N=61 Frequency Percent 
<49,999  42 67.1 
50,000-74,999  10 16.4 
75,000-99,999  2 3.3 
100,000->  2 3.3 
Unwilling to answer/don’t know  6 9.8 
How Many in Household Including Self N=62   
1-2 people  38 37.1 
3-4  29 46.8 
5-7  10 16.2 
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Table 37. Descriptive Statistics: MacArthur Subjective Status Scale (Cont.) 
How Many Are Children N=62   
0-1  45 72.6 
2-3  15 24.2 
4-5  2 3.2 
How Many are Adults N=62   
0-1  5 8.1 
2-3  51 82.3 
4-5  6 9.7 
Of the Adults, How Many Bring Income to Home N=61   
0-1  15 24.6 
2-3  44 72.2 
4-5  2 3.2 
Is your Home: N-60   
Owned or Being Bought by You  30 50.0 
Rented  27 45.0 
Occupied Without Payment  1 1.7 
Other  2 3.3 
Income in Past 12 months N=61   
<49,999  22 36.1 
50,000-74,999  11 18 
75,000-99,999  8 13.1 
100,000->  12 19.7 
Unwilling to Answer/Don’t Know  8 13.1 
If Lost All Income, How long Could You Live With 
Standard of Living 
N=60   
Less than 1 Month  12 20 
1-2 Months  12 20 
3-6 Months  15 25 
7-12 Months  6 10 
More than 1 Year  15 25 
If You Needed Money Quickly, How Much Do You 
Have With All Savings/Checking Accounts 
N=62   
<$500  10 16.1 
500-4,999  12 19.4 
5,000-9,999  2 3.2 
10,000-19,999  7 11.3 
20,000-49,999  11 17.7 
50,000-199,999  13 20.9 
Unwilling to Answer/Don’t Know  7 11.3 
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Distress Composite Score  
A score was developed to establish a single composite score of distress 
experienced during pregnancy.  This created a single factor score for “distress” in Time 1 
and Time 2.  This “distress” composite score (representing generalized distress during 
pregnancy) was created using anxiety (STAI-state), depression (CES-D), perceived stress 
(PSS), mood disturbance (POMS-65), and sleep disturbance (PSQI duration).  In the next 
section, the research questions and hypothesis testing will use the principal component 
analysis, which was used to create the single “Distress Composite Score”.  
Biological Variables 
A blood sample for cytokine measures and hair sample for cortisol analysis were 
collected in the second and third trimesters of pregnancy.  Levels of plasma IL-6 for T1 
ranged from 0.20-4.12 pg/ml (N=87, M= 0.86, SD= 0.67), while T2 ranged from 0.19-
2.22 pg/ml (N=61, M= 0.90, SD= 0.44). Levels of plasma TNF alpha for T1 ranged from 
0.47-13.18 pg/ml (N=87, M= 1.67, SD= 1.72), while T2 ranged from 0.13-9.88 pg/ml 
(N=61, M= 1.43, SD= 1.50).  The level of hair cortisol for T1 ranged from 1.10- 33.90 
pg/mg (N=66, M= 7.11, SD= 5.29), while T2 ranged from 1.10-30.40 pg/mg (N=52, M= 
7.82, SD= 4.70).  Normative range for the R&D systems quantikine high sensitivity (HS) 
Table 37. Descriptive Statistics: MacArthur Subjective Status Scale (Cont) 
If You Subtracted All Debt (Credits, Unpaid Loans etc.) 
How Much Would You Have? 
N=62   
<$500  28 45.2 
500-4,999  6 9.7 
5,000-9,999  4 6.5 
20,000-199,999  6 9.6 
Unwilling to Answer/Don’t Know  18 29.0 
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Elisa (Minneapolis, MN) IL6 is .156 -10 pg/ml (serum EDTA Plasma Citrate Plasma), 
while the normative range for TNF alpha is .50-32 pg/ml (serum, EDTA plasma, heparin, 
Plasma, citrate plasma). The range of values for both IL-6 and TNF alpha are within this 
normative range with two values in the TNF alpha slightly below normative range.  Hair 
cortisol mean normative range for Dr. Laudenslager’s lab is 27 pg/mg, which in 
comparison, is higher than mean values in this study.  This analysis was measured using 
ELISA high sensitivity kit, by Salimetrics and measured in Dr. Laudenslager’s 
laboratory.   
Examining descriptive statistics of the current study’s biological variables 
revealed that each of them failed to show evidence of a normal distribution by both 
graphic illustration of the distribution and by the distance from zero (skewness and 
kurtosis < = 2.0) (Lewis-Beck, Bryman, & Liao, 2004). As a result, each biological 
variable was log transformed and achieved adequate normality after transformation.  This 
is illustrated in Table 38. To ensure reliability in the study’s parametric analysis, natural 
log transformed biological variables were used for all subsequent analyses.  
Table 38. Descriptive Statistics: Biological Study Variables 
 N Mean SD Skewness Kurtosis Min. Max. 
IL-6 T1 87 0.86 0.67 3.12 12.11 0.20 4.12 
Log IL-6 T1 87 -0.34 0.59 0.43 0.87 -1.61 1.42 
IL-6 T2 61 0.90 0.44 1.19 1.47 0.19 2.22 
Log IL-6 T2 61 -0.22 0.50 -0.44 0.84 -1.66 0.80 
TNF Alpha T1 87 1.67 1.72 4.21 23.83 0.47 13.18 
Log TNF Alpha T1 87 0.25 0.66 1.00 0.96 -0.75 2.58 
TNF Alpha T2 61 1.43 1.50 3.99 18.91 0.13 9.88 
Log TNF Alpha T2 61 0.09 0.69 0.42 2.27 -2.05 2.29 
Hair Cortisol T1 66 7.11 5.29 2.85 11.14 1.10 33.90 
Log Hair Cortisol T1 66 1.76 0.65 -0.24 1.16 0.10 3.52 
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Table 38. Descriptive Statistics of Biological Study Variables (cont.) 
       
        
Hair Cortisol T2 52 7.82 4.70 2.29 9.55 1.10 30.40 
Log Hair Cortisol T2 52 1.90 0.60 -0.59 1.27 0.10 3.41 
Note: T1 represents the second trimester of pregnancy (16-24 weeks gestation); T2 
represents the third trimester of pregnancy (28-32 weeks gestation); IL-6 and TNF alpha 
are in pg/ml; Hair cortisol is in pg/mg . All biologic variables were log transformed 
because they failed to show evidence of normal distribution.  Once natural log 
transformed, these data met the requirements to for a normal distribution.  
 
Specific Aims and Hypotheses (IRB Protocol) 
 
Aim 1: Examine the relationship between maternal childhood adversity and maternal 
psycho-neuroendocrine-inflammatory (Kopnisky) profile during pregnancy. 
Hypothesis 1. Maternal childhood adversity will be related to maternal 
psychosocial profile, higher levels of hair cortisol, and higher levels of plasma 
IL6 and TNF alpha during pregnancy.  
Hypothesis 2. Maternal psychosocial profile during pregnancy will be related to 
higher levels of both maternal hair cortisol and plasma IL-6 and TNF-alpha. 
Aim 2: Evaluate maternal risk and protective factors as moderators of maternal PNI 
profile during pregnancy. 
Hypothesis 3. Maternal risk (income) and protective factors (social support) will 
moderate the relationship between maternal childhood adversity and: 
a. Maternal PNI profile during pregnancy. 
b. Neonatal outcomes. 
Aim3: Explore the relationship among maternal childhood adversity, maternal PNI 
profile during pregnancy, and neonatal outcomes.   
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Hypothesis 4. Worse neonatal outcomes will be related to: 
a. Greater maternal childhood adversity and altered PNI profile during 
pregnancy. 
b. Higher maternal hair cortisol IL-6 and TNF-alpha levels during 
pregnancy. 
Hypothesis Testing 
Concerning Hypothesis 1—Maternal childhood adversity will be related to 
maternal psychosocial profile, higher levels of hair cortisol, and higher levels of plasma 
IL6 and TNF alpha during pregnancy —the following protocol was performed: 
First a Pearson’s r correlation coefficient was calculated to determine the 
relationship between each of the psychosocial variables.  Next, a Pearson’s r correlation 
coefficient was calculated to determine the relationship between maternal childhood 
adversity (CTQ) and psychosocial distress indices. These findings are illustrated in 
Tables 39, 40, and 50 below. Findings revealed that greater levels of maternal childhood 
adversity (total score) were significantly associated with higher scores on the Distress 
Composite Score as well as with higher levels of perceived stress (PSS), depression (EDS 
and CES-D), and anxiety (STAI), at T1; while greater levels of maternal childhood 
adversity (total score) was significantly associated with higher scores on Distress 
Composite Score, and higher levels of depression (CES-D), mood disorder POMS-65) at 
T2.  [Note: the Distress Composite Scale is described below.]  In contrast, greater levels 
of maternal childhood adversity were significantly related to lower levels of social 
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support at both T1 and T2. [Note: these correlations were corrected using a Bonferroni 
correction as listed in each of their respective tables.] 
With respect to biological measures, findings revealed that maternal childhood 
adversity was not significantly correlated with hair cortisol concentration.  In addition, no 
significant correlations were observed at either T1 or T2 between maternal childhood 
adversity and plasma levels of proinflammatory cytokines, IL-6 and TNF-alpha.  Even 
when controlling for pre-pregnancy BMI using partial correlation, no significant 
associations were revealed between maternal childhood adversity and any of the 
biological measures at either T1 or T2; see Table 41. 
Concerning Hypothesis 2—Maternal psychosocial profile during pregnancy will 
be related to higher levels of maternal hair cortisol and higher levels of plasma IL-6 and 
TNF-alpha—the following protocol was performed: 
 No significant correlation was found between the Distress Composite Score and 
levels of hair cortisol, evaluated at both T1 and T2. Further, hair cortisol levels were not 
correlated with perceived stress (PSS), depression (CES-D and EPDS), state anxiety 
(STAI), total mood disturbance (POMS-65), or global sleep (poor sleep) disturbance 
(PSQI), evaluated at both T1 and T2.   
 Findings revealed that the Distress Composite Score T1 and Distress Composite 
Score T2 did not correlate with TNF-alpha at T1 and T2, respectively. In addition, TNF 
alpha was not correlated with perceived stress (PSS), depression (CES-D and EPDS), 
state anxiety (STAI), total mood disturbance (POMS-65), or poor sleep (PSQI global 
sleep), at T1 or T2.  
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Table 41. Correlations (Pearson’s r): Biological Variables and Maternal Childhood 
Adversity, Controlling for Pre-pregnancy BMI (only with proinflammatory cytokines) 
 
 Plasma IL-
6 
T1 
Plasma IL-
6 
T2 
TNF-
alpha 
T1 
TNF-
alpha 
T2 
Hair 
Cortisol 
T1 
Hair 
Cortisol 
T2 
CTQ -.023 .279 .051 .040 .058 .025 
 n=39 n=30 n=39 n=30 n=41 n=34 
CTQ=Child Trauma Questionnaire  
 
  
Table 39. Correlations (Pearson’s r): Psychosocial Variables and Maternal Childhood 
Adversity Time 1 
 
 
PSS 
T1 
EDS 
T1 
CESD 
T1 
POMS 
T1 
STAI 
T1 
SPA 
T1 
PSQI 
Global 
T1 
CTQ Total r .572* .400
*
 .613
*
 .412 .494
*
 -.550* 258 
*Bonferroni correction: p = <.007. 
 
Table 40. Correlations (Pearson’s r): Psychosocial Variables and Maternal Childhood 
Adversity Time 2 
 
PSS 
T2 
EDS 
T2 
CESD 
T2 
POMS 
T2 
STAI 
T2 
SPA 
T2 
PSQI 
Global 
T2 
CTQ Total r .459 .389 .654
*
 .565
*
 .432 -.694* 229 
*Bonferroni correction: p = <.007. 
 
*Bonferroni Correction: p<.008 
**Correlation is significant at the 0.05 level (2-tailed). 
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Table 42. Correlations (Pearson’s r): Biological Variables and Neonatal Birthweight and 
Gestational Age, Controlling for Pre-pregnancy BMI (only with proinflammatory 
cytokines) 
 
 Plasma 
IL-6 
T1 
Plasma 
IL-6 
T2 
TNF-
alpha 
T1 
TNF-
alpha 
T2 
Hair 
Cortisol 
T1 
Hair 
Cortisol 
T2 
Birthweight      .026     -.080     -.182     -.295**      .126     .209 
 
Table 42. Correlations (cont.)       
       
Gestational 
age 
.044 -.207 .006 -.181 .127 .200 
 n=53 n=42 n=53 n=42 n=62 n=50 
CTQ=Child Trauma Questionnaire  
**Correlation is significant at the 0.05 level (2-tailed). 
 
The following tables, Tables 43-48, display correlations of key stress variables 
with biological variables, at Time 1 and Time (T1 and T2), controlling for pre-pregnancy 
BMI.  
Table 43.  Correlations (Pearson’s r): Key Psychosocial Variables and Plasma IL-6 
Psychosocial  
Variable N=47 
Plasma IL-6  
T1 
Psychosocial 
Variable N=27 
Plasma IL-6  
T2 
PSS T1              -175          PSS T2            .051 
EDS T1             -.128          EDS T2            .020 
CES-D T1             -.159          CES-D T2            .321 
POMS T1             -.257          POMS T2            .256 
STAI T1             -
.
208          STAI T2           -.064 
SPA T1             .154          SPA T2           -.284 
PSQI T1             -.085          PSQI T2           -.146 
T1= 2
nd
 Trimester; T2=3
rd
 Trimester; controlling for pre-pregnancy BMI was controlled 
 
  
*Bonferroni Correction: p<.008 
*Bonferroni Correction: p<.007 
**Correlation is significant at the 0.05 level (2-tailed). 
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Table 44.  Correlations (Pearson’s r): Key Psychosocial Variables and Plasma TNF alpha 
Psychosocial  
Variable N=64 
Plasma TNF alpha 
T1 
Psychosocial 
Variable N=43 
Plasma TNF 
alpha  
T2 
            PSS T1 .184 PSS T2 -.158 
            EDS T1 .221 EDS T2 -.154 
            CES-D T1 .286** CES-D T2 -.138 
            POMS T1 .049 POMS T2 .036 
            STAI T1 .120 STAI T2 -.181 
             SPA T1              .058 SPA T2             .107 
             PSQI T1              .217 PSQI T2 -.048 
T1= 2
nd
 Trimester; T2=3
rd
 Trimester 
 
Table 45. Correlations (Pearson’s r): Key Psychosocial Variables and Hair Cortisol 
Psychosocial  
Variable N=50 
Hair Cortisol 
T1 
Psychosocial 
Variable N=37 
Hair Cortisol 
T2 
            PSS T1             .112         PSS T2             .018 
            EDS T1             .078         EDS T2            -.110 
            CES-D T1            -.018         CES-D T2             .059 
            POMS T1            -.087         POMS T2            -.078 
            STAI T1            -.067         STAI T2            -.149 
            SPA T1             .010         SPA T2            -.078 
            PSQI T1             .213         PSQI T2             .107 
T1=2
nd
 Trimester; T2=3
rd
 Trimester 
 
Table 46. Correlations (Pearson’s r): CTQ Subscales and Proinflammatory Cytokine  
IL-6 
Psychosocial Variable Plasma IL-6  
T1 n=39 
Plasma IL-6  
T2 n=30 
Emotional Neglect  .                 102                  .346** 
Emotional Abuse                  -.031                  .130 
Physical Neglect                   .075                  .194 
Physical Abuse                  -.197 .                 447*,** 
Sexual Abuse                  -
.
.158                  -.087 
T1= 2
nd
 Trimester; T2=3
rd
 Trimester; controlling for pre-pregnancy BMI was controlled 
*Bonferroni Correction: p<.007 
**Correlation is significant at the 0.05 level (2-tailed). 
*Bonferroni Correction: p<.007 
**Correlation is significant at the 0.05 level (2-tailed). 
*Bonferroni Correction: p<.01 
**Correlation is significant at the 0.05 level (2-tailed). 
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Table 47.  Correlations (Pearson’s r): CTQ Subscales and Proinflammatory Cytokine 
TNF-alpha 
 
Psychosocial Variable Plasma TNF-alpha 
T1 n=39 
Plasma TNF-alpha  
T2 n=30 
Emotional Neglect                   .019                  .064 
Emotional Abuse                  -.078                  -.016 
Physical Neglect                  .113                  .183 
Physical Abuse                  .152                  .033 
Sexual Abuse                  .076                  -.130 
T1= 2
nd
 Trimester; T2=3
rd
 Trimester; controlling for pre-pregnancy BMI was controlled 
 
Table 48.  Correlations (Pearson’s r): CTQ Subscales and Hair Cortisol 
Psychosocial Variable n=30 Hair Cortisol 
T1 n=41 
Hair Cortisol 
T2 n=34 
Emotional Neglect                   .209                  .158 
Emotional Abuse                  .014                  -.017 
Physical Neglect                  .107                  -.030 
Physical Abuse                  -.159                  -.090 
Sexual Abuse                  -
.
.031                  .046 
T1= 2
nd
 Trimester; T2=3
rd
 Trimester; controlling for pre-pregnancy BMI was controlled 
 
Table 49.  Correlations (Pearson’s r): Distress Composite Score and Proinflammatory 
Cytokines (IL-6 and TNF Alpha), Controlling for Pre-pregnancy BMI 
 
 Plasma  
IL-6 T1 
 Plasma  
IL-6 T2 
Distress Composite Score 
T1 n=48 
-227 Distress Composite Score 
T2 n=27 
.110 
 Plasma  
TNFalphaT1 
 Plasma  
TNFalphaT2 
Distress Composite Score 
T1 n=48 
.064 Distress Composite Score 
T2 n=27 
-.086 
T1= 2
nd
 Trimester; T2=3
rd
 Trimester; controlling for pre-pregnancy BMI was controlled 
 
  
*Bonferroni Correction: p<.01 
**Correlation is significant at the 0.05 level (2-tailed). 
*Bonferroni Correction: p<.01 
**Correlation is significant at the 0.05 level (2-tailed). 
*Bonferroni Correction: p<.007 
**Correlation is significant at the 0.05 level (2-tailed). 
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Table 50.  Correlations (Pearson’s r): Distress Composite Score and Hair Cortisol 
 
 Hair Cortisol 
 T1 
 Hair Cortisol 
T2 
Distress Composite Score 
T1 n=42 
.047 Distress Composite Score 
T2 n=28 
-.017 
T1= 2
nd
 Trimester; T2=3
rd
 Trimester 
 
Distress Composite Score  
A principal component analysis (PCA) was used create a single factor score for 
“stress” in Time 1 and Time 2.  As stated earlier, this “Distress Composite Score” was 
created using anxiety (STAI-state), depression (CES-D), perceived stress (PSS), mood 
disturbance (POMS-65), and sleep disturbance (PSQI duration).  In the next section, the 
research questions and hypothesis testing will use the principal component analysis as 
indicated.  
 Initially, an attempt to make an “Adversity Composite Score” using CTQ total 
score, SES (poverty variable), and social status (MacArthur Scale, rungs on a ladder) 
showed that these variables were uncorrelated with each other; and thus were unable to 
be combined to make a single construct.  See inter-item correlation matrix below in Table 
51. 
Table 51. Inter-item Correlation Matrix: Adversity Composite Score 
 
 Maternal Childhood 
Trauma 
Rungs on a Ladder Indicator of Poverty 
Maternal Childhood 
Trauma 
1.000 -.159 -.157 
Rungs on a Ladder -.159 1.000 -.079 
Indicator of Poverty -.157 -.079 1.000 
*Bonferroni Correction: p<.007 
**Correlation is significant at the 0.05 level (2-tailed). 
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 Subsequently, a “distress composite score” (generalized distress) was created 
using anxiety (STAI-state), depression (CES-D), perceived stress (PSS), mood 
disturbance (POMS-65), and sleep disturbance (PSQI duration).  Composite scores for 
second trimester (T1) and third trimester (T2) showed one factor was supported.  Global 
sleep had the lowest percent of the variance explained but was maintained in the model.  
 
Figure 2. Scree plot Distress Composite Score 1.  
Table 52. Component Matrix: Distress Composite Score 1 
 
Component Matrix
a
 
 Component  
1 
Perceived Stress T1 .887 
General Depression T1 .918 
General Anxiety T1 .887 
Global_PSQI_T1 .616 
Total Mood Disturbance T1 .870 
Extraction Method: Principal Component Analysis. 
a
1 component extracted. 
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Figure 3. Scree plot Distress Composite Score 2. 
 
Table 53. Component Matrix: Distress Composite Score 2  
 
Component Matrix
a
 
 
Component 
1 
Perceived Stress T2 .920 
General Depression T2 .864 
General Anxiety T2 .895 
Global_PSQI_T2 .682 
Total Mood Disturbance T2 .889 
Extraction Method: Principal Component Analysis. 
a
1 component extracted. 
The Distress Composite Score at T1 and T2 were highly correlated with maternal 
childhood adversity (CTQ) but not with birthweight, gestational age, pregnancy 
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complications, age, race dichotomous (recoded into White, non-White), or income; see 
Table 54 below.   
 
Table 54. Correlations (Pearson’s r): Distress Composite Scores, CTQ, and Other 
Variables  
 
 
CTQ Birth 
Weight 
Pregnancy 
Complications 
Age Race 
Dichotomous 
Income 
Distress 
Composite 
Score (T1) 
.589* 
-.194 -.114 -.069 -.043 
           
.106 
Distress 
Composite 
Score (T2) 
.584* 
-.230 .215 .009 .108 
              
.261 
T1=2
nd
 Trimester; T2=3
rd
 Trimester 
* Bonferroni correction: p< .005 
 
Income and Social Support as Moderators of Maternal PNI Profile 
As noted earlier, Aim 2 was the following:  Evaluate maternal risk and protective 
factors as moderators of maternal PNI profile during pregnancy.  Hypothesis 3 of Aim 2 
was the following: 
Hypothesis 3. Maternal risk (income) and protective factors (social support) will 
moderate the relationship between maternal childhood adversity and: 
a. Maternal PNI profile during pregnancy 
b. Neonatal outcomes. 
Income and Social Support as Moderators of Childhood Adversity on IL-6 and  
TNF alpha, and Hair Cortisol  
Moderating effect of income on IL-6 at Time 1 and Time 2. Regressions 
analysis was used to determine if income level moderated the association between 
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childhood adversity and IL-6 at T1, while controlling for BMI at T1, race, and pregnancy 
complications.  Biological variables IL-6, TNF alpha, and hair cortisol analysis were each 
log transformed prior to regression analysis to achieve a normal distribution. Possible 
control variables evaluated included pregnancy complications, race (as a dichotomous 
variable, White, Non-White), planned pregnancy, feelings about pregnancy multiparas, 
and week prenatal care started. For this analysis, only those variables that were 
significantly correlated with childhood adversity or log IL-6 were included in the final 
regression model.  Results indicated that of the control variables considered only BMI 
and race were significantly associated with IL-6 at T1 (beta= .06, p< .001, beta=.42, 
p=.025, respectively); thus, BMI and race were included in the final regression model.  
Results revealed that together with the covariates, income and childhood adversity 
predicted 45% of the variability in log IL-6 at T1; however, neither childhood adversity 
nor income were significant predictors of IL-6 at T1. Adding an interaction term of 
income by-childhood adversity explained an additional <1% of the variability in log IL-6 
T1, which was not significant.  
 Further regression analysis was used to determine if income moderated the 
association between childhood adversity and log IL-6 T2 controlling for BMI at T1, race, 
and pregnancy complications.  The results revealed income and childhood adversity 
predicted approximately 21% of the variability in log IL-6 T2 in the current sample, with 
neither childhood adversity nor income, significantly predicting log IL-6 T2.  Adding an 
interaction term of income by-childhood adversity explained an additional 3% of the 
variability in log IL-6 T2, and was not significant.  
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Moderating effect of social support on IL-6 at Time 1 and Time 2. Next, 
regression analyses were used to determine if social support moderated the association 
between maternal childhood adversity and log IL-6 at T1 controlling for BMI at T1, race, 
and pregnancy complications.  Results indicated that along with covariates, social support 
and childhood adversity predicted 48% of variability in log IL-6 T1. Social support and 
childhood adversity were not significant predictors. Adding an interaction term of social 
support by-childhood adversity explained an additional <1% of the variability in log IL-6 
T1, which was not significant. From the covariates, BMI, and race were significantly 
associated with IL-6 T1 (p=.001, p=.02, respectively). 
Finally, a regression analysis was used to determine if social support at T2 
moderated the association between childhood adversity and log IL-6 at T2, controlling 
for BMI at T1, race, and pregnancy complications. Results indicated that social support 
and childhood adversity predicted 21% of variability in log IL-6 T2, along with other 
covariates. However, neither social support at T2 nor childhood adversity significantly 
predicted IL-6 at T2.  Adding an interaction term of social support at T2-by-childhood 
adversity, explained an additional 3% variability in IL-6 at T2, however, this was not 
significant. 
Moderating effect of income on TNF alpha at Time 1 and Time 2. First, 
regression analysis was used to determine if income level moderated the association 
between childhood adversity and log TNF alpha at Time 1.  Potential control variables 
were first examined with respect to their relationship with childhood adversity and log 
TNF alpha.  Decision was made to include only those variables that were significantly 
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associated with childhood adversity or TNF alpha. The possible control variables 
included pregnancy complications, race (as a dichotomous variable, White, Non-White), 
planned pregnancy, feelings about pregnancy multiparas, and week prenatal care started.  
In this case, results indicated that none of the potential control variables were 
significantly associated with childhood adversity or TNF alpha; thus were included in the 
final model. Results of the regression analysis revealed that income and childhood 
adversity predicted approximately 8% of variability in TNF alpha at T1. Both childhood 
adversity and income were not statistically significant predictors of TNF alpha at T1.  
Adding an interaction term of income-by-childhood adversity explained an additional 1% 
of variability in TNF alpha T1, indicating that income was not a significant moderator of 
the association between childhood adversity and TNF alpha.  
Further, regressions analysis was used to determine if income level moderated the 
association between childhood adversity and log TNF alpha at T2.  Results indicated that 
income and childhood adversity predicted 5% of variability in TNF alpha T2 in the 
current sample; however, neither childhood adversity nor income significantly predicted 
TNF alpha at T2.  Adding an interaction term of income-by-childhood adversity 
explained an additional <1% of variability in TNF alpha at T2, which was not significant.  
Thus, income was not a significant moderator of the association between childhood 
adversity and TNF alpha at Time 1 and Time 2. 
Moderating effect of social support on TNF alpha at Time 1 and Time 2. Next 
a regression analysis was used to determine if social support moderated the association 
between childhood adversity and log TNF alpha. Results indicated that neither social 
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support nor childhood adversity significantly predicted TNF alpha at T1, explaining only 
3% of the variability.  Adding an interaction term of social support-by-childhood 
adversity explained an additional 1% of variability in TNF alpha T1, which was not 
significant.   
Finally, a regressions analysis was used to determine if social support at T2 
moderated the association between childhood adversity and log TNF alpha at T2. Results 
indicated that neither social support at T2 nor childhood adversity significantly predicted 
TNF alpha at T2, explaining only 7% of the variability in the current sample.  Adding an 
interaction term of social support-by-childhood adversity explained an additional 2% of 
variability in TNF alpha at T2, which was not significant.  Thus, social support was not a 
significant moderator of the association between childhood adversity and TNF alpha at 
Time 1 and Time 2. 
Moderating effect of income on hair cortisol at Time 1 and Time 2.  
Regression analysis was used to determine if income moderated the association between 
childhood adversity and log hair cortisol at T1. Possible control variables assessed for 
this analysis included the following: pregnancy complications, race (as a dichotomous 
variable, White, Non-White), planned pregnancy, feelings about pregnancy multiparas, 
and week prenatal care started.  Feelings about pregnancy and race were significant, and 
thus were controlled for in the final models.  The set of variables including childhood 
adversity and income explained 28% of variability in log hair cortisol T1; however 
neither of the variables were significant predictors.  Adding an interaction term of 
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income-by-childhood adversity explained an additional 1% of the variability in log hair 
cortisol T1, which also was not significant.  
Further, regression analysis was used to determine if income moderated the 
association between childhood adversity and log hair cortisol at T2 controlling for 
feelings about pregnancy and race.  Results indicated that income and childhood 
adversity predicted approximately 16% of variability in log hair cortisol at T2 and neither 
childhood adversity, nor income, significantly predicted hair cortisol.  Adding an 
interaction term of income-by-childhood adversity explained an additional <1% of the 
variability in log hair cortisol at T2, which was not significant.   
Moderating effect of social support on TNF alpha at Time 1 and Time 2. 
Next, a regression analysis was used to determine if social support at T1 moderated the 
association between childhood adversity and hair cortisol at T1, while controlling for 
feelings about pregnancy and race.  However, neither social support nor childhood 
adversity significantly predicted hair cortisol at T1, explaining 25% of the variability in 
the current sample.  Adding an interaction term of social support-by-childhood adversity 
explained an additional <1% of variability hair cortisol T1, indicating that social support 
was not a significant moderator of the association between childhood adversity and hair 
cortisol at T1. 
Finally, regression analysis was used to determine if social support moderated the 
association between childhood adversity and log hair cortisol at T2 while controlling for 
feelings about pregnancy and race.  Results indicated that the control variables were not 
significantly associated with hair cortisol at T2. Additionally, neither social support nor 
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childhood adversity significantly predicted hair cortisol at T2, explaining 20% of the 
variability in the current sample.  Adding an interaction term of social support-by-
childhood adversity explained an additional <1% of variability hair cortisol at T2 
indicating that social support was not a significant moderator of the association between 
childhood adversity and log hair cortisol at Time 2. 
Income and Social Support as Moderators of Childhood Adversity on  
Neonatal Outcomes 
Moderating effect of income on birthweight and gestational age. Regression 
analysis was used to determine if income level moderated the association between 
childhood adversity and birthweight.  For this analysis, only variables that were 
significantly correlated with childhood adversity or birthweight were included in the final 
regression model. The possible control variables evaluated included pregnancy 
complications, race (as a dichotomous variable, White, Non-White), planned pregnancy, 
feelings about pregnancy multiparas, and week prenatal care started.  The results 
indicated that the control variable that assessed pregnancy complications was negatively 
and significantly associated with birthweight (beta=-.373, p=.05).  In the final model, 
income level and child adversity predicted approximately 17% of variability in 
birthweight, with neither child adversity nor income significantly predicting birthweight. 
Adding an interaction term of income-by-childhood adversity explained an additional 1% 
of variability in birthweight, which was not significant. 
Additionally, a regression analysis was used to determine if income moderated the 
association between childhood adversity and gestational age, while controlling for 
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pregnancy health care before pregnancy, feelings about pregnancy, and pregnancy 
complications.  Results indicated that income and childhood adversity predicted 
approximately 13% of variability in gestational age in the current sample, with neither 
childhood adversity nor income significantly predicting gestational age.  Adding an 
interaction term of income-by-childhood adversity explained an additional <1% of 
variability in gestational age, which was not significant. 
Moderating effect of social support at Time 1 and Time 2 on birthweight  
and gestational age. Next, a regression analysis was used to determine if social support 
at T1 moderated the association between childhood adversity and birthweight while 
controlling for age, race (dichotomous), education, health care before pregnancy, planned 
pregnancy, feeling about pregnancy, and pregnancy complications.  Results indicated that 
the control variables, pregnancy complications were significant predictors (or) in the 
model (N=43, beta= -.430.0, p=.02 respectively); these were significantly associated with 
birthweight.  Results indicated that the variables including social support and childhood 
adversity predicted approximately 27% of variability in birthweight in the current sample, 
with neither childhood adversity nor social support mid-pregnancy significantly 
predicting birthweight.  Adding an interaction term of social support at mid-pregnancy-
by-childhood adversity explained an additional 2% of variability in birthweight, which 
was not significant.  
Finally, a regressions analysis was used to determine if social support at T2 
moderated the association between childhood adversity and birthweight controlling for 
age, race (dichotomous), education, health care before pregnancy, planned pregnancy, 
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feeling about pregnancy, and pregnancy complications. Results indicated that the control 
variables—feeling about pregnancy, planned pregnancy, pregnancy complications (beta= 
418.1, p=.04, beta=-196.6 p=.03, beta= -214.6, p=.03 respectively)—were significantly 
associated with birthweight.  In this model, social support and childhood adversity 
predicted approximately 38% of variability in birthweight in the current sample, with 
neither childhood adversity nor social support at mid-pregnancy significantly predicting 
birthweight.  Adding an interaction term of social support-by-childhood adversity 
explained an additional 23% of variability in birthweight. The interaction term was 
significant (n=30, beta=1.5, p=. 004) indicating that social support moderated the effects 
of childhood adversity on birthweight.  To further examine this interaction to understand 
the moderating effect of social support The Johnson-Neyman Technique was 
implemented (Hayes and Matthes, 2009). This technique computes the region of 
significance for the moderating variable, in this case social support. Results of the follow-
up test revealed that values ≥ 86.7 on the social support questionnaire (i.e., Social 
Provision Scale) were demarcated as values that fall within the region of significance (at 
alpha=.05). That is, the conditional effect of childhood adversity on birthweight was 
statistically significant when the scores on the Social Provision Scale were above 86.7.  
In other words, those women with greater childhood adversity and greater social support 
(greater than 86.7) had higher birthweight babies than women with the same level of 
adversity but lower social support.  In the present sample, 56.7% of the women 
responded with scores greater than 86.7.   
 
144 
 
 
 
 
Figure 4. Impact of maternal childhood adversity on infant birthweight (N=43). 
 
Therefore, social support buffers the negative impact of maternal childhood 
adversity on infant birthweight. 
Regression analysis was used to determine if social support at T1 moderated the 
association between childhood adversity and gestational age, while controlling for age, 
race (dichotomous), education, planned pregnancy, feeling about pregnancy, and 
pregnancy complications.  The results indicated that social support and childhood 
adversity predicted approximately 14% of variability in gestational age in the current 
sample, with neither childhood adversity nor social support late-pregnancy significantly 
predicting gestational age.  Adding an interaction term of social support-late-pregnancy-
by-childhood adversity explained an additional 3% of variability in gestational age, 
which was not significant.  
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Additionally, a regressions analysis was used to determine if social support at T2 
moderated the association between childhood adversity and gestational age, controlling 
for age, race (dichotomous), education, planned pregnancy, feeling about pregnancy, and 
pregnancy complications.  Results indicated that social support and childhood adversity 
predicted approximately 27% of variability in gestational age in the current sample, with 
neither childhood adversity nor social support late-pregnancy significantly predicting 
gestational age.  Adding an interaction term of social support-late-pregnancy-by-
childhood adversity explained an additional 24% of variability in gestational age, which 
was significant (N= 30, beta=.005, p=. 007).  The Johnson-Neyman Technique was again 
utilized to further probe the significant interaction (Hayes and Matthes, 2009).  Results of 
these follow-up analyses revealed that values ≤ 65.5 or values  ≥ 87.6 were identified as 
points that defined the region of significance (at alpha=.05) of the effect of childhood 
adversity on gestational age.  The conditional effect of childhood adversity was 
statistically significant when the scores on the social provision scale were either below 
65.5 or above 87.6.  In the present sample, approximately 7 % of the women had scores 
lower than 65.5 and 53% had scores greater than 87.6.  As shown in Figure 6 (below) 
women with higher exposure to child adversity were more likely to deliver babies with 
higher gestational age if they also had greater social support (i.e., greater than 87.6) as 
compared to women who had low levels of social support (i.e., lower than 65.5).  Thus, 
the harmful effects of maternal childhood adversity on gestational age are buffered in 
women with higher levels of social support.  
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Figure 5. Harmful effects of maternal childhood adversity on gestational age (N=30). 
 
Childhood Adversity as a Moderator of IL-6 at Time 1 and Time 2 on Infant 
Outcomes 
As noted earlier, Aim 3 was the following:  Explore the relationship among 
maternal childhood adversity, maternal PNI profile during pregnancy, and neonatal 
outcomes.  Hypothesis 4 of Aim 3 was the following: 
Hypothesis 4. Worse neonatal outcomes will be related to: 
a. Greater maternal childhood adversity and altered PNI profile 
during pregnancy and neonatal outcomes; and 
b. Higher maternal hair cortisol, IL-6 and TNF-alpha levels during 
pregnancy. 
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Hypothesis 4a. Pearson’s r correlation coefficient was used to evaluate neonatal 
outcomes, both birthweight and gestational age with childhood adversity and 
psychosocial distress variables.  Findings revealed that birthweight at T1 or T2 was not 
associated with maternal childhood adversity (total score), Distress Composite Score, 
perceived stress, depression (EDS and CES-D), anxiety (STAI), pregnancy specific 
anxiety (PAS), global sleep disturbance (PSQI), total mood disturbance (POMS-65), 
family dysfunction, or household global childhood abuse. Further, gestational age at T1 
or T2 was not associated with maternal childhood adversity (total score), Distress 
Composite Score, perceived stress (PSS), depression (EDS), anxiety (STAI) pregnancy 
specific anxiety/distress (PAS and TPDS), global sleep disturbance (PSQI), total mood 
disturbance (POMS-65), family dysfunction and household global childhood abuse.  
However, gestational age was negatively correlated with depressive symptoms (CES-D at 
T2) (r=-.30, p=.05), but not at T1. Given that the correlational analyses were driven by an 
a priori hypothesis, no correction for familywise Type 1 error was used. 
Hypothesis 4b. Using Pearson’s r correlation coefficient, findings revealed that 
birthweight was positively correlated (approaching significance) with log hair cortisol at 
T2 (r=.262, p=.07) but not at T1.  In contrast, gestational age was not correlated with log 
hair cortisol at T1 and T2. Further, no significant correlations were found between 
plasma TNF alpha (both non- and log-transformed values) and infant birthweight or 
gestational age at T1 or T2. Similarly, no correlations were found between levels of 
plasma IL-6 (both non- and log transformed) and infant birthweight or gestational age at 
T1 or T2. 
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Childhood adversity as a moderator of IL-6 at Time 1 and Time 2 on  
infant outcomes Regression analysis was subsequently used to determine if childhood 
adversity moderated the association between IL-6 at T1 and birthweight, controlling for 
BMI at T1, healthcare before pregnancy, feeling about pregnancy, and pregnancy 
complications.  Of these covariates, only pregnancy complications were significantly 
related to birthweight (N=43, beta -458.74 p=. 02) and were therefore controlled in the 
final model.  Results revealed that IL-6 at T1 and childhood adversity predicted 
approximately 21% of variability in birthweight, with neither childhood adversity nor IL-
6 at T1 significantly predicted infant birthweight.  Adding an interaction term of IL-6 at 
T1-by-childhood adversity explained an additional 4% of variability in birthweight, 
which was not significant. 
Then, a regressions analysis was used to determine if IL-6 at T2 moderated the 
association between childhood adversity and birthweight, controlling for BMI at T1, 
healthcare before pregnancy, feeling about pregnancy, and pregnancy complications.  
Results indicated that IL-6 at T2 and childhood adversity predicted approximately 20% of 
variability in birthweight, with neither childhood adversity nor IL-6 at T2 significantly 
predicting birthweight.  Adding an interaction term of IL-6 at T2-by-childhood adversity 
explained an additional 11% of variability in birthweight, which was significant (N=33, 
beta= -17.1, p=0.03).  
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Figure 6.  Childhood adversity interaction with plasma IL-6 levels: birth weight (N=33). 
 
The Johnson-Neyman technique to probe the significant interaction indicated that 
women who scored greater than 58.1(“58.1 and above” was defined as a point of the 
region of significance at alpha = .05) on the Childhood Trauma Questionnaire (CTQ) 
were at a significantly greater risk to have lower birthweight babies if they also had 
greater IL-6 at T2. In the present sample, 6% of women scored greater than the boundary 
for the region of significance.  In sum, childhood adversity interacted with plasma IL-6 
levels, such that greater exposure to childhood adversity and higher IL-6 levels predicted 
lower birthweight. (N=33, beta= -17.1, p=0.03). 
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Next, a regression analysis was used to determine if childhood adversity 
moderated the association between IL-6 at T1 and gestational age, controlling for BMI at 
T1, healthcare before pregnancy, feeling about pregnancy, and pregnancy complications.  
Results indicated that IL-6 at T1 and childhood adversity predicted approximately 12% of 
variability in birthweight in the current sample, with neither childhood adversity nor IL-6 
at T1 significantly predicting gestational age.  Adding an interaction term of IL-6 at T1-
by-childhood adversity explained an additional 1% of variability in gestational age, 
which was not significant. 
Finally, a regression analysis was used to determine if childhood adversity 
moderated the association between IL-6 at T2 and gestational age, controlling for BMI at 
T1, health care before pregnancy, feeling about pregnancy, and pregnancy complications. 
The results indicated that childhood adversity and IL-6 T2 predicted approximately 21% 
of variability in gestational age in the current sample, with childhood adversity (N=33, 
beta=-.036, p=. 056)—but not IL-6 T2—significantly predicting gestational age.  Adding 
an interaction term of IL-6 at T2-by-childhood adversity explained an additional 15% of 
variability in gestational age, which was significant (N=33, beta= -.07, p=0.02). The 
Johnson-Neyman technique to probe the significant interaction indicated that women who 
scored greater than 51.1 (“51.1 and above” was defined as a point of the region of 
significance at alpha = .05) on the Childhood Trauma Questionnaire (CTQ) were at a 
significantly greater risk to have lower gestational age babies if they also had greater IL-6 
at T2. In the present sample, 9% of women scored greater than the boundary for the 
region of significance. 
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Figure 7.  Childhood adversity interaction with plasma IL-6 levels: gestational age 
(N=33). 
 
Childhood adversity interacted with plasma IL-6 levels such that greater exposure 
to childhood adversity and higher IL-6 levels predicted earlier gestational age. That is, 
women who experienced higher levels of maternal childhood adversity and who had 
higher levels of plasma IL-6 delivered infants at earlier gestational age (N=33, beta= -.07, 
p=0.02). 
Childhood adversity as a moderator of TNF alpha at Time 1 and Time 2  
on infant outcomes. Regression analysis was then used to determine if childhood 
adversity moderated the association between log TNF alpha T1 and birthweight. For this 
analysis, possible control variables that were evaluated included pregnancy 
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complications, race (as a dichotomous variable, White, Non-White), planned pregnancy, 
feelings about pregnancy multiparas, and week prenatal care started; and only those 
variables that were significantly correlated with childhood adversity or birthweight were 
included in the final regression models.  Results indicated that the control variable that 
assessed pregnancy complications significantly predicted birthweight (N= 44, beta=-
446.0, p=.02), such that greater pregnancy complications were associated with lower 
birthweight.  Log TNF alpha at T1 and childhood adversity predicted approximately 19% 
of variability in birthweight in the current sample, with neither childhood adversity nor 
TNF alpha T1 significantly predicting birthweight.  Adding an interaction term of log 
TNF alpha at T1-by-childhood adversity explained an additional 3% of variability in 
birthweight, which was not significant.  
Additionally, a regression analysis was used to determine if childhood adversity 
moderated the association between log TNF alpha at T2 and birthweight, controlling for 
feelings about pregnancy, healthcare before pregnancy, and pregnancy complications.  
Results indicated that log TNF alpha T2 and childhood adversity predicted approximately 
20% of variability in birthweight in the current sample, with neither childhood adversity 
nor TNF alpha T2 significantly predicting birthweight.  Adding an interaction term of log 
TNF alpha T2-by-childhood adversity explained an additional 2% of variability in 
birthweight, which was not significant.  
Next, a regression analysis was used to determine if childhood adversity 
moderated the association between log TNF alpha T1 and gestational age. The possible 
control variables evaluated included pregnancy complications, race (as a dichotomous 
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variable, White, Non-White), planned pregnancy, feelings about pregnancy multiparas, 
and week prenatal care started; only health care before pregnancy, feelings about 
pregnancy, and pregnancy complications were significant control variables.  The results 
indicated that log TNF alpha at T1 and childhood adversity predicted approximately 8% 
of variability in gestational age in the current sample, with neither childhood adversity 
nor TNF alpha at T1 significantly predicting gestational age.  Adding an interaction term 
of log TNF alpha at T1-by-childhood adversity explained an additional 3% of variability 
in gestational age, which was not significant.  
Finally, a regression analysis was used to determine if childhood adversity 
moderated the association between log TNF alpha T2 and gestational age.  Results 
indicated that log TNF alpha at T2 and childhood adversity predicted approximately 20% 
of variability in gestational age in the current sample, with neither childhood adversity 
gestational age but not TNF alpha at T2, significantly predicting gestational age.  Adding 
an interaction term of log TNF alpha at T2-by-childhood adversity explained an 
additional <1% of variability in gestational age, which was not significant.  
Childhood adversity as a moderator of the effects of hair cortisol on  
infant outcomes.  Regression analysis was used to determine if childhood adversity 
moderated the association between log hair cortisol at T1 and birthweight controlling for 
race dichotomous (recoded into White, non-White), health care before pregnancy, 
feelings about pregnancy, pregnancy complications.  Results indicated that childhood 
adversity and log hair cortisol at T1 predicted approximately 9% of variability in 
birthweight in the current sample, while neither childhood adversity nor hair cortisol at 
154 
 
 
T1 significantly predicting birthweight.  Adding an interaction term of log hair cortisol at 
T1-by-childhood adversity explained an additional <1% of variability in birthweight, 
which was not significant.  
Additionally, a regression analysis was used to determine if childhood adversity 
moderated the association between log hair cortisol at T2 and birthweight. Results 
indicated that log hair cortisol at T2 and childhood adversity predicted approximately 
11% of variability in birthweight in the current sample, with neither childhood adversity 
nor hair cortisol T2 significantly predicting birthweight.  Adding an interaction term of 
log hair cortisol at T2-by-childhood adversity explained an additional 15% of variability 
in birthweight, which was significant (N=28: race dichotomous: White 15, non-White 13, 
beta= 29.33, p= .05). The Johnson-Neyman technique was used to further explore the 
moderating effects of childhood adversity on the relationship between hair cortisol and 
birthweight.  Results identified values on the Childhood Trauma Questionnaire (CTQ) 
equal or above 51.9 as a boundary for the region of significance (at alpha = .05).  In the 
present sample, 10% of women scored greater than this boundary. 
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Figure 8. Childhood adversity interaction with hair cortisol levels at T2: birth weight 
(N=28). 
 
As seen in Figure 8, childhood adversity interacted with hair cortisol levels at T2, 
such that women exposed to high levels of childhood adversity in combination with 
higher hair cortisol had infants with greater birthweight. In contrast, women in late 
pregnancy with lower childhood adversity had no association between hair cortisol and 
birthweight (N=28: White 15, non-White 13, beta= 38.43, p= .02). Given the small 
sample size in this analysis, caution should be used in its interpretation. It is contrary to 
what was hypothesized. 
Next, a regression analysis was used to determine if childhood adversity 
moderated the association between log hair cortisol at T1 gestational age.  Results 
indicated that childhood adversity and log hair cortisol at T1 predicted approximately 
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13% of variability in gestational age in the current sample, with neither childhood 
adversity nor hair cortisol at T1 significantly predicting gestational age.  Adding an 
interaction term of log hair cortisol at T1-by-childhood adversity explained an additional 
<1% of variability in gestational age, which was not significant.  
Finally, a regression analysis was used to determine if childhood adversity 
moderated the association between log hair cortisol at T2 and gestational age.  Results 
indicated that log hair cortisol at T2 and childhood adversity predicted approximately 
25% of variability in gestational age in the current sample, with neither childhood 
adversity nor hair cortisol at T2 significantly predicting gestational age.  Adding an 
interaction term of log hair cortisol atT2-by-childhood adversity explained an additional 
24% of variability in gestational age, which was significant (N=28, race dichotomous, 
White 15, non-White 13, beta= .10, p= .04). The Johnson-Neyman technique was used to 
further explore the moderating effects of childhood adversity on the relationship between 
hair cortisol and gestational age.  Values on the Childhood Trauma Questionnaire (CTQ) 
equal or above 50.5 defined the boundary for the region of significance (at alpha = .05).  
In the present sample, 10% of women scored greater than this boundary. 
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Figure 9. Childhood adversity interaction with hair cortisol at T2: gestational age (N=28).  
 
As seen in Figure 9 (above) women in the late pregnancy with higher childhood 
adversity had a positive relationship between hair cortisol and gestational age, whereas 
women in late pregnancy with lower childhood adversity had no association between hair 
cortisol and gestational age. Given the small sample size (N=28) in this analysis, caution 
should be used in its interpretation.  It is contrary to what was hypothesized.   
Also it should be noted that no correction for the familywise Type 1 error was 
applied as all of the analyses were performed based on theory-driven a priori hypotheses. 
Post Hoc Evaluation 
In the post hoc evaluation, first CTQs subscales were evaluated to determine what 
specific subscales were associated with the key biological and psychological variables.  
Bonferonni correction was used to control for the familywise Type 1 error.  Accordingly, 
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alpha level for the following analyses was set at .005.  When looking at the CTQ total 
and subscales, only emotional neglect and physical abuse were correlated with IL6 at T2 
(N= 30 r=.346, p= .05, N= 30 r= .447, p= .01, respectively).  None of the other subscales 
(emotional abuse, physical neglect, or sexual abuse) were correlated with the biologic 
variables (IL6, TNF alpha or hair cortisol). For psychological variables, the CTQ total 
and each of the subscales were correlated with perceived stress at T1 and T2, while 
approaching significance on sexual abuse at both T1 and T2. Both the CTQ total and each 
of the subscales, except on sexual abuse, were highly correlated with depression risk 
measures (CESD and EDS) at both.  Additionally, state anxiety (STAI) at T1 was highly 
correlated with total CTQ and all subscales, except for sexual abuse.  Further, anxiety 
(STAI) at late pregnancy, physical abuse and neglect were highly correlated with total 
CTQ, while emotional neglect approached significance; while both sexual abuse and 
emotional abuse were not correlated with CTQ subscales (see Table 55 below).  These 
positive associations suggest that the subscales may provide additional information 
regarding the impact of emotional and physical neglect and abuse, in addition to sexual 
abuse, which influence the impact of stressors across pregnancy.   
 
 
  
Table 55. Correlations: Key Distress Variables with CTQ Subscales with PSS 
 
 
Emotional 
Neglect 
Emotional 
Abuse 
Physical 
Neglect 
Physical  
Abuse 
Sexual 
Abuse 
PSS T1 r .472
*
 .483
*
 .565
*
 .436
*
 .257 
PSS T2 r .355 .352
 
 .426 .468 .318 
* Bonferroni Correction p <.005  
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Table 56. Correlations: Key Distress Variables with CTQ Subscales with CES-D 
 
* Bonferroni Correction p< .005 
 
Table 57. Correlations: Key Distress Variables with CTQ Subscales with EDS 
 
* Bonferroni Correction p< .005  
 
Table 58. Correlations: Key Distress Variables with CTQ Subscales with STAI 
 
* Bonferroni Correction p < .005 
 
Table 59. Correlations: Key Distress Variables with CTQ Subscales with POMS-65 
 
* Bonferroni Correction p< .005 
 
Emotional 
Neglect 
Emotional 
Abuse 
Physical 
Neglect 
Physical  
Abuse 
Sexual 
Abuse 
CESD T1 r .511
 *
 .484
*
 .655
*
 .493
*
 .212 
CESD T2 r .623
*
 .517
 *
 .574
*
 .635
*
 .236 
 
Emotional 
Neglect 
Emotional 
Abuse 
Physical 
Neglect 
Physical  
Abuse 
Sexual 
Abuse 
EDS T1 r .356 .335 .408 .289 .123 
EDS T2 r .348 .248 .406 .371 .239 
 
Emotional 
Neglect 
Emotional 
Abuse 
Physical 
Neglect 
Physical  
Abuse 
Sexual 
Abuse 
STAI T1 r .433
*
 .408
*
 .410
*
 .387 .291 
STAI T2 r .344 .299 .458 .470 .209 
 
Emotional 
Neglect 
Emotional 
Abuse 
Physical 
Neglect 
Physical  
Abuse 
Sexual 
Abuse 
POMS T1 r .349 .361 .281 .406 .245 
POMS T2 r .543
*
 .439 .569
*
 .558
*
 .125 
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Table 60. Correlations: Key Distress Variables with CTQ Subscales with PSQI 
 
* Bonferroni Correction p< .005 
 
Table 61. Correlations: Key Distress Variables with CTQ Subscales with SPA 
 
* Bonferroni Correction p < .005 
 
Group Differences in Stressors, Depression, Anxiety and Social Support, for  
Low versus High Income Women 
In the post hoc evaluation, independent t-test was used to evaluate differences in 
stressors in low versus high-income women as illustrated in Table 62.  In this sample, 
women with low income had differences in mean psychological variables compared to 
women with higher income.  Specifically, women with lower income had greater mean 
scores on depression (CESD T1), and lower mean scores on social support (SPA T1).  
Further, women that were economically disadvantaged had greater depression (risk), 
anxiety, and lower social support across pregnancy. Bonferonni correction was used to 
control for the familywise Type 1 error was set at p< .005. 
  
 
Emotional 
Neglect 
Emotional 
Abuse 
Physical 
Neglect 
Physical  
Abuse 
Sexual 
Abuse 
PSQI T1 r .331 .162 .290 .168 -.06 
PSQI T2 r .293 .099 .264 .141 -.129 
 
Emotional 
Neglect 
Emotional 
Abuse 
Physical 
Neglect 
Physical  
Abuse 
Sexual 
Abuse 
SPA T1 r -460
*
 -.393 -.597
*
 -.427
*
 -.288 
SPA T2 r -.651
*
 -.502
*
 -.740
*
 -.649
*
 -.235 
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Table 62. Differences in Psychological Variables in High versus Low Income Women: 
Income (Cut Score) and Psychological Distress Variables 
 
 Below 60K Income Above 60K Income 
t-test 
Effect 
Size 
(d)  N M SD N M SD 
EDS T1 31 8.0 5.8 33 5.5 3.4 t(61)=2.54 .74 
EDS T2 20 5.9 4.8 22 3.5 2.9 t(40)=1.95 .70 
CESD T1 31 17.1 12.9 30 8.9 9.5 t(62)=2.90* .78 
STAI T1 31 40.7 13.9 33 32.4 10.9 t(62)=2.66 .68 
STAI T2 18 39.9 13.6 21 30.0 9.7 t(39)=2.64 .86 
SPA T1 31 79.9 11.5 33 88.7 6.9 t(62)=3.68* 1.06 
SPA T2 20 83.8 9.3 21 89.8 9.3 t(39)=2.07 .66 
Perceived Stress Scale (PSS); Edinburgh Depression Scale (EDS); Center for Epidemiologic Studies 
Depression Scale (CESD); State-Trait Anxiety Inventory (STAI); Profile of Mood States – Mood 
Disturbance (POMS-65); Childhood Trauma Questionnaire (CTQ); Maternal childhood adversity; Social 
Provisions Scale – Social Support (SPA); 
Income Cut Off = $60,000/year (60K) 
* Bonferroni Correction P>. 005 
Effect size d= range 0-2; .2=small, .5=medium, .8=large. 
 
Social support is important during pregnancy.  Therefore, social support was 
investigated looking at differences in women above and below the cut score based on 
normative mean values.  An independent t-test revealed that perceived stress (PSS) at T1 
was significantly higher for pregnant women with social support levels below the cut 
score than for women above cut score (see Table 63).  An independent t-test revealed that 
at mid-pregnancy there were mean differences in perceived stress (PSS), depression 
(CES-D) anxiety (STAI) and mood disorder (POMS-65) in pregnant women with low 
social support (below the cut score) than for women with high social support (above the 
cut score). Bonferonni correction was used to control for the familywise Type 1 error was 
set at .008. 
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Table 63. Differences in Psychological Variables in High versus Low Social Support  
 Low Social Support T1 High Social Support T1 
t-test 
Effect 
Size (d)  N M SD N M SD 
PSS T1 12 24.5 8.2 52 14.3 5.6 t(62)=5.27* 1.34 
EDS T1 12 11.3 6.6 51 5.7 3.7 t(61)=2.89 1.62 
CESD T1 12 29.6 13.6 52 9.1 7.4 t(62)=5.04* 2.85 
STAI T1 12 53.8 10.2 52 32.5 10.0 t(62)=6.54* 3.25 
POMS-65 
T1 8 56.3 35.7 45 13.9 15.5 t(51)=3.29* 2.40 
CTQ 9 47.3 24.0 36 30.5 6.3 t(43)=2.08 1.45 
Perceived Stress Scale (PSS); Edinburgh Depression Scale (EDS); Center for Epidemiologic Studies 
Depression Scale (CESD); State-Trait Anxiety Inventory (STAI); Profile of Mood States – Mood 
Disturbance (POMS-65); Childhood Trauma Questionnaire (CTQ); Maternal childhood adversity;  
Social Support Cut Score >78; 
* Bonferroni Correction P<.008 
Effect size d= range 0-2; .2=small, .5=medium, .8=large. 
 
Women with higher maternal childhood adversity with greater CTQ scores had 
greater depression (EDS T1), anxiety (STAI T1), and lower social support (SPA T1 and 
T2, approaching significance) using uncorrected correlations. 
Post-hoc analysis was conducted to determine differences in psychological 
variables in women stratified into high versus low childhood adversity (using median 
split). As illustrated in Table 64, women who had higher exposure to childhood adversity 
reported significantly higher levels of depression at mid-pregnancy (EDS). Bonferonni 
correction was used to control for the familywise Type 1 error was set at .008. 
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Table 64. Differences in Psychological Variables in High versus Low Maternal 
Childhood Adversity (CTQ) 
 
 Low CTQ High CTQ 
t-test 
Effect 
Size (d)  N M SD N M SD 
PSS T1 23 14.3 5.3 22 18.6 9.1 t(43)=1.96 1.03 
EDS T1 22 5.0 .7 22 9.2 5.8 t(33)=2.95* .68 
CESD T1 23 10.7 8.2 22 17.7 15.2 t(32)=1.92 .67 
STAI T1 23 33.4 10.4 22 42.0 16.1 t(36)=2.01 .62 
SPA T1 23 86.0 7.7 22 80.1 13.6 t(33)=1.78 .62 
SPA T2 17 88.9 5.1 15 81.8 13.6 t(17)=1.91 .92 
Perceived Stress Scale (PSS); Edinburgh Depression Scale (EDS); Center for Epidemiologic Studies 
Depression Scale (CESD); State-Trait Anxiety Inventory (STAI); Profile of Mood States – Mood 
Disturbance (POMS-65); Childhood Trauma Questionnaire (CTQ); Maternal childhood adversity; Social 
Provisions Scale – Social Support (SPA); 
Maternal Childhood Adversity Cut Score = Scale Median  
* Bonferroni Correction P<.008 
Effect size d= range 0-2; .2=small, .5=medium, .8=large. 
 
Post Hoc Analysis:  
Childhood Adversity as a Moderator of the Distress Composite 
Score on Infant Outcomes 
A regressions analysis was used to determine if childhood adversity moderated 
the association between the Distress Composite Score at T1 and birthweight, controlling 
for BMI at T1, race as dichotomous variable, and pregnancy complications.  Results 
indicated that the Distress Composite Score at T1 and childhood adversity predicted 
approximately 34% of variability in birthweight in the current sample, with Distress 
Composite Score T1 and pregnancy complications, significantly predicting birthweight 
(N=35, beta=-277.63, p=.04, beta=-660.18, p=.002, respectively) while maternal 
childhood adversity did not predict birthweight. Adding an interaction term of Distress 
Composite Score T1-by-childhood adversity explained an additional 5% of variability in 
birthweight, which was not significant. For further clarification, there were significant 
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and negative main effects of Distress Composite Score T1 and pregnancy complications 
on birthweight but not an interaction with childhood adversity. 
Finally, a regression analysis was used to determine if childhood adversity 
moderated the association between the Distress Composite Score at T2 and birthweight, 
controlling for BMI at T1, race as a dichotomous variable, and pregnancy complications.  
Results indicated that the Distress Composite Score at T2 and childhood adversity 
predicted approximately 13% of variability in birthweight in the current sample, but this 
was not significant. Adding an interaction term of Distress Composite Score T2-by-
childhood adversity explained an additional 24% of variability in birthweight, which was 
significant (N= 23, beta= -14.71, p=.02). The Johnson-Neyman post hoc analyses 
revealed that for women who scored greater than 56.3 on the Childhood Trauma 
Questionnaire (approximately 10% of the present sample), the negative relationship 
between Distress Composite Score and birthweight was significant.  That is, women who 
had higher Distress Composite Score were more likely to deliver lower birthweight 
babies if they reported greater exposure to childhood adversity (≥56.3).      
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Figure 10. Post hoc analysis, showed a negative relationship between Distress Composite 
Score in late-pregnancy and birth weight (N=23). 
 
Similarly, There were no main or interaction effects when looking at the 
regressions analysis used to determine if childhood adversity moderated the association 
between Distress Composite Score T1 and gestational age, while controlling for BMI at 
T1, race (dichotomous variable), and pregnancy complications.  There were no main 
effects of interaction between Distress Composite Score T1 and maternal childhood 
adversity.  Results indicated that Distress Composite Score T1 and childhood adversity 
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predicted approximately 22% of variability in gestational age in the current sample, with 
pregnancy complications, significantly predicting gestational age (beta=-1.85, p=.04) 
while Distress Composite Score T1, and maternal childhood adversity did not predict 
gestational age. Adding an interaction term of Distress Composite Score T1-by-childhood 
adversity explained an additional 2% of variability in gestational age, which was not 
significant. 
Finally, there were no main effects but an interaction effect between the 
moderator, maternal childhood adversity, and Distress Composite Score at T2, and infant 
gestational age, controlling for BMI at T1, race as dichotomous variable, and pregnancy 
complications.  Results indicated that Distress Composite Score at T2 and childhood 
adversity predicted approximately 36% of variability in gestational age in the current 
sample, with Distress Composite Score at T2 and maternal childhood adversity did not 
predict predicting gestational age.  Adding an interaction term of Distress Composite 
Score at T2-by-childhood adversity explained an additional 24% of variability in 
gestational age, which was significant (N=23, beta= -.036, p=.04). The Johnson-Neyman 
post hoc analyses revealed that for women who scored greater than 49.4 on the 
Childhood Trauma Questionnaire (approximately 13% of the present sample), the 
negative relationship between Distress Composite Score and birthweight was significant.  
That is, women who had higher Distress Composite Score were more likely to deliver 
lower gestational age babies if they reported greater exposure to childhood adversity 
(≥49.4).      
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Figure 11.  Post hoc analysis, showed a negative relationship between Distress Composite 
Score at Time 2 and gestational age (N=23) 
 
Thus, there is a negative relationship between Distress Composite Score at T2 and 
gestational age in women with high maternal childhood adversity, whereas this effect is 
not apparent with women with low childhood adversity. Maternal childhood adversity 
moderated the relationship between the Distress Composite Scores and infant gestational 
age, such that women with greater childhood adversity and higher Distress Composite 
Score at T2 delivered infants with lower gestational age (i.e., earlier delivery). 
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CHAPTER FIVE 
DISCUSSION 
Introduction  
 The overall purpose of this chapter is to discuss key study findings, convergence 
and divergence from previous research, and implications for the health of pregnant 
women and their newborns.  A successful pregnancy is vital to the health of future 
generations, and research to improve maternal infant health, including psychological 
well-being, is a national priority (People, 2011).  Yet maternal-child outcomes can be 
jeopardized by a variety of environmental influences. Evolving evidence suggests that 
exposure to maternal stressors and mood disturbance negatively impact maternal mental 
health, birth outcomes, and subsequent child development (de Weerth & Buitelaar, 2005; 
Diego et al., 2006; Van den Bergh, Van Calster, Smits, Van Huffel,  & Lagae, 2008).  
However, the underlying biological mechanisms are poorly understood.  Further, little is 
known about the effect of prior life (antenatal) adversity on psychological, 
neuroendocrine and inflammatory responses of women who face the adaptive challenges 
inherent to pregnancy and anticipation of parenting.   
The overarching objective of this project was to evaluate the influence of a 
woman’s history of childhood adversity on her psychological, neuroendocrine, and 
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proinflammatory profile during her pregnancy.  In addition, the effect of maternal 
childhood adversity on infant outcomes was evaluated. 
The central hypothesis was that adverse childhood experiences prior to pregnancy 
prime stress response systems, leading to greater psychological distress, neuroendocrine 
activation, and dysregulated proinflammatory cytokine levels.  Such alterations in 
maternal stress-response systems may contribute to poor infant outcomes. It is anticipated 
that the results of this investigation will have the potential to positively impact maternal-
infant health, by contributing to better identification of antenatal psychosocial risk that 
portend poor maternal-child health outcomes. 
Summary of Key Study Findings 
Psychological Status 
Women enrolled in this study reported elevated levels of stress perception, with 
63% and 52% scoring above the normative mean value for the PSS at mid-pregnancy 
(T1) and late pregnancy (T2), respectively.  Forty-one percent of women reported high 
levels of state anxiety at mid-pregnancy, while only 24% had high anxiety at late 
pregnancy. Sleep disturbance was high, with nearly 60% of women scoring above the 
PSQI cut-score at both mid- and late-pregnancy.  Twenty-eight percent of women at mid-
pregnancy (T1) had CES-D scored at or above the cut-score (>16), suggesting risk for 
depression. As pregnancy progressed, only 7% of women scored above the cut-score for 
depressive risk at T2; however this decrease may have been influenced by attrition of 
subjects from T1 to T2.  An evaluation of differences in psychological status by 
household income (above and below $60,000) revealed that women with household 
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incomes less than $60,000 reported significantly greater levels of depression (CES-D) 
and lower social support.  These findings demonstrate that women with lower income 
have greater risk for psychological morbidity during pregnancy. 
Childhood Adversity 
To date few studies have evaluated the influence of maternal childhood adversity 
on maternal prenatal mental health and birth outcomes, as accomplished in this study.  
Women enrolled in this study experienced childhood trauma in the low to moderate range 
of intensity, and of the five CTQ subscales, the most frequent forms of adversity were 
emotional abuse and neglect and physical neglect.  Frequency of adversity for each 
subscale ranged from 15% to 23%. 
Key findings demonstrated that at mid-pregnancy and late-pregnancy, higher 
levels of maternal childhood adversity (CTQ) were associated with higher levels of 
perceived stress (PSS), depression (EDS and CES-D), anxiety (STAI-State), and lower 
social support (SPA).  With respect to CTQ subscales, emotional neglect was positively 
related to perceived stress (PSS T1), depression (CES-D T1 and T2), anxiety (STAI T1), 
and mood disorder (POMS-65 T2), and negatively related to social support (SPA T1 and 
T2). Emotional abuse was positively related to perceived stress (PSS T1), depression 
(CES-D T1and T2), and anxiety (STAI T1), and negatively related to social support (T2). 
Additionally, physical neglect was positively related to perceived stress (PSS T1), 
depression (CES-D T1and T2), anxiety (STAI T1), and mood disorder (POMS-65 T2), 
and negatively related to social support (SPA T1 and T2). Physical abuse was positively 
related to perceived stress (PSS T1), depression (CES-D T1and T2), and mood 
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disturbance (POMS-65–total score T2), and negatively related to social support (SPA T1 
and T2).  Mean differences in depression (EDS) were observed in women above the 
normative mean cut-score for the CTQ when compared to women below the cut-score.  
Distress Composite Score 
Unlike prior studies, which measured only stress perception or mood, in the 
present study a Distress Composite Score was derived to provide a more comprehensive 
and integrated index of maternal stress perception, which included the 
emotional/behavioral response to that perception.  Findings revealed that women 
exposed to greater levels of childhood adversity had higher Distress Composite Scores. 
Furthermore, women who had higher Distress Composite Scores and higher levels of 
childhood adversity delivered infants with lower birthweight and lower gestational age. 
Sleep Quality 
 Sleep disturbance was found to be an important predictor of worse psychological 
well-being during pregnancy. In the present sample, over 50% of women reported poor 
and interrupted sleep at mid- and at late-pregnancy; while increased sleep disturbance 
(global PSQI) was associated with greater perceived stress, depressive risk (both EDS 
and CES-D), anxiety (STAI), and mood disturbance—but with lower social support 
(SPA). Moreover, poor sleep during late pregnancy was associated with lower 
birthweight and earlier gestational age. 
Social Support 
Social support emerged as an important moderator of maternal mental health and 
infant outcomes.  Women with greater exposure to childhood adversity reported having 
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lower social support at both mid-pregnancy and late-pregnancy.  Moreover, social 
support moderated the association between childhood adversity and birthweight.  Those 
results revealed that women who experienced greater childhood adversity, together with 
less social support during their pregnancy, delivered infants with lower birthweight; in 
contrast, this effect was attenuated in women who reported higher levels of social 
support. In a similar manner social support also attenuated the association between 
childhood adversity and gestational age. These findings are significant as they suggest 
social support buffers the negative impact of maternal childhood adversity on infant 
birthweight.  As such, these findings support the assessment of a women’s level of social 
support as part of her prenatal care, as well as the incorporation of approaches aimed at 
fostering meaningful social relationships in pregnant women.   
Proinflammatory Cytokines 
It is well-established that proinflammatory cytokines play a role in embryo 
implantation and timing of delivery, and levels of these cytokines can be influenced by 
maternal psychological distress (Challis et al., 2009).  A key finding of this study was 
that childhood adversity moderated the association between IL-6 and infant outcomes.  
That is, women with a history of greater childhood adversity who had higher circulating 
levels of IL 6 in late-pregnancy (T2) delivered lower birthweight infants and infants with 
earlier gestational age.  Furthermore, an analysis of the five subscales within the CTQ 
revealed that physical abuse was positively correlated with circulating levels of IL-6 at 
T2 (controlling for pre-pregnancy BMI).  
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Hair Cortisol 
Hair cortisol was measured in this study as an index of total HPA activation over 
the preceding three months. The findings revealed that hair cortisol was not correlated 
with key psychosocial variables or CTQ subscales at mid-pregnancy or late-pregnancy. 
These findings are inconsistent with earlier work showing that higher levels of hair 
cortisol correlated with increased psychological distress during pregnancy (Karlen, 
Frostell, Theodorsson, Faresjo, & Ludvigsson, 2013) (Kalra, Einarson, Karaskov, Van 
Uum, & Koren, 2007). The lack of finding such a relationship in the present study may 
be due to the small sample size.  Furthermore, it is important to note that the 
psychometric instruments did not ask women to assess each psychological construct over 
the past three months (as hair cortisol does); and this difference in time domain may have 
impacted the study findings.  However, results from the present study revealed that 
maternal childhood adversity moderated the association between hair cortisol and 
birthweight; such that women evaluated during the third trimester who were exposed to 
greater childhood adversity and higher concentrations of hair cortisol had infants with 
greater birthweight. Similarly, maternal childhood adversity moderated the association 
between hair cortisol and gestational age late in pregnancy; such that women with greater 
childhood adversity and higher hair cortisol delivered infants with greater gestational age.  
 The discussion of key findings is organized under the following topics: Maternal 
Childhood Adversity and Psychological Morbidity; Stress, Inflammation and Infant 
Outcomes; Other Factors Related to Inflammation and Birth Outcomes; Stress Perception 
and Distress Composite Score; Maternal Depression and Inflammation; Sleep 
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Disturbance During Pregnancy; Social Support During Pregnancy; Hair Cortisol and 
Stress Perception; Hair Cortisol and Infant Outcomes; Limitations; Conclusions and 
Implications.  Of note, findings related to levels of proinflammatory cytokines and 
neonatal outcomes are integrated throughout. 
Discussion of Key Findings 
Maternal Depressive Symptoms and Inflammation 
A major objective of this study was to evaluate the impact of maternal childhood 
adversity on psychological well-being of pregnant women, infant birthweight, and 
gestational age.  Childhood abuse and/or maltreatment are a major public health issues, as 
they are associated with later life risky behaviors as well as adult mental and physical 
health problems (Molnar, Buka, & Kessler, 2001; Seng, Sperlich, & Low, 2008). A 
surprising number of women experience some form of childhood abuse or maltreatment.  
For example, findings from a community-based sample (Memphis, Tennessee; N=947) of 
women revealed that as many as 30% of women experienced enduring childhood abuse, 
neglect, or hardship (Scher, Forde, McQuaid, & Stein, 2004). The most common forms of 
trauma were physical abuse, physical neglect, and emotional abuse. A more recent 
population-based epidemiologic study (Boston Area Community Health Survey; 
N=3,201) revealed the prevalence of childhood physical, emotional, and sexual abuse in a 
diverse community-dwelling sample of women to be 21%, 19%, and 26%, respectively 
(Chiu et al., 2013). Further, such adversity is even more common in women raised under 
conditions of socioeconomic disadvantage (Holzman et al., 2006).   
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Early life adversity is known to have long-lasting effects on adult stress reactivity 
and mental health, particularly risk for depression (Molnar et al., 2001). Yet few studies 
have evaluated the impact of early life adversity on maternal psycho-neuro-immune 
profile and infant outcomes, as in the present investigation.  For this study, maternal 
childhood adversity was measured retrospectively using the Childhood Trauma 
Questionnaire (CTQ).  The CTQ assesses childhood trauma in five domains: emotional 
neglect and abuse, physical neglect and abuse, and sexual abuse.  For women in the 
present sample, the intensity of childhood trauma was in the low to moderate range; and 
frequency for each of the subscales ranged from 15-23%.  
Findings from this study revealed that women exposed to higher levels of 
childhood adversity had significantly higher levels of perceived stress and anxiety, as 
well as increased depressive risk (CES-D and EDS).  There is a limited literature linking 
exposure to childhood adversity with poorer maternal mental health during pregnancy 
(Lang, Rodgers, & Lebeck, 2006).  Of note, Rich-Edwards and colleagues reported a 
26% higher risk for depression during pregnancy in women exposed to abuse during 
childhood or adolescence. This larger risk was observed in two economic and ethnic 
distinct cohorts (Rich-Edwards et al., 2011), suggesting that childhood adversity impacts 
women independent of income and ethnicity. Yet others do find that the association 
between childhood adversity and prenatal depression is especially strong among 
disadvantaged women, possibly contributing to health disparities in birth outcomes 
(Holzman et al., 2006).  In the present study, an evaluation of CTQ scores based on 
income revealed no differences, likely reflecting the fact that most participants had 
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household incomes above the federal poverty line. Furthermore, an evaluation of CTQ 
scores and subscales of the CTQ revealed no mean differences based on race (White 
n=21, non-White n=32); yet, the sample size is small and evaluation of racial differences 
in CTQ is underpowered. 
Overall the results of the present study add to growing evidence linking childhood 
adversity to poor mental health during pregnancy. Most importantly, the findings 
demonstrate a significant correlation between childhood adversity and depressive 
symptoms; that is, higher scores on the CTQ were significantly related to higher scores 
on the CES-D T1 and T2 (general depressive risk at both mid and late-pregnancy), as 
well as the EDS T1 (pregnancy depressive risk at mid-pregnancy). Additionally, higher 
CTQ scores were significantly related to higher scores on PSS T1 (perceived stress at 
mid-pregnancy) and STAI T1 (anxiety at mid-pregnancy). Others have shown that greater 
maternal depressive symptoms are related to lower birthweight (Grote et al., 2010) and to 
poor neurobehavioral outcomes (Field, 2011). Thus, finding a positive relationship 
between childhood adversity and depressive symptoms is not inconsequential, but 
suggests that childhood adversity is an important vulnerability factor for prenatal 
depressive risk.   
Lastly, women in the present study who reported greater exposure to childhood 
adversity also reported less social support during their pregnancy.  Given that this data is 
correlative, it is impossible to determine if these two variables are causally related.  Yet, 
these results suggest that pregnant women who have greater childhood adversity may be 
in need of more supportive relationships. Social support reduces maternal depressive 
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symptoms (Razurel & Kaiser, 2015) and  levels of psychological distress (Iranzad, Bani, 
Hasanpour, Mohammadalizadeh, & Mirghafourvand, 2014; S., Hasanpour, S. et al, 
2014).  Given that childhood adversity has been linked to increased lifetime risk of 
depression in non-pregnant women (Gilman, Kawachi, Fitzmaurice, & Buka, 2003) 
(Gilman, Kawachi, Garrett, & Buka, 2002), social support may provide psychological 
benefit to pregnant women exposed to childhood adversity (Gilman et al., 2003; Gilman 
et al., 2002).   
Stress, Inflammation, and Infant Outcomes  
Pregnancy is characterized by defined fluctuations in the circulating levels of 
immune-derived inflammatory molecules (Challis et al., 2009), which influence the 
timing of gestation and fetal growth (Challis et al., 2009). In normal pregnancy the first 
and third trimesters are predominately characterized by a proinflammatory milieu, 
whereas the second trimester is dominated by an anti-inflammatory milieu (Mor, 
Cardenas, Abrahams, & Guller, 2011). As demonstrated in prior research, increased 
maternal distress perception during pregnancy can lead to elevations in proinflammatory 
cytokines, particularly IL-6 and TNF-alpha (Coussons-Read et al., 2007; Coussons-Read 
et al., 2005). Disruption in the balance of pro- and anti-inflammatory cytokines is also 
implicated in adverse birth outcomes, such as intrauterine growth restriction (J. R. Challis 
et al., 2009) and onset of premature labor and parturition (Romero et al., 1989; Hillier et 
al., 1993). Others (Georgiou et al., 2011) have shown that of 21 cytokines/chemokines 
measured at 7-10 weeks gestation, increases in proinflammatory cytokines (interferon-γ, 
interleukin [IL]-2, -7, -12) and decreases in anti-inflammatory cytokines (IL-1 receptor 
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antagonist, -4, -10, -13) were associated with small for gestational age infants 
(Andersgaard et al.). In addition, eotaxin and macrophage inflammatory protein-1α were 
higher; and monocyte chemoattractant protein-1 and IL-8 were lower (Georgiou et al., 
2011). Others demonstrated a significant correlation between elevated inflammatory 
markers in cord blood from SGA infants, suggesting an inflammatory process in 
intrauterine growth restriction (Lausten-Thomsen, Olsen, Greisen, & Schimiegelow, 
2014).  A more recent integrated review concluded that the most consistent finding within 
this literature is that increased levels of proinflammatory cytokines (measured in blood), 
especially IL-6, IL-1beta, and TNF-alpha, are associated with preterm birth. However, 
those authors note that there are relatively few studies and results are inconsistent (Lyon 
et al., 2010).   
The findings from the present study did not reveal any relationships between 
proinflammatory cytokines (IL-6 and TNF-alpha) and infant birthweight or gestational 
age (when applying the Bonferroni correction). It is likely that the small sample size and 
low number of low birth weight and preterm births reduced the likelihood of finding such 
a relationship.  Nevertheless, there remains a need for further research to determine if and 
how proinflammatory cytokines during pregnancy contribute to poor infant outcomes.  
Furthermore, as discussed below, maternal exposure to childhood adversity may interact 
with the proinflammatory environment of pregnancy to influence birth outcomes. 
Maternal Childhood Adversity, Inflammation, and Infant Outcomes 
 Low birthweight (LBW) is a significant public health problem, as LBW is not 
only associated with complications in the neonatal period, but is also linked to worse 
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health for such infants over their life span (Barker, 2002; Rich-Edwards et al., 2011; 
Rich-Edwards et al., 2005).  Importantly, a series of investigations find LBW to be linked 
to major adult chronic disease, such as cardiovascular disease, obesity, and diabetes 
(Oken & M.W., 2003; Whincup et al., 2008). These observations have given rise to the 
fetal origins of disease theory; also, referred to as the Developmental Origins of Health 
and Disease (DOHaD) theory (Barker, 2002).  Investigations aimed at understanding risk 
for infant LBW are now extending beyond the narrow window of pregnancy to include 
the examination of risk antecedent to a women’s pregnancy, including experience of 
early life adversity. Such investigations can inform the development of preventive 
strategies delivered prior to conception (i.e., pre-conception care).  In this respect, 
“prenatal care” should be expanded to incorporate a lifespan approach and to include 
intervention strategies aimed at addressing early life maternal psychosocial conditions 
(Gavin, Thompson, Rue, & Guo, 2012). 
At this time, there is a limited literature describing linkages between maternal 
early life adversity and increased risk for infant LBW (Gavin, Hill, Hawkins, & Maas, 
2011; Gavin et al., 2012; Plant, Barker, Waters, Pawlby, & Pariante, 2012). However, a 
few prospective studies find maternal low SES in childhood and exposure to maternal 
childhood hardship to be associated with delivery of LBW infants (Atstone, Misra, & 
Lynch, 2007; Gisselmann, 2006; Atstone et al., 2007).  Recent findings from a study that 
evaluated California birth records from 153,762 live singleton infants born to adolescent 
mothers concluded that maltreatment history was associated with infant LBW (<2500 
gm) (Putnam-Hornstein, Cederbaum, King, Eastman, & Trickett, 2015). [Of note, 
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maternal maltreatment history was determined based on child protection data from public 
records.]   
Currently, there is little understanding of the biological mechinisms that link 
maternal early life adversity to poor infant outcomes and this remains an area of evolving 
investigation.  Findings from the present study demonstrate that childhood adversity and 
IL-6 interact with influence infant birthweight and gestational age, which has not been 
previously reported. That is, women with a history of greater childhood adversity who 
also had higher circulating levels of IL 6 in late-pregnancy delivered infants with lower 
birthweight and earlier gestational ages. Probing this interaction using the Johnson-
Neyman technique revealed that women who scored greater than 58.1 on the CTQ were 
at significantly greater risk to have lower birthweight babies if they also had higher levels 
of plasma IL-6.  Similarly, the findings of the present study revealed a significant 
interaction between exposure to childhood adversity and plasma IL-6 levels. That is, 
women who experienced higher levels of childhood adversity and who had higher levels 
of plasma IL-6 delivered infants with earlier gestational age. Probing this interaction 
using the Johnson-Neyman technique revealed that women who scored greater than 51.1 
on the Childhood Trauma Questionnaire (CTQ) were at significantly greater risk to 
deliver lower gestational age infants if they also had higher levels of IL-6. Such findings 
regarding the interaction between maternal childhood adversity and IL-6 to influence 
infant birthweight and gestational age have not been previously reported.  
It is possible that exposure to childhood adversity modifies the inflammatory 
response to stressful life events experienced during adulthood.  Early life stress alters 
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neurobiological processes of the brain during development (including childhood), a time 
when the brain is more plastic and thus more susceptible to adverse environmental 
stimuli; and these changes persist over the lifespan (Danese and McEwen, 2011; Heim et 
al., 2010; Nemeroff, 2004).  Non-pregnant adults exposed to childhood adversity 
manifest greater emotional responsiveness to stressors (McLaughlin et al., 2010a), as well 
as an increased autonomic nervous system and dysregulated HPA stress response (Heim 
et al., 2008).  Prior work also demonstrates that early life adversity predisposes to a 
proinflammatory phenotype. For example, those who experienced lower childhood 
socioeconomic status, and likely more adversity, exhibited higher circulating levels of IL-
6 (Carroll et al., 2011). Findings from a longitudinal study demonstrated childhood 
maltreatment predicted risk for low-grade inflammation during adulthood, independent of 
adult and child socioeconomic status and health behaviors (Danese et al., 2007).  In 
response to acute stress, exposure to childhood adversity resulted in an exaggerated 
proinflammatory response. Healthy adults who experienced childhood maltreatment 
mounted a greater plasma IL-6 response to an acute laboratory social evaluative stress 
test (Trier Social Stress Test–TSST), compared to those without a history of childhood 
maltreatment (Carpenter et al., 2010).  Consistent with this finding, older adults exposed 
to childhood adversity were found to have greater circulating IL-6 and TNF-alpha levels 
when experiencing the naturalistic and chronic stress associated with caregiving for 
others with dementia (Kiecolt-Glaser et al., 2010).  Other evidence showed that this 
proinflammatory phenotype linked to early life adversity emerged during young 
adulthood, as peripheral blood mononuclear cells derived from young women raised in a 
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harsh family climate produced more IL-6 in response to in vitro challenge with 
lipopolysaccharide and in response to real life psychological stressors (Miller & Chen, 
2010). Moreover, individuals with a history of adversity during childhood are at higher 
risk for depression and mood disorders later in life, especially when under acute stressful 
situations (Chen et al., 2010b; Heim et al., 2010; Hill et al., 2000; Nemeroff, 2004), and 
pregnancy can be associated with multiple life challenges and emotional upheaval.  Leigh 
and colleagues found that women with low income and history of abuse had greater risk 
for antenatal depression (Leigh & Milgrom, 2008). In line with this, the present findings 
revealed a positive correlation between maternal childhood adversity and increased 
depressive symptoms. 
In summary, the results from the present study support the concept that childhood 
adversity interacts with elevated levels of proinflammatory cytokines to alter timing of 
birth and fetal growth.  These results add to the existing body of evidence in non-pregnant 
individuals that suggests childhood adversity engenders an adult proinflammatory 
phenotype, in turn suggesting an extension of this concept to risk of lower birthweight 
and earlier gestational age. To the author’s knowledge, this has never been reported 
previously. 
Other Factors Related to Inflammation and Birth Outcomes 
Other factors may also play a role in modulating levels of maternal 
proinflammatory cytokines.  For example, elevations in maternal inflammatory markers 
may be associated with greater BMI and this may also contribute to altered fetal growth.  
Findings from the present study revealed that higher pre-pregnancy BMI (n=60, r=.573, 
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p<.000, n=46, r=.546, p<.000), as well as higher mid-pregnancy BMI (n=60, r=.572, 
p<.000, n=46, r=.573, p<.000), was significantly associated with higher levels of 
circulating IL-6 at both T1 (second trimester) and T2 (third trimester). Of note, the 
present study relied upon maternal self-report of pre-pregnancy BMI, which may not be 
accurate, but was the only possible way to access BMI in the women participating in this 
study.  Interestingly, a recent study (Aye et al., 2014) showed that maternal BMI was not 
only associated with elevated maternal proinflammatory cytokines but also activation of 
placental inflammatory pathways; although no changes in fetal circulating inflammatory 
molecules were observed. These authors suggest that elevated maternal BMI may 
influence fetal growth by altering placental function.  Although beyond the scope of this 
dissertation research, findings from several other studies suggest that greater risk of 
small-for-gestational age (Andersgaard et al.) infants (Andersgaard et al.) is associated 
with common anti-inflammatory cytokine polymorphisms, and this may vary with race 
(Engel et al., 2005).  More recent data confirms the existence of gene-level associations 
between IL-6 and SGA among African American women (Harmon et al., 2014).  These 
findings demonstrate that both environmental and genetic risk factors can modulate 
inflammatory risk for SGA.  
In addition to inflammatory processes, health behaviors may also influence the 
relationship between childhood adversity and birth outcomes.  For example (Gavin et al., 
2012), using structural equation modeling to investigate paths whereby childhood 
adversity influenced infant birthweight, poor maternal health behaviors during adolesence 
(substance abuse and cigarette use) were found to partially mediate the relationship 
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between maternal SES and infant birthweight, indicating that maternal depressive 
symptoms and adult SES partially mediated this relationship as well.  Additionally, 
findings from that study showed maternal substance abuse and prenatal cigarette use 
partially mediated the relationship between maternal childhood maltreatment and 
offspring birthweight; and that maternal adolescent depressive symptoms and adult SES 
also partially mediated this relationship.  Women in the current sample reported low 
levels of cigarette use (3%) and alcohol use (6%), so these risk factors likely play little 
role in study findings.   
Stress Perception and Distress Composite Score  
 Perceived stress was measured at both mid and late pregnancy using the Perceived 
Stress Scale (PSS).  This is a general tool in which respondents rate how manageable 
events in their life were perceived over the past month (Cohen, Kamarck, & 
Mermelstein).  In this sample of pregnant women, 63% and 52% reported levels of 
perceived stress above the population norm of 13 during their second and third trimester 
of pregnancy, respectively; and mean levels were above the reported norms for healthy 
non-pregnant women in this age group (Sheldon Cohen & Janicki-Deverts, 2012).  
Further, mean perceived stress scores were higher in women who had experienced greater 
levels of childhood adversity, with total and subscale CTQ scores positively correlating 
with perceived stress at mid- and late-pregnancy.  Although correlative, these findings 
suggest that women who were exposed to greater adversity during their childhood are 
more likely to perceive events in their life as less manageable, escalating risk for mood 
disturbance during their pregnancy. 
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To provide a more comprehensive and multifaceted index that captures both stress 
perception and emotions/mood across pregnancy, a Distress Composite Score was 
derived based on scores from instruments measuring perceived stress (PSS), depressive 
risk (CESD), anxiety (STAI), mood disorder (POMS-65), and sleep quality (PSQI).  
Factor analysis revealed these measures comprised a single factor at both mid-pregnancy 
and late-pregnancy.  [Of note, the weakest variable in the model was sleep quality; 
however, it was maintained in the final model.]  It was anticipated that the use of a 
composite score would provide an index that more fully captured the multiple facets that 
encompass the psychological stress response; that is, inclusion of the perception of stress, 
as well as the emotional and behavioral response to stress perception.  This approach, in 
fact, did yield valuable insight as to the interactions among maternal childhood adversity, 
distress, mood, and infant birth outcomes; which were not observed when solely using 
the PSS.  Specifically, findings from evaluation of regression models revealed a 
significant interaction between the Distress Composite Score at T2 (late pregnancy) and 
childhood adversity; such that women who had higher Distress Composite Scores and 
higher levels of childhood adversity delivered lower birthweight infants.  Additional 
probing of this interaction (Johnson-Neyman post hoc analyses) revealed that for women 
who scored greater than 56.3 on the Childhood Trauma Questionnaire (approximately 
10% of the present sample), the negative relationship between the Distress Composite 
Score and birthweight was significant.  In a similar manner, regression analysis revealed 
a significant interaction between the Distress Composite Score at T2 and childhood 
adversity, such that women who had higher Distress Composite Scores and higher levels 
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of childhood adversity delivered infants with lower gestational age.  Probing this 
interaction (i.e., Johnson-Neyman post hoc analyses) revealed that for women who scored 
greater than 49.4 on the Childhood Trauma Questionnaire (approximately 13% of the 
present sample), the negative relationship between Distress Composite Score and 
birthweight was significant.   
Together these findings suggest that women with exposure to higher levels of 
childhood adversity together with higher Distress Composite Scores delivered infants 
with lower birthweight and earlier gestational age (i.e., earlier delivery).  These findings, 
however, are limited in that this was a convenience sample of low-risk pregnant women, 
who overall had a low incidence of preterm and low birth weight infants (based on 
clinical definitions), compared to high risk pregnant women.  As noted earlier, the 
national rate of premature delivery is 11.4%, while low birthweight delivery accounts for 
8.0% of births (Martin et al., 2015).  Premature delivery in the present study was slightly 
lower than national average (9%), but consistent with the incidence of low birthweight 
delivery (8.6%).  As well, preterm infants vary by race and ethnicity, with higher rates for 
African American women (16.8%) and Hispanic women (12.1%), compared to White 
women (10.5%) (March of Dimes, 2015).  Thus, future studies should enroll high-risk 
pregnant women to gain further insight as to the role of exposure to maternal 
psychological stressors and early life adversity on infant outcomes. 
Nevertheless, the above results are consistent with a growing body of evidence 
which documents that maternal prenatal daily hassles, depression, anxiety, and the 
experience of negative life events during pregnancy, result in earlier delivery and lower 
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birthweight infants (Talge, 2007).  Notably, a recent meta-analysis (Littleton, Bye, Buck, 
& Amacker, 2010 & Amacker, 2010) of 35 studies (N=31,323 women) demonstrated that 
exposure to psychosocial stressors during pregnancy was significantly associated with 
risk for low birthweight; but this association, although significant, was very small.  The 
authors concluded that other lifestyle variables and/or risk factors (i.e., vulnerability 
factors) need to be considered in combination with measures of psychosocial distress to 
more fully address the role of prenatal distress on prematurity and birthweight.  As the 
results of the present study suggest, maternal childhood adversity represents a potentially 
important prenatal (and pre-conceptual) vulnerability factor for poor neonatal outcomes. 
Maternal Depressive Symptoms and Inflammation 
Depression during the prenatal period has major consequences for mothers and 
their children, including greater risk for prematurity, low infant birthweight (Grote et al., 
2010), and poor neurobehavioral outcomes (Field, 2011).  However, the biological 
pathways mediating risk for depressive disorders in the perinatal period remains to be 
clarified. Many potential mechanisms are currently investigated and these include genetic 
risk (Mahon et al., 2009), dysregulation of the HPA axis (Brummelte & Galea, 2010; 
Groer & Morgan, 2007), sensitivity to changes in steroid hormone levels (Brummelte & 
Galea, 2010) (Bloch et al., 2000) and altered levels of proinflammatory cytokines 
subsequent to sleep disruption (Okun & Coussons-Read, 2007; Okun et al., 2007).  
Women enrolled in this study reported mean CES-D scores of 12.9 and 7.8 for T1 
and T2, respectively. At T1 28% of the women scored above the established CES-D score 
(>16), suggesting risk for depression; while only 7% scored above this score at T2, 
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suggesting that depressive risk numerically decreased with progression of pregnancy. 
However, it is also possible that the women who did not complete the T2 time-point (due 
to attrition) may have been the women with greater depressive risk; hence, contributing to 
lower T2 CES-D scores. Interestingly, only 10% and 7% of the women scored above the 
cut-score on the Edinburgh Depression Scale (>13), for T1 and T2, respectively.  CES-D 
is a measure of general depressive risk, while EDS is more specific to signs and 
symptoms of depressive risk during pregnancy and the post-partum period.  It is possible 
that rates of depressive risk may be higher on the CES-D when compared to the EDS 
because the CES-D includes items that address fatigue, sleep, and other vegetative 
symptoms of depression that overlap with normal “symptoms” of pregnancy.   
 Contrary to what was hypothesized, this study did not find any relationship 
between both proinflammatory cytokines (IL-6 or TNF-alpha) and depressive symptoms 
(when applying the Bonferroni correction).  These findings do not support the 
inflammatory theory of depression, which posits that increases in circulating levels of 
proinflammatory cytokines engender symptoms of depression; however, the evidence in 
humans for this theory is largely based on studies of individuals with major depressive 
disorder (Raison, Capuron, & Miller, 2006).  For example, a recent meta-analysis found 
that compared to control subjects, individuals with major depression had significantly 
higher levels of IL-6 and TNF-α; while associations with other cytokines were not 
significant (Dowlati et al., 2010).  The exclusion of women with major depressive 
disorder likely limited the finding of a relationship between proinflammatory cytokines 
and depressive symptoms in the present study.  
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Furthermore, there are mixed findings in the literature as to whether there is any 
relationship between proinflammatory cytokines and depressive symptoms in pregnant 
and postpartum women; and this evidence was recently reviewed (Osborne & Monk, 
2013).  One key study evaluated pregnant women during the late first and early second 
trimester and found depressive symptoms (CES-D) were associated with increased 
circulating levels of IL-6 and marginally increased levels of TNF-alpha, while controlling 
for pre-pregnancy BMI (Christian et al., 2009). In that study nearly 60% of participants 
were low-income African American women, with half scoring at or above the clinical 
cut-off score for depressive risk using the CES-D.  Others also report depressive 
symptoms (CES-D) to be correlated with higher circulating levels of IL-6 and IL-1 beta, 
but not TNF-alpha, during the second trimester of pregnancy (Cassidy-Bushrow et al., 
2012).  The sample for that study included a sizable number of African American women 
with varied SES backgrounds, and almost 40% of this sample reported CES-D scores 
suggestive of depressive risk.  Additionally, 70% of the samples were overweight or 
obese (based on pre-pregnancy weight), and BMI moderated the association between 
depressive symptoms and IL-6.  Leaner women with depressive symptoms had higher 
circulating levels of IL-6, but the relationship between IL-6 and depressive symptoms 
lessened as BMI increased; these results emphasize the potential contribution of pre-
pregnancy BMI in the linkages between inflammation and depression during pregnancy.  
For the present study, pre-pregnancy BMI was controlled in order to account for any 
potential influence of adiposity on circulating levels of IL-6 and TNF-alpha. 
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In contrast to the above studies, Blackmore et al., 2014 reported no relationship 
between depressive mood and IL-6 in a sample of low income women evaluated at 18 
and 32 weeks of gestation (Blackmore Robinson, Groth, Gilchrist, O'Connor, & 
Moynihan, 2014); that study used the Edinburgh Prenatal Depression (EDS) scale.  This 
finding is consistent with the results of the present study.  However, even though the 
study by Blackmore et al. (2014) had many strong features, including large sample size, 
multiple assessment times, and within-participant comparisons, it did not include high 
risk women with diverse socioeconomic backgrounds for whom the inflammation-
depression link may be most clinically pertinent and evident.  As well, the present study 
did not enroll a substantial number of high-risk women with diverse socioeconomic 
background. In another study, White women evaluated during the second trimester 
exhibited an inverse association between depressed mood and three cytokines (IL-1 beta, 
TNF-alpha, and IL-7) (Shelton, Schminkey, & Groer, 2015). That study was limited by 
the use of the non-specific depression/dejection subscale of the Profile of Moods State 
(POMS) to measure depressive mood; and furthermore, the sample included few women 
reporting depressive symptoms, suggesting a possible ‘floor effect.’ Likewise, no 
association was found in this study between scores on the POMS subscale and 
proinflammatory cytokine levels.  
Another potential caveat is that the majority of studies investigating the 
relationship between proinflammatory cytokines and perinatal depression measured 
resting levels of circulating proinflammatory cytokines.  As pointed out by others, greater 
insight may be obtained by evaluating the proinflammatory response to a stress 
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challenge, which will induce greater variability among subjects and increase the 
possibility that individual differences will be measurable (Christian, 2014). One such 
study evaluated the inflammatory response to influenza vaccine challenge in a sample of 
pregnant women, assessed before and one week after the vaccine.  Findings revealed that 
women scoring in the highest tertile for depressive symptoms (CES-D) had significantly 
higher levels of the cytokine macrophage migration inhibitory factor (MIF) at the post-
vaccine time point. MIF is a proinflammatory molecule and has been associated with 
premature birth (Pearce et al., 2008). 
There are many factors that contribute to mixed results and limit comparison 
across studies, including: variation in the timing of maternal evaluation, socio-
demographics of the sample, control of confounders, instruments used to measure 
depressive mood, range of depressive scores, and variation in inflammatory outcomes 
measured.  Osborn and Monk emphasize the need for a more “nuanced” approach to be 
able to discern linkages between proinflammatory cytokines and maternal depressive 
symptoms (Osborne & Monk, 2013), and recommend that future studies enroll women 
who have greater psychosocial risk and more diverse socio-demographic backgrounds. 
Importantly, there is a need for future investigations to enroll high-risk women, especially 
African American women, who are known to mount a greater inflammatory response to 
stressors than other racial groups (Carroll et al., 2009; Gruenewald, Cohen, Matthews, 
Tracy, & Seeman, 2009; Gruenewald et al., 2012). Evidence suggests that African 
American women have cytokine genotypes that up-regulate inflammation (Ness, 
Haggerty, Harger, & Ferrell, 2004), and this may be linked to worse pregnancy outcomes 
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(Dominguez, Dunkel Schetter, Mancuso, & Hobel, 2005). Further, stress-
induced inflammatory responses are more robust among pregnant African American 
women compared to pregnant White women (Christian, Iams, Porter, & Leblebicioglu, 
2013).  In the present study, the small number of African American women enrolled did 
not allow an evaluation of the interaction between African American race and 
inflammation on depressive risk.   
A deeper understanding of the depression-inflammation link will also be gained 
by including measurement of resilience factors, such as social support, spirituality, and 
the meaning women associate with being pregnant and parenting.  Social support was 
found in this study to buffer the negative impact of childhood adversity and is discussed 
below.  It is also important that valid measures of depressive symptoms are not 
confounded by assessment of somatic symptoms that occur in normal pregnancy, and 
may require new instrument development.  Although beyond the scope of this study, 
cytokines measured should include both pro- and anti-inflammatory cytokines, as well as 
assessment at multiple time periods to more carefully evaluate shifts in cytokines across 
pregnancy.  Finally, depression during specific trimesters of pregnancy and the 
postpartum period needs to be differentiated, as each trimester of pregnancy and the 
postpartum period are distinct physiologic states characterized by significant 
psychological adaptation, as well as unique adaptations of the immune system that may 
result in dynamic fluxes in the proinflammatory milieu.  
Depressive symptoms, along with anxiety and stressors during pregnancy, may 
affect infant birth outcomes.  A systematic review of 39 studies found significant but 
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complex paths of interactions between depression, anxiety and stressors, and risk factors 
for preterm birth. Of note, pregnancy distress was associated with spontaneous but not 
with medically indicated preterm births (Staneva, Boggossian, Pritchard, & Wittkowski, 
2015). This is consistent with findings from the present study in which depressive 
symptoms at late pregnancy were significantly related to lower gestational age (not 
preterm birth per se); however these findings were no longer apparent once a Bonferroni 
correction was applied to reduce chance for Type 1 error.  Nevertheless, these results 
suggest women who experience greater depressive symptoms are more likely to deliver 
an infant with lower gestational age; perhaps increasing the risk for premature delivery.  
These findings imply that provision of appropriate support to women experiencing 
depressive symptoms may improve outcomes for both mothers and infants.   
Sleep Disturbance during Pregnancy 
During pregnancy and the postpartum period, women are at higher risk for sleep 
disturbance because of pregnancy-related physical alterations and the demands of caring 
for a newborn.  During the first trimester of a healthy pregnancy, women have an 
increase in total sleep time and experience high levels of daytime sleepiness, implying 
that sleep needs are increased in early pregnancy (Hedman, Pohjasvaara, Tolonen, 
Suhonen-Malm, & Myllyla, 2002); whereas during the third trimester women report a 
decrease in sleep time and an increase in nocturnal awakenings (Hertz et al., 1992). 
Evidence demonstrates that sleep disturbance has high potential to moderate and possibly 
compound the adverse effects of prenatal stressors and negative mood (Field, Diego, 
Hernandez-Reif, Figueiredo, Deeds, Ascencio, Schanberg, & Kuhn, 2010; O’Connor et 
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al., 2007), increasing the risk for adverse maternal and fetal outcomes.  Thus, in this 
study maternal sleep quality was measured using the Pittsburgh Sleep Quality Index 
(PSQI).  The PSQI is a general sleep quality index used extensively in healthy and ill 
populations (Okun & Coussons-Read; Okun et al.; Okun, Luther, Wisniewski, & Wisner; 
Okun, Roberts, Marsland, & Hall; Okun, Roberts, Marsland, & Hall; Okun, Schetter, & 
Glynn).  More recently the PSQI was demonstrated to be a reliable and valid tool for use 
during pregnancy and postpartum (Okun, Hanusa et al., 2009; Okun et al., 2013).  In the 
present study over half of the sample reported poor and interrupted sleep at mid- and at 
late-pregnancy.  In addition, during mid-pregnancy, increased sleep disturbance (global 
PSQI) was significantly related to greater perceived stress, depressive risk (both EDS and 
CESD), anxiety (STAI), and mood disturbance. These relationships remained significant 
during late pregnancy, except for anxiety.  These findings are consistent with results of a 
recent longitudinal study demonstrating distinct trajectories of sleep quality (using the 
PSQI) in women from pregnancy through the postpartum period.  Finding from that study 
revealed that women who reported the highest levels of poor sleep during pregnancy also 
had the highest levels of anxiety and depressive symptoms in early pregnancy and the 
lowest levels of social support. Further, women with the worst subjective sleep quality 
during pregnancy were also the most likely to experience high symptoms of depression in 
the postpartum period (Tomfohr, Buliga, Letourneau, Campbell, & Giesbrecht, 2015). 
Together these findings indicate that sleep can be an important predictor of worse 
psychological well-being during pregnancy and the postpartum period, and suggest health 
care providers should assess both duration and quality of sleep in women during the 
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perinatal period.  Findings of previous studies suggest sleep disturbance may exacerbate 
risk for maternal depression (Chang, Pien, Duntley, & Macones, 2010). As such, these 
findings identify maternal childhood adversity as a vulnerability factor that may 
predispose to greater sleep disturbance and risk for perinatal depression. Of note, in this 
study sleep disturbance was positively related to greater depressive risk.  Okun, Kiewra, 
Luther, Wisniewski, and Wisner (2011), identify pregnant women with poor sleep are 
greater in women with depression as compared to women without depression.  This is an 
important finding given that poor sleep during pregnancy and the postpartum period is 
linked to postpartum depression (Chang et al., 2010) and poor maternal care behaviors 
endanger infant/child development (Murray, Cooper, & Fearon, 2014). 
In addition, sleep deprivation during pregnancy may elevate risk for preterm 
delivery, and systematic inflammation has been hypothesized to underlie this association 
(Chang et al., 2010). Findings from this study show that poor sleep during late pregnancy 
was not related to lower birthweight and earlier gestational age once a Bonferroni 
correction applied.  Also, no associations between sleep quality and the proinflammatory 
cytokines measured (IL-6 and TNF-alpha) were found.  Prior research linking sleep 
disturbance, proinflammatory cytokines, and poor birth outcomes is mixed.  Some 
investigators report that third trimester sleep disruption is associated with increased levels 
of the pro-inflammatory cytokine, IL-6 (Okun & Coussons-Read, 2007; Okun et al., 
2007).  In contrast, others report no effects of third trimester sleep disruption on IL-6 
levels (Okun et al., 2007).  This inconsistency across studies is likely attributed to 
varying measures of sleep, variation in the time during pregnancy when sleep is assessed, 
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small and often non-representative samples, and lack of control for covariates—
especially BMI (Chang et al., 2010). Further research, especially longitudinal studies, is 
needed to clarify the contribution of biological mechanisms as to how poor sleep 
jeopardizes maternal and neonatal health. The findings from this study, however, do 
suggest that the development and testing of behavioral and/or educational interventions 
designed to provide information, strategies, and support to promote maternal and 
newborn sleep can benefit maternal health and infant development. This direction is 
consistent with findings from a recent study which showed that greater maternal napping 
frequency was associated with better cognitive development of the infant (Ronzio, 
Huntley, & Monaghan, 2013). 
Social Support during Pregnancy 
Findings from this study revealed that lower levels of social support were 
associated with higher levels of perceived stress, depressive symptoms (EDS and CES-
D), and anxiety at both mid-pregnancy and late-pregnancy.  Prior results from a meta-
analysis reveal that low levels of social support, along with higher levels of emotional 
stressors, during pregnancy are strong predictors of postpartum depression (Robertson, 
Grace, Walllington, & Stewart, 2004) and these findings were confirmed in a recent 
prospective study (Morikawa et al., 2015). As well, others recently reported that maternal 
satisfaction with social support at late pregnancy and early postpartum was associated 
with lower depressive symptoms and anxiety after delivery (Razurel & Kaiser, 2015), 
while others identified women with low social support as experiencing greater stressors 
across pregnancy (Iranzad et al., 2014 S., Hasanpour et al, 2014).  Thus, the present 
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findings add to the existing literature demonstrating that social support during pregnancy 
may lower stressors and protect against postpartum depression.  
Few, if any studies, have evaluated the relationship between maternal early life 
adversity and social support during pregnancy. The findings of the present study revealed 
that women who reported greater exposure to childhood adversity also reported lower 
levels of social support; this association was observed for the total CTQ scale, as well as 
for CTQ subscales: emotional neglect and abuse, and physical neglect and abuse. 
Although correlative, these results suggest that women who have greater exposure to 
childhood adversity may either have inadequate social networks available to them or lack 
social skills needed to form meaningful social relationships. Moreover, the current 
findings suggest that levels of social support influence birth outcomes. Specifically, 
regression analysis revealed that social support moderated the association between 
childhood adversity and infant birthweight, such that women who experienced greater 
maternal childhood adversity together with lower social support during their pregnancy 
delivered infants with lower birthweight.  In contrast, the negative impact of childhood 
adversity was attenuated (i.e., buffered) in women who reported higher levels of social 
support. In a similar manner social support attenuated the association between childhood 
adversity and gestational age. As such, these results suggest that the harmful effects of 
maternal childhood adversity on birthweight and gestational age can be reduced in 
women who have higher levels of social support during their pregnancy.  These findings 
lend support to implementation of clinical approaches that engender the development of 
meaningful (supportive) relationships, particularly for women at risk due to high 
198 
 
 
exposure to childhood adversity.  For example, prenatal classes and support groups may 
be designed to include not just the birth couples, but other family members and friends, 
as well. Ideally such support should be provided prior to or early on during pregnancy to 
maximize benefits. Other suggestions to increase social support during pregnancy are 
described in Conclusions and Implications at the end of this chapter. 
Hair Cortisol and Stress Perception 
During pregnancy the HPA axis undergoes remarkable change to accommodate 
the developing fetus (Davis & Sandman, 2010).  Most striking is the increase in maternal 
plasma CRH (Lowry, 1993), which results from a positive feedback loop whereby 
cortisol stimulates CRH production by the placenta.  As a result, ACTH and cortisol 
increase as pregnancy advances (Petraglia et al., 1996; Robinson et al., 1988).  However, 
by term, this positive feedback loop is blunted because maternal receptors for stress 
hormones become down-regulated.  Consequently, during late gestation environmental 
stress is less effective in triggering the HPA axis; thus, women become less responsive to 
stressors (Glenn, 2010; Glenn et al., 2001; Schuetze & Das Eiden, 2005).   
Abundant evidence derived from animal models of prenatal stress demonstrate 
that prenatal stress exposure affects behavioral and biological development through 
activation of the HPA axis, and in particular its end product, the adrenal glucocorticoid 
hormone, cortisol (Coe et al., 2003; Maccari et al., 1996; Weinstock, 2005).  Yet 
evidence in humans is not as definitive.  It is known, however, that maternal stress 
response is associated with an increase in cortisol and CRH in the maternal-fetal dyad 
(Field, Diego, Dieter, Hernandez-Reif, Schanberg, Kuhn, Yando, & Bendell, 2004; 
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Weinstock, 2008).  Others have observed that fetuses of depressed women with increased 
prenatal cortisol exhibit growth retardation and that these women deliver more preterm 
and low birthweight infants (Diego et al., 2009). Yet, there are inconsistent findings in 
the literature, suggesting complexity in the relationship among prenatal maternal 
stressors, cortisol, and child outcomes.  The inconsistent findings are attributed to varied 
study designs, differences in defining and measuring stressors, timing of stress 
measurement, and sample characteristics. Likely this relationship is multifactorial with no 
single factor serving as the underlying mechanism (Shaikh et al., 2013).  
It is also suggested that chronic or enduring stressors during pregnancy is more 
important than acute episodic stressors, as assessed by measuring plasma and salivary 
cortisol (O’Connor et al., 2002; Stott, 1973; Wadhwa, Sandman, Garite, 2001). More 
recently hair cortisol has been shown to be a reliable, non-invasive, retrospective measure 
of HPA axis activity (Russell et al., 2011); and the use of hair cortisol as an index of the 
HPA stress response during pregnancy has been validated (D'Anna-Hernandez, 2011).  
For example, hair cortisol was found to correlate with cortisol measured in salivary 
samples during the second and third trimesters of pregnancy; and both hair and salivary 
cortisol increased as gestation progressed, consistent with the known physiologic increase 
in cortisol over late pregnancy (D'Anna-Hernandez, 2011).  Others also showed that hair 
cortisol levels (range = 0.06 and 0.23 nmol/g of hair) in a small sample of healthy 
pregnant women positively correlated with levels of perceived stress using the PSS 
(Kalra, Einarson, Karaskov, Uum, and Koren, 2007). 
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Given the potential for hair cortisol to index chronic HPA activity, hair cortisol 
was measured in this study during mid- and late-pregnancy as an index of HPA activity 
over the prior three-month time interval. In the present study, no significant relationships 
were found between psychological variables and hair cortisol. These findings do not 
support earlier work showing that higher levels of hair cortisol correlated with increased 
psychological stressors during pregnancy (Kalra, Einarson, Karaskov, Uum, and Koren, 
2007; Karlen et al., 2013); these negative findings likely reflect the small sample size of 
this dissertation study.  
Recent studies find maternal child sexual abuse (based on the CTQ) to be 
associated with increased salivary cortisol awakening response over the second and third 
trimesters of pregnancy (Bublitz, & Stroud, 2012; Bublitz & Stroud, 2013), implying that 
such abuse produces long-lasting changes of the HPA axis that manifest during 
pregnancy. Findings from the present study, however, did not reveal a relationship 
between childhood adversity and hair cortisol.  Moreover, this is also in contrast to recent 
findings demonstrating that pregnant women with a history of childhood physical and/or 
sexual abuse had greater hair cortisol levels, compared to women with no history of 
abuse. (Schreier, Enlow, Gennings, & Wright, 2015).  That study did find, however, that 
childhood rates of abuse and hair cortisol levels varied by race/ethnicity. Subsequent 
analysis of the association between childhood adversity and hair cortisol by race revealed 
that such associations were only significant among African American women. The low 
number of African American women providing hair samples in the present dissertation 
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study undoubtedly limited the ability to detect similar associations between maternal 
childhood adversity and hair cortisol in this racial group.  
Hair Cortisol and Infant Outcomes  
There is also evidence that hair cortisol may associate with infant birth outcomes.  
Results from the study herein revealed that hair cortisol in mid and late pregnancy was 
not associated with gestational age, when controlling for pre-pregnancy BMI.  These 
findings are in contrast with a much larger study demonstrating a positive correlation 
between hair cortisol (measured at delivery) and gestational age (Kramer et al., 2009).  In 
that sample of women (N=117), cortisol concentrations were significantly higher in the 
hair of women who delivered at term (mean = 190.6 (SD, 99.0) ng/g) than in those who 
delivered at <34 weeks of gestation (148.6 (SD, 39.2) ng/g).  Others also found maternal 
hair cortisol at early, mid and late pregnancy to be positively correlated with infant 
birthweight (Karlen et al., 2013). While Kramer (2009) found hair cortisol to be 
positively correlated with gestational age, it was measured at delivery. It is possible that 
the levels of hair cortisol at delivery (i.e., term) simply reflect the normal increase in 
cortisol that occurs as pregnancy advances. In contrast, the lower hair cortisol in women 
with preterm delivery may reflect the shortened gestational time needed for cortisol to 
increase physiologically, as opposed to reflecting differences in maternal stress response 
activation (Kramer et al., 2009).  This thinking is consistent with Kramer’s lack of 
finding any association of hair cortisol with pregnancy-specific anxiety or other stress 
response measures (Kramer et al., 2001).   
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Moreover, findings from the present study also showed that childhood adversity 
interacted with hair cortisol levels at late-pregnancy (T2) to influence both birthweight 
and gestational age.  These results showed that women exposed to higher levels of 
childhood adversity in combination with higher hair cortisol had infants with greater 
birthweight and increased gestational age. In contrast, women in late pregnancy with 
lower levels of childhood adversity exhibited no association between hair cortisol and 
birthweight or gestational age.  However, given the small sample size in this analysis, 
caution should be used in interpreting this data.   
In summary, evaluation of the association of maternal hair cortisol with 
pregnancy outcomes is in the early stages of investigation.  Prospective, longitudinal 
studies with larger sample sizes are needed, as there are likely many covariates that 
influence levels of hair cortisol across pregnancy. This is best exemplified by a recent 
study, which measured maternal hair cortisol in the last trimester of pregnancy. That 
study found significantly higher cortisol concentrations in obese compared to normal 
weight and in smoking as opposed to non-smoking pregnant women. In contrast, women 
who delivered by cesarean section had lower hair cortisol compared to spontaneous 
delivery. Seasonal relationships were also observed, with higher hair cortisol in summer 
and autumn versus winter. Additionally, maternal education, numbers of persons in the 
household, premature delivery, and hair characteristics were associated with levels of hair 
cortisol (Braig et al., 2015). As the study by Braig et al. (2015) demonstrates, hair cortisol 
can be influenced by many factors, and the findings from the present study must be 
interpreted with caution.  
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Limitations 
 This study, conducted to fulfill requirements for a Ph.D. in nursing, has several 
limitations.  An important limitation is the subject attrition from mid (T1) to late (T2) 
pregnancy; the reasons for this attrition are not known.  Further, it is not clear if women 
who withdrew from the study had greater levels of perceived stress, depressive 
symptoms, or mood disturbance; prompting their withdrawal from the study. Ideally, 
evaluating women across pregnancy over three or more time points (as opposed to two 
time points) would have allowed use of hierarchical linear modeling (HLM) (K. E. Grant 
et al., 2003; K.A. Grant et al., 2010).  HLM allows for analysis of subjects with 
incomplete and unbalanced data across time points, increasing statistical power and 
reducing bias.  Also, HLM permits the ability to evaluate trajectories of individual 
differences among participants at study entry and across pregnancy and postpartum; this 
may allow greater understanding of heterogeneity among subjects.  Furthermore, HLMs 
treat time as a continuous variable letting both time-variant and time-invariant covariates 
to be included in the model.  In the present study, because of missing data, outcomes for 
some of the measures (especially those with greater variability) likely lacked sufficient 
power to detect significance.  In particular, a number of women declined to provide hair 
samples for measurement of hair cortisol; this was especially the case for African 
American women and is a limitation of the study, especially in light of the very recent 
findings that maternal childhood adversity directly associated with hair cortisol only in 
African American women (Schreier et al., 2015).  
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As noted, the sample enrolled into this study comprised predominately White, 
well-educated, and middle class women; and most pregnancies were perceived positively.  
Accordingly, the insufficient numbers of lower income and minority women, who likely 
experience more childhood and current life adversity, limited detection of significant 
relationships. Further, the low numbers of these women prevented the evaluation of 
differences in outcomes based on race and ethnicity.  Disadvantaged minority women are 
at greater risk for perinatal depression, as well as lower birthweight and premature 
infants; and thus represent a more vulnerable population.  In the current sample, about 
half of the women reported depressive symptoms at or above the cut-scores; however, the 
incidence of premature birth and low birthweight was small, precluding stratifying births 
as ‘premature,’ ‘low birthweight’ and ‘very low birthweight,’ using clinical designations 
for these strata.  As such, the generalizability of the results of the present study is limited 
to women who are at lower risk for delivery of either premature or low birth weight 
infants. Nevertheless, the findings are a first step toward a more comprehensive 
understanding of the associations among childhood adversity and maternal prenatal PNI 
profile and birth outcomes. 
The National Institute for Health (NIH) stipulates for any clinical research 
projects that Ethnicity (Hispanic Latino or not Hispanic or Latino be asked first, then race 
asked to represent the five designated categories (White, Black or African American, 
Asian, American Indian or Alaska Native, and Native Hawaiian or other Pacific Islander) 
and allow the respondent to select more than one race (Wallman, 1997). When this 
research was conceptualized, I used the combination of race ethnicity given this is what 
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was listed in nearly all of the research studies and continues to be used.  In future 
research, I will list as advised on the NIH guidelines to provide complete ethnic and race 
information for study participants.  
Another limitation was the use of a retrospective measure of childhood adversity 
(i.e., CTQ), which relies upon the memory of participants, as well as their willingness to 
disclose adverse events.  Although it is possible that retrospective assessment of early life 
experiences can have a high level of false-negative rates (Hardt & Rutter, 2004), the 
Childhood Trauma Questionnaire is considered a valid measure with wide use (Paivio, 
2001).  Furthermore, the degree of adversity is often underreported due to either 
suppression of memory of traumatic events or embarrassment to admitting adverse life 
experiences.  Thus, if anything, adverse events are likely more frequent and of greater 
intensity than reported by this sample of women. 
Additionally, this study assessed pre-pregnancy BMI by self-report. It is possible 
that women may underreport their body weight, compromising this measure, which was 
used to normalize levels of IL-6 and TNF-alpha.  Lastly, the time domains for 
psychometric instruments varied from one instrument to another and may have limited 
findings.  For example, the PSS (perceived stress) and PSQI (sleep quality) asked 
respondents to rate levels of stress and sleep, respectively, over the past month; other 
psychometric instruments asked respondents to assess levels of depressive mood (CES-
D) and mood disturbance (POMS) over the past week, and the STAI (state anxiety) asked 
respondents to indicate how they feel at the moment.  In contrast, the blood samples for 
proinflammatory cytokines likely reflect the levels for that particular day.  Such 
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dissonance in time domain across measures may have limited finding significant 
associations among variables. 
Conclusions and Implications 
This investigation evaluated a community sample of healthy women during 
pregnancy to better understand the impact of stressors (across pregnancy) on maternal, 
psychological, circulating proinflammatory cytokines (IL-6, TNF alpha), as well as on 
neuroendocrine function (hair cortisol); and further to explore the impact of these on 
neonatal outcomes. Moreover, the contribution of maternal exposure to childhood 
adversity (as a predictor variable) and social support (as a moderating variable) were 
evaluated.  Despite the above noted limitations, the findings of this study contribute to the 
evidence supporting the negative impact of psychological stressors on maternal mental 
health and infant birthweight and gestational age.  In particular, the results add new 
knowledge as to the influence of maternal childhood adversity on maternal mental health 
during pregnancy.  Women who were exposed to greater childhood adversity were shown 
to experience increased maternal prenatal stress perception, anxiety, mood disturbance, 
poor sleep, and risk for depression during pregnancy. Few previous studies have 
evaluated maternal childhood adversity as a risk factor during pregnancy, and as such, 
these findings can generate greater understanding for what makes certain women more 
susceptible to the challenges associated with pregnancy and future motherhood. 
Moreover, these initial findings can drive future research to investigate cumulative life 
stressors and apply an allostatic load framework to understand maternal bio-behavioral 
adaptation to pregnancy.     
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The findings also emphasize the interaction between maternal childhood adversity 
and increased proinflammatary cytokines and the risk for lower birthweight and earlier 
gestational age. That is, women who experienced higher levels of maternal childhood 
adversity and who had higher levels of plasma IL-6 delivered infants at earlier gestational 
age and with lower birthweight. Childhood adversity has been shown to engender a 
proinflammatory phenotype in non-pregnant individuals (Danese et al., 2007).  However, 
this is likely the first such finding in pregnant women. These findings suggest that one 
way whereby maternal childhood adversity may negatively impact birth outcomes is 
through interacting with elevation of proinflammatory cytokines. The health implications 
are significant given that infant birthweight and gestational age are strong predictors of 
adult health over the life span. Thus, these results emphasize that a mother’s history of 
childhood adversity can have major consequences for the next generation’s health. As a 
whole, fhese findings emphasize the interplay of biolgical, psychological and social 
factors in poor birth outcomes, and extend understanding of predictors of poor birth 
outcomes.  For health practitioners, these findings highlight the need to identify early life 
risk exposure, such as childhood adversity, which may negatively affect maternal mental 
health and the course of gestation.  This is even more critical as evidence demonstrates 
that a history of childhood abuse is associated with a greater risk of being a victim of all 
types of abuse as an adult, with re-victimization occurring in a dose response manner 
(Chiu et al., 2013); and domestic violence during pregnancy is a major public health issue 
affecting the mother and the unborn child (Jahanfar, Howard, & Medley, 2013). Thus, 
implementing a life course perspective within prenatal (or pre-conceptual) care practice 
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can broaden maternal risk assessment, target vulnerable women, and foster tailored 
interventions.  As such these findings are a first step in understanding the negative 
sequlae of maternal childhood adversity, and can serve as impetus for future research to 
include the examination of psychosocial risk antecedent to a women’s pregnancy, 
including experience of early life adversity, to understand preterm and low birthweight. 
This is in line with the recent call for prenatal care delivery practices that allow for an 
understanding of the impact of trauma on a woman’s life and future mental health.  Such 
trauma-informed care, provided in a trusted environment, can pave the way for recovery 
from such traumatic experiences (Torchalla, Linden, Strehlau, Neilson, & Krausz, 2015). 
Success of preventive interventions for mother and child is exemplified by the work of 
David Olds who pioneered the use of a nurse home visiting program (Nurse-Family 
Partnership), which over many years has proved successful in improving the health and 
social conditions of vulnerable pregnant women and their families (Olds et al., 2014). 
Social support emerged as an important variable that can influence maternal 
psychological well-being and infant outcomes.  Importantly, the results of the present 
study suggest that harmful effects of maternal childhood adversity on birthweight and 
gestational age are even worse for women with low social support during their 
pregnancy.  These findings provide impetus for health care providers to include an 
assessment of levels of social support in pregnant women during risk stratification, and to 
implement approaches that enable vulnerable women to develop sustainable and 
meaningful social support networks early on in pregnancy (or even when pregnancy is 
planned).  The latter may take place in prenatal classes or even through use of technology 
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in which women can access peer support or support from trusted health care 
professionals.  Another example is to foster prenatal family support groups and to provide 
child care for pregnant women with children, increasing their ability to attend prenatal 
programs. Future studies are needed that address additional resilience factors, such as 
spirituality, and the meaning women associate with being pregnant and parenting.  An 
evaluation of faith based prenatal support groups may prove to be especially beneficial 
for African American women. Such research can lead to innovative models of care, 
which aim at increasing a woman’s well-being and resilience, supporting them in their 
adaptive capacity during pregnancy and as new mothers.   
An alternative and promising strategy to improve pregnancy outcomes is 
computer tailoring, an intervention in which advice is not delivered face-to-face, but via a 
computer (Lustria, Cortese, Norar, & Glueckauf, 2009). Although the content of this 
advice is computer-generated, it is tailored based on individual responses to questions. 
Accordingly, the feedback messages are adapted to the unique situation of the individual. 
This approach has been shown to be effective in promoting health behavior change in a 
variety of populations (Krebs, Prochaska, & Rossi, 2010) and recently in counseling 
pregnant women to reduce alcohol intake (van der Wulp et al., 2014). 
This study was unique in that a Distress Composite Score was derived and used in 
regression analyses.  Most importantly, findings revealed that women with higher 
Distress Composite Scores had higher circulating levels of IL-6.  Further, the findings 
revealed that women exposed to higher levels of childhood adversity together with higher 
Distress Composite Scores delivered infants with lower birthweight and earlier 
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gestational age (i.e., earlier delivery).  These findings suggest that the use of a more 
comprehensive index of the perception of psychological stressors and the emotional 
response to stressors during pregnancy will yield greater insight as to how psychological 
variables affect maternal and infant health outcomes.   
Another unique finding of this study was that women who experienced higher 
levels of childhood adversity reported greater sleep disturbance than those experiencing 
lower levels of childhood adversity.  Poor sleep may predispose to psychological 
morbidity, especially perinatal depression. Moreover, poor sleep during late pregnancy 
was associated with poor neonatal outcomes (lower birthweight and earlier gestational 
age) but did not meet significance using a Bonferroni correction. Thus, these data support 
the need to provide information regarding strategies to improve maternal sleep quality, 
which in the end can benefit maternal health and infant development. 
In summary, the findings from this dissertation research highlight the importance 
of utilizing a PNI framework to provide an integrated bio-behavioral understanding of the 
impact of maternal perception of psychological stressors on the adaptation to pregnancy. 
In particular, this study revealed unique findings that demonstrated that exposure to 
adversity early in life has long-lasting effects that influence perceived stress levels, 
anxiety, and depressive mood during pregnancy; and that this may disrupt inflammatory 
and neuroendocrine regulation needed for optimal maternal-infant health outcomes. 
Further, the findings emphasize the potential for social support to buffer the negative 
impact of maternal childhood adversity. Such knowledge can contribute to improved 
approaches to identify and stratify risk for adverse maternal-infant health outcomes, as 
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well as guide the development of early intervention programs and health policy for 
women who are pregnant or who plan to become pregnant (i.e., pre-conception 
counseling and care).  It is vital that risk assessment extends beyond the window of 
pregnancy and includes assessment of vulnerability factors antecedent to pregnancy—a 
lifespan approach.  Ultimately, such evidenced-based practice will have major health 
significance, as the well-being of mothers and infants determines the health of the next 
generation.  
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APPENDIX A 
PERCENTAGES OF PREMATURE DELIVERIES BY GESTATION
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(Martin et al., 2010). 
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APPENDIX B 
 
PRETERM BIRTH AS A PERCENTAGE OF LIVE BIRTHS,  
 
BY RACE AND ETHNICITY, 1992 TO 2003 
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APPENDIX C 
RATES OF VERY LOW BIRTHWEIGHT (VLBW) AND LOW BIRTHWEIGHT 
(LBW) IN PREMATURE INFANTS, BY RACE AND ETHNIC ORIGIN (2008 DATA) 
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(Martin et al., 2010) 
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APPENDIX D 
EXAMPLES OF THE TYPES OF STRESS EXPOSURE DURING PREGNANCY AND 
ASSOCIATION WITH A RANGE OF NEURODEVELOPMENTAL OUTCOMES 
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(O'Donnell, 2009).  
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APPENDIX E 
EFFECT OF ANTENATAL DEPRESSION ON THE RISK OF LOW BIRTHWEIGHT 
(LBW) IN DEVELOPING NATIONS, EUROPEAN SOCIAL DEMOCRACIES, AND 
THE UNITED STATES
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(Grote et al., 2010) 
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APPENDIX F 
SCHEMATIC ILLUSTRATION OF CONNECTIONS BETWEEN THE NERVOUS AND 
IMMUNE SYSTEMS 
 (Sternberg, 2006)
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APPENDIX G 
 
REGULATION OF THE HPA AXIS ACROSS PREGNANCY IMPLICATIONS  
FOR MOTHER-INFANT HEALTH OUTCOMES 
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APPENDIX H 
 
DATA COLLECTION TOOLS 
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Demographic Information Form 
 
                                                                                   Date of Birth   _____/_____/______ 
                                                                                                            Month/day/year 
1. Race/Ethnic Group:  
             
   _____White                                    _____Native Hawaiian or Other Pacific Islander 
   _____African American                 _____Other_______________ 
   _____Hispanic/Latina                    _____Asian 
   _____American Indian/Alaska Native   _____More Than One Race    
2. Marital Status:     _____Single 
                                     _____Married 
                                     _____Divorced/Separated 
                                     _____Widowed 
3. Education: (Please circle the highest level of education completed in each 
category that applies to you) 
 
High School: 9 10 11 12 
College: 1 2 3 4  
Graduate School: 1 2 3 4 5 6 7 8  
Vocational/Technical School: 1 2 3 4  
Other (please specify)________________________ 
4. Current Employment: (Please check all that apply to you) 
                                        _____Full time 
                                        _____Part time (Hours/week_____) 
                                        _____Employed and work at home 
                                        _____Homemaker 
                                        _____Unemployed 
                                        _____Student 
                                              _____Other 
5. What is your usual occupation? ___________________________ 
6. What is your total household income? 
_____less than $9,999 
_____$10,000to$19,000 
_____$20,000 to $29,000 
_____$30,000 to $39,000 
_____$40,000 to $49,000 
_____$50,000 to $59,000 
_____$60,000 to $69,000 
_____$70,000 and higher          
     7. How many people/dependents live off this income? ____________ 
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Pregnancy Health Assessment Survey (HAS) (developed from MIHA, 2009 and 
PRAMS) 
Please answer questions or circle response. 
 
1 Today's Date  mo/day/year    
2 Due date by last menstrual period mo/day/year   
 Due date by Ultrasound  mo/day/year 
4 How many times have you been pregnant? _____ 
 How many miscarriages have you had? _____      
5 How many biologic children do you have? _____ 
6 Did you ever have a baby that weighted less than 5 lbs., 8oz (2.5kg) at birth?  
 Yes / No    
7 Did you ever have a baby that was born prematurely (born before 37 weeks of 
pregnancy)?  Yes / No    
8 What was your birthweight?     ____ lbs    _____ don't know    
9 Did you ever have a Cesarean delivery or C-section? Yes / No   
10 Before this pregnancy have you ever received WIC (Women, Infant, and Children 
supplementary food program)?  Yes / No    
11 Did you have regular health care in the year before this pregnancy?  Yes / No  
12 Did you need fertility treatment for this pregnancy?  Yes / No    
13 What type of health care coverage did you have just prior to getting pregnant? 
 No Health Insurance Private Insurance (i.e. BC/BS; HMO) 
 Public Insurance Combined Public and Private  
14 How would you rate your Physical Health just prior to getting pregnant? 
 Excellent / Good / Fair / Poor  
15 How would you rate your Mental Health just prior to getting pregnant? 
 Excellent / Good / Fair / Poor  
16 What was your pre-pregnancy weight?       
17 What is your current weight?       
18 What is your height       
19 In the month before you got pregnant, how many times a week did you take a 
multivitamin, prenatal vitamin, or folic acid? 
 Never / 1-3 times/week / 4-6 times/wk. / Daily  
20 In the last month, how many times a week do you take a multivitamin, prenatal 
vitamin, or folic acid? 
 Never / 1/3 times/wk. / 4-6 times/wk. / Daily  
21 When you got pregnant, were you using birth control (condoms, birth control pills, 
shots or another method? Yes No    
22 Was this pregnancy was planned? Yes No    
23 When did you find out you were pregnant? 
 #weeks _____  #months _____ 
24 When your pregnancy was confirmed, how did you feel? 
 Very happy / Somewhat happy / Somewhat Unhappy / Very Unhappy 
 Unsure how I felt 
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25 Before you got pregnant, did you have… ? (Check if you took medication)  
 Diabetes (high blood sugar) Yes No     
 Hypertension (high blood pressure) Yes No     
 Anemia Yes No     
 Thyroid problems Yes No     
 Asthma Yes No     
 Depression Yes No     
 Anxiety Yes No     
 Eating disorder (anorexia, bulimia, etc) Yes No     
26 During your current pregnancy, do you have… Check if you took medication)  
 Diabetes (high blood sugar) Yes No     
 Hypertension (high blood pressure) Yes No     
 Anemia Yes No     
 Thyroid problems Yes No     
 Asthma Yes No     
 Depression Yes No     
 Anxiety Yes No     
 Eating disorder (anorexia, bulimia, etc) Yes No     
27 Current health problems…        
 Labor pains before 37 weeks of pregnancy Yes No    
 Water broke before 37 weeks of pregnancy Yes No    
 Pre-eclampsia, eclampsia, or toxemia Yes No    
 Placental problems (i.e. Abruptio placenta, placenta previa, low-lying placenta) 
  Yes No    
 Cervical problems needing a cerclage (cervix sewn shut) because of an incompetent 
cervix. Yes No    
 Other problems? Explain 
28 Prenatal Care: or Health Care for Pregnancy         
 When did you start getting prenatal care? # weeks # months     
 During this pregnancy, did any health care worker suggest you get testing for a birth 
defect in your baby? Yes No Not Sure   
 If yes, did you have the testing done? Yes No Not Sure   
 What tests did you have during this pregnancy?      
 AFP or expanded AFP test Yes No Not Sure  
 Amniocentesis or amnio (putting a needle in your belly to sample the amniotic fluid 
around the baby Yes No Not Sure   
 CVS (chronic villi sampling)  
 to take a tiny piece of placenta Yes No Not Sure   
 NT (nuchal translucency) (an ultrasound  
 to measure thickness of the baby's neck) Yes No Not Sure   
 Other test: please describe         
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29. Did any of these events happen to you during this pregnancy?      
 Separated or divorced from partner Yes No    
 Moved to a new address Yes No    
 Homeless (sleeping outside, in car, or in homeless shelter 
  Yes No    
 Husband or partner lost their job Yes No    
 I lost my job, even though I wanted to continue working 
  Yes No    
 I have many bills I cannot pay Yes No    
 My partner went to jail Yes No    
 Someone very close to me has problems with drugs or alcohol 
  Yes No    
30 Health Questions: Right now during pregnancy        
 Do you smoke? Yes No    
 How many cigarettes/day? _____    
 Do you drink alcohol? Yes No    
 How many drinks/day _____      
 Do you drink caffeinated drinks? Yes No    
 How many drinks/day (8 oz. drinks) _____      
31 After delivery how do you intend to feed your baby?        
 Breast feed Yes No Not Sure   
 Bottle feed Yes No Not Sure   
 Combination Breast and Bottle Yes No  Not Sure   
  If you plan to Breast feed, how long are you planning to do this? 
  weeks /  months _____     
 Were you breast fed as an infant Yes No     
 Do any of your friends breast feed their infants? 
  Yes No     
32 Describe your pregnancy overall: 
 One of the happiest times of my life 
 Happy time without many problems 
 Moderately hard time 
 Very hard time 
 One of the worse times of my life 
       
33 Please describe any events during this pregnancy that were stressful to you. 
  
 
  
  
34 Please explain what you worried about during this pregnancy. 
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Perceived Stress Scale (PSS)  (S. Cohen et al., 1988) 
      
The questions in this scale ask you about your feelings and thoughts 
during the last month. In each case, you will be asked to indicate by 
circling how often you felt or thought a certain way.      
0 = Never 1 = Almost Never 2 = Sometimes 3 = Fairly Often 4 = Very 
Often      
 
 
1 
In the last month, how often have you been upset 
because of something that happened unexpectedly? 0 1 2 3 4 
2 
In the last month, how often have you felt that you were 
unable 
to control the important things in your life? 0 1 2 3 4 
3 
In the last month, how often have you felt nervous and 
“stressed”?  0 1 2 3 4 
4 
In the last month, how often have you felt confident 
about your ability 
to handle your personal problems? 0 1 2 3 4 
5 
In the last month, how often have you felt that things 
were going your way? 0 1 2 3 4 
6 
In the last month, how often have you found that you 
could not cope 
with all the things that you had to do? 0 1 2 3 4 
7 
In the last month, how often have you been able 
to control irritations in your life? 0 1 2 3 4 
8 
In the last month, how often have you felt that you were 
on top of things? 0 1 2 3 4 
9 
In the last month, how often have you been angered 
because of things that were outside of your control?  0 1 2 3 4 
10 
In the last month, how often have you felt difficulties 
were piling up so high that you could not overcome 
them? 0 1 2 3 4 
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Profile of Mood States (POMS-65) (McNair et al., 1992 1971) 
 
Directions: Describe HOW YOU FEEL RIGHT NOW by checking one space after each 
of the words listed below: 
 
FEELING  
1.Not at all  
2. A little  
3. Moderate 
4. Quite a bit  
5. Extremely 
 
1 Friendly 1 2 3 4 5 
2 Tense 1 2 3 4 5 
3 Angry 1 2 3 4 5 
4 Worn Out 1 2 3 4 5 
5 Unhappy 1 2 3 4 5 
6 Clear-headed 1 2 3 4 5 
7 Lively 1 2 3 4 5 
8 Confused 1 2 3 4 5 
9 Sorry for things done 1 2 3 4 5 
10 Shaky 1 2 3 4 5 
11 Listless 1 2 3 4 5 
12 Peeved 1 2 3 4 5 
13 Considerate 1 2 3 4 5 
14 Sad 1 2 3 4 5 
15 Active 1 2 3 4 5 
16 On Edge 1 2 3 4 5 
17 Grouchy 1 2 3 4 5 
18 Blue 1 2 3 4 5 
19 Energetic 1 2 3 4 5 
20 Panicky 1 2 3 4 5 
21 Hopeless 1 2 3 4 5 
22 Relaxed 1 2 3 4 5 
23 Unworthy 1 2 3 4 5 
24 Spiteful 1 2 3 4 5 
25 Sympathetic 1 2 3 4 5 
26 Uneasy 1 2 3 4 5 
27 Restless 1 2 3 4 5 
28 Unable to Concentrate 1 2 3 4 5 
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29 Fatigued 1 2 3 4 5 
30 Helpful 1 2 3 4 5 
31 Annoyed 1 2 3 4 5 
32 Discouraged 1 2 3 4 5 
33 Resentful 1 2 3 4 5 
34 Nervous 1 2 3 4 5 
35 Lonely 1 2 3 4 5 
36 Miserable 1 2 3 4 5 
37 Muddled 1 2 3 4 5 
38 Cheerful 1 2 3 4 5 
39 Bitter 1 2 3 4 5 
40 Exhausted 1 2 3 4 5 
41 Anxious 1 2 3 4 5 
42 Ready to Fight 1 2 3 4 5 
43 Good-natured 1 2 3 4 5 
44 Gloomy 1 2 3 4 5 
45 Desperate 1 2 3 4 5 
46 Sluggish 1 2 3 4 5 
47 Rebellious 1 2 3 4 5 
48 Helpless 1 2 3 4 5 
49 Weary 1 2 3 4 5 
50 Bewildered 1 2 3 4 5 
51 Alert 1 2 3 4 5 
52 Deceived 1 2 3 4 5 
53 Furious 1 2 3 4 5 
54 Effacious 1 2 3 4 5 
55 Trusting 1 2 3 4 5 
56 Full of Pep 1 2 3 4 5 
57 Bad-tempered 1 2 3 4 5 
58 Worthless 1 2 3 4 5 
59 Forgetful 1 2 3 4 5 
60 Carefree 1 2 3 4 5 
61 Terrified 1 2 3 4 5 
62 Guilty 1 2 3 4 5 
63 Vigorous 1 2 3 4 5 
64 
Uncertain about 
Things 1 2 3 4 5 
65 Bushed 1 2 3 4 5 
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Name:  ______________________________           Address:  ___________________________ 
Your Date of Birth:  ____________________       ___________________________ 
Baby’s Date of Birth:  ___________________  Phone: _________________________ 
As you are pregnant or have recently had a baby, we would like to know how you are feeling.  Please check 
the answer that comes closest to how you have felt , not just how you feel today. 
Here is an example, already completed. 
I have felt happy: 
Yes, all the time 
Yes, most of the time This would mean:  “I have felt happy most of the time” during the past week. 
No, not very often Please complete the other questions in the same way. 
No, not at all 
In the past 7 days: 
1. I have been able to laugh and see the funny side of things *6.  Things have been getting on top of me 
As much as I always could Yes, most of the time I haven’t been able 
Not quite so much now to cope at all 
Definitely not so much now Yes, sometimes I haven’t been coping as well 
Not at all as usual 
2. I have looked forward with enjoyment to things No, I have been coping as well as ever 
As much as I ever did 
Rather less than I used to *7 I have been so unhappy that I have had difficulty sleeping 
Definitely less than I used to Yes, most of the time 
Hardly at all Yes, sometimes 
Not very often 
*3. I have blamed myself unnecessarily when things No, not at all 
went wrong 
Yes, most of the time *8 I have felt sad or miserable 
Yes, some of the time Yes, most of the time 
Not very often Yes, quite often 
No, never Not very often 
No, not at all 
4.    I have been anxious or worried for no good reason 
No, not at all *9 I have been so unhappy that I have been crying 
Hardly ever Yes, most of the time 
Yes, sometimes Yes, quite often 
Yes, very often Only occasionally 
No, never 
*5  I have felt scared or panicky for no very good reason 
Yes, quite a lot *10 The thought of harming myself has occurred to me 
Yes, sometimes Yes, quite often 
No, not much Sometimes 
No, not at all Hardly ever 
Never 
Administered/Reviewed by ________________________________    Date  ______________________________ 
1 
Source: Cox, J.L., Holden, J.M., and Sagovsky, R. 1987.  Detection of postnatal depression: Development of the 10-item 
Edinburgh Postnatal Depression Scale.  British Journal of Psychiatry 150:782-786 . 
2 
Source:  K. L. Wisner, B. L. Parry, C. M. Piontek, Postpartum Depression N Engl J Med vol. 347, No 3, July 18, 2002, 
194-199 
Users may reproduce the scale without further permission providing they respect copyright by quoting the names of the 
authors, the title and the source of the paper in all reproduced copies.
No, most of the time I have coped quite well 
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Pregnancy Experience Scale-Brief (PES-Brief) 
(J. A. DiPietro, Christensen, A. L., & Costigan, K. A., 2008) 
 
Below are 10 items that you may consider to be uplifting aspects of your pregnancy and 
10 
items that may be less appealing. Please circle the degree to which each item 
 
0 = Not at all 1 = Somewhat 2 = Quite a bit 3 = A great deal 
 
How much have each of the following made you feel happy, positive, or uplifted? 
 
1 How much is the baby moving 0 1 2 3 
2 Discussion with spouse about baby names 0 1 2 3 
3 Comments from others about your pregnancy/appearance 0 1 2 3 
4 Making or thinking about nursery arrangements 0 1 2 3 
5 Feelings about being pregnant at this time 0 1 2 3 
6 Visits to obstetrician/midwife 0 1 2 3 
7 Spiritual feelings about being pregnant 0 1 2 3 
8 Courtesy/assistance from others because you are pregnant 0 1 2 3 
9 Thinking about the baby's appearance 0 1 2 3 
10 Discussions with spouse about pregnancy/childbirth issues 0 1 2 3 
 
How much have each of the following made you feel unhappy, negative, or upset? 
 
1 Getting enough sleep  0  1  2  3 
2 Physical intimacy  0  1  2  3 
3 Normal discomforts of pregnancy  0  1  2  3 
4 Your weight  0  1  2  3 
5 Body Changes due to pregnancy  0  1  2  3 
6 Thoughts about whether the baby is normal  0  1  2  3 
7 Thinking about your labor and delivery  0  1  2  3 
8 Ability to do physical tasks/chores  0  1  2  3 
9 Concerns about physical symptoms (pain, spotting, etc)  0  1  2  3 
10 Clothes/shoes don't fit  0  1  2  3 
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The MacArthur Network on SES and Health has developed a sociodemographic 
questionnaire, which is currently being used in a number of network sponsored  
projects. The instrument begins with subjective social status questions developed  
by the network; (see MacArthur Subjective Social Status Scale in the Psychosocial 
Notebook). The remaining questions assess educational attainment, occupational  
status, income and assets. Ideally, all questions would be used; if a subset must  
be selected, items 1, 2, 3, 4, 6b and 6c, 7 and 9 are recommended.  
Sociodemographic Questionnaire  
       
      Question 1.  
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               Question 2.  
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Question 3. What is the highest grade or year of regular school you have complete?  
 
Check box Elementary High School College Graduate School 
 
01 09 13 17 
 02 10 14 18 
 03 11 15 19 
 04 12 16 20+ 
 05    
 06    
 07    
 08    
 
Question 4. What is the highest degree you earned? 
 
Check Box 
 
 
High school diploma or equivalency (GED) 
 
Associate Degree (Junior College 
 
Bachelor’s Degree 
 
Master’s Degree 
 
Doctorate 
 
Professional (MD,JD,DDS,etc.) 
 
Other (please specify) 
 
None of the above (less than High School) 
 
Question 5. Which of the following best describes your current main daily activities 
and/or responsibilities? 
 
Check Box  
 Working full time 
 Working part-time 
 Unemployed or laid off 
 Looking for work 
 Keeping house or raising children full time 
 Retired 
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Question 6. With regard to your current or most recent job activity: 
 
In what kind of business or industry do (did) you work? 
(For example: hospital, newspaper publishing, mail order house, auto engine 
manufacturing, breakfast cereal manufacturing.) 
 
What kind of work do (did) you do? (Job Title) 
(For example: registered nurse, personnel manager, and supervisor of order department, 
gasoline engine assembler, and grinder operator.) 
 
How much did you earn, before taxes and other deductions, during the past 12 
months? 
 
Check box  
 Less than $5,000 
 $5,000 through $11,999 
 $12,000 through $15,999 
 $16,000 through $24,999 
 $25,000 through $34,999 
 
$35,000 through $49,999 
 $50,000 through $74,999 
 $75,000 through $99,999 
 $100,000 and greater 
 Don’t know 
 
No response 
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Question 7. How many people are currently living household, including yourself? 
 
 Number of people in household? 
 Of these people, how many are children? 
 Of these people, how many are adults? 
 Of the adults, how many bring income into household? 
 
Question 8. Is the home where you live: 
 
Check 
Box 
 
 Owned or being bought by you (or someone in the household)? 
 Rented for money? 
 Occupied without payment of money or rent? 
 Other (specify) 
 
[Some might try to get a “market value” estimate of the value of owned homes and an 
estimate of how much principal was outstanding on the mortgage.] 
 
Question 9. Which of these categories best describe your total combined income for 
the past 12 months? 
This should include income (before taxes) form all sources, wages, rent from properties, 
social security, disability and or veteran’s benefits, unemployment benefits, workman’s 
compensation, help from relatives (including child payments and alimony), and so on. 
 
Check Box  
 Less than $5,000 
 $5,000 through $11,999 
 $12,000 through $15,999 
 $16,000 through $24,999 
 $25,000 through $34,999 
 $35,000 through $49,999 
 $50,000 through $74,999 
 $75,000 through $99,999 
 $100,000 or greater 
 Don’t know 
 No response 
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Question 10. If you lost all your current source(s) of household income(your 
paycheck, public assistance, or other forms of income), how long could you continue 
to live at your current address and standard of living? 
Check box  
 Less than 1 month 
 1 to 2 months 
 3 to 6 months 
 7 5o 12 months 
 More than 1 year 
 
Question 11. Suppose you needed money quickly, and you cashed in all of your (and 
your spouse’s) checking and savings accounts, and any stocks and bonds.  If you 
added up what you would get, about how much would this amount to? 
Check box  
 Less than $500 
 $500 to $4,999 
 $5,000 to $9.999 
 $10,000 to $19,999 
 $20,000 to $49,999 
 $50,000 to $99,000 
 $100,000 to $199,999 
 $200,000 to $499,999 
 $500,000 and greater 
 Don’t know 
 No response 
 
Question 12. If you now subtracted out any debt that you have (credit card debt, 
unpaid loans including car loans, home mortgage), about how much would you have 
left? 
Check box  
 Less than $500 
 $500 to $4,999 
 $5,000 to $9.999 
 $10,000 to $19,999 
 $20,000 to $49,999 
 $50,000 to $99,000 
 $100,000 to $199,999 
 $200,000 to $499,999 
 $500,000 and greater 
 Don’t know 
 No response 
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Social Provisions Scale 
 
Instructions: Using the scale below, please circle the number after each statement that 
indicates how much each statement describes your situation.  If you feel a statement is 
VERY TRUE, you would circle STRONGLY AGREE.  If you feel a statement 
CLEARLY does not describe your relationships, you would answer STRONGLY 
DISAGREE. 
 
1=STRONGLY DISAGREE 
2= DISAGREE 
3= AGREE 
4=STRONGLY DISAGREE 
 
1 There are people I know who will help me if I really need it 1 2 3 4 
2 I do not have close relationships with others 1 2 3 4 
3 There is no one I can turn to in times of stress 1 2 3 4 
4 There are people who call on me to help them 1 2 3 4 
5 There are people who like the same social activities I do 1 2 3 4 
6 Other people do not think I am good at what I do 1 2 3 4 
7 I feel responsible for taking care of someone else 1 2 3 4 
8 
I am with a group of people who think the same way I do 
about things 1 2 3 4 
9 I do not think that other people respect what I do 1 2 3 4 
10 If something went wrong, no one would help me 1 2 3 4 
11 I have close relationships that make me feel good 1 2 3 4 
12 I have someone to talk to about decisions in my life 1 2 3 4 
13 There are people who value my skills and abilities 1 2 3 4 
14 
There is no one who have the same interested and concerns 
as me 1 2 3 4 
15 There is no one who needs me to take care of them 1 2 3 4 
16 I have a trustworthy person to turn to if I have problems 1 2 3 4 
17 I feel a strong emotional tie with at least one other person 1 2 3 4 
18 There is no one I can count on for help if I really need it 1 2 3 4 
19 
There is no one I feel comfortable talking about problems 
with 1 2 3 4 
20 There are people who admire my talents and abilities 1 2 3 4 
21 I do not have a feeling of closeness with anyone 1 2 3 4 
22 There is no one who likes to do the things I do 1 2 3 4 
23 There are people I can count on in an emergency 1 2 3 4 
24 No one needs me to take care of them 1 2 3 4 
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Subject Initials: _______________ Subject #:  _______________ Visit Date: ___________ Visit # _______      pg. 1 
 
CTQ 
 
 
When I was growing up… Never 
True 
Rarely 
True 
Sometimes 
True 
Often 
True 
Very 
Often 
True 
1. I didn’t have enough to eat 1 2 3 4 5 
2. I knew that there was someone to take care of me 
and protect me. 
1 2 3 4 5 
3. People in my family called me things like 
“stupid,” “lazy,” or “ugly”. 
1 2 3 4 5 
4. My parents were too drunk or high to take care of 
the family 
1 2 3 4 5 
5. There was someone in my family who helped me 
feel that I was important or special. 
1 2 3 4 5 
6. I had to wear dirty clothes. 1 2 3 4 5 
7. I felt loved. 1 2 3 4 5 
8. I thought that my parents wished I had never been 
born. 
1 2 3 4 5 
9. I got hit so hard by someone in my family that I 
had to see a doctor or go to the hospital. 
1 2 3 4 5 
10. There was nothing I wanted to change about my 
family. 
1 2 3 4 5 
11. People in my family hit me so hard that it left me 
with bruises or marks. 
1 2 3 4 5 
12. I was punished with a belt, a board, a cord, or 
some other hard object. 
1 2 3 4 5 
13. People in my family looked out for each other. 1 2 3 4 5 
14. People in my family said hurtful or insulting 
things to me. 
1 2 3 4 5 
15. I believe that I was physically abused. 1 2 3 4 5 
16. I had a perfect childhood. 1 2 3 4 5 
17. I got hit or beaten so badly that it was noticed by 
someone like a teacher, neighbor, or doctor. 
1 2 3 4 5 
18. I felt that someone in my family hated me. 1 2 3 4 5 
19. People in my family felt close to each other. 1 2 3 4 5 
20. Someone tried to touch me in a sexual way, or 
tried to make me touch them 
1 2 3 4 5 
21. Someone threatened to hurt me or tell lies about 
me unless I did something sexual with them. 
1 2 3 4 5 
22. I had the best family in the world. 1 2 3 4 5 
23. Someone tried to make me do sexual things or 
watch sexual things. 
1 2 3 4 5 
24. Someone molested me. 1 2 3 4 5 
25. I believe that I was emotionally abused. 1 2 3 4 5 
26. There was someone to take me to the doctor if I 
needed it. 
1 2 3 4 5 
27. I believe that I was sexually abused. 1 2 3 4 5 
28 My family was a source of strength and support. 1 2 3 4 5 
 
 
 
 
 
  
The Pittsburgh Sleep Quality Index (PSQI) 
Instructions: The following questions relate to your usual sleep habits during the past month only. Your answers should indicate the 
most accurate reply for the majority of days and nights in the past month. Please answer all questions. During the past month: 
1. When have you usually gone to bed? ___________________ 
2. How long (in minutes) has it taken you to fall asleep each night? ___________________ 
3. When have you usually gotten up in the morning? ___________________ 
4. How many hours of actual sleep do you get at night? (This may be different than the number of hours you spend in bed) ___ 
________________ 
5 
During the past month, how often have you had trouble sleeping 
because you… 
Not 
during the 
past 
month (0) 
Less than 
once a 
week (1) 
Once or 
twice a 
week (2) 
Three or 
more times 
a week 
(Anum, 
Springel, 
Shriver, & 
Strauss) 
  a. Cannot get to sleep within 30 minutes         
  b. Wake up in the middle of the night or early morning         
  c. Have to get up to use the bathroom         
  d. Cannot breathe comfortably         
  e. Cough or snore loudly         
  f. Feel too cold         
  g. Feel too hot         
  h. Have bad dreams         
  i. Have pain         
  
j. Other reason(s), please describe, including how often you have had 
trouble sleeping because of this reason(s):         
6 
During the past month, how often have you taken medicine 
(prescribed or "over the counter") to help you sleep?         
2
4
6
  
  
7 
During the past month, how often have you had trouble staying awake 
while driving, eating meals, or engaging in social activity?         
8 
During the past month, how much of a problem has it been for you to 
keep up enthusiasm to get things done?         
    
Very 
good (0) 
Fairly 
good (1) 
Fairly bad 
(2) 
Very bad 
(Anum, et 
al.) 
9 During the past month, how would you rate your sleep quality overall?         
    
No 
partner or 
roommate 
Partner or 
roommate 
in other 
room 
Partner or 
roommate 
in same 
room, not in 
same bed 
Partner or 
roommate 
in same bed 
10 Do you have a bed partner or roommate?         
            
            
  
If you have a roommate or bed partner , ask him/her how often in the 
past week you had… 
Not 
during 
past 
month 
Less than 
once a 
week 
Once or 
twice a 
week 
Three times 
or more a 
week 
  a. loud snoring         
  b. Long pauses between breaths while asleep         
  c. leg twitching or jerking while you sleep         
  d. Episodes of disorientation or confusion during sleep         
  e. Other restlessness while you sleep; please describe                                             
 
 
 
 
2
4
7
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Pregnancy Anxiety Scale (PAS) (Rini et al., 1999). 
 
Instructions: Indicate the frequency or the extent to which you feel worried or concerned 
 
1= Never or not at all 
2= Some or a little of the time 
3= Occasionally, or a moderate amount of the time 
4= A lot of the time or very much 
 
   
Never  
or  
not at all 
Some or  
a little of 
the time 
Occasion
ally or a 
moderate 
amount 
of the 
time 
A lot 
of the 
time or 
very 
much 
1 
I am confident of having a 
normal childbirth 1 2 3 4 
2 
I think my labor and delivery 
will go normally 1 2 3 4 
3 
I have a lot of fear regarding 
the health of my baby 1 2 3 4 
4 
I am worried that the baby 
could be abnormal 1 2 3 4 
5 
I am afraid that I will be 
harmed during delivery 1 2 3 4 
6 
I am concerned (worried) about 
how the baby is growing and 
developing inside me 1 2 3 4 
7 
I am concerned (worried) about 
losing the baby   2 3 4 
8 
I am concerned (worried) about 
having a hard or difficult labor 
and delivery 1 2 3 4 
9 
I am concerned (worried) about 
taking care of a new baby 1 2 3 4 
10 
I am concerned (worried) about 
developing medical problems 
during my pregnancy 1 2 3 4 
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Table 2. Tools and Data Collection Time Points. 
  
T1: 16-24 
WEEKS 
GESTATION  
T2: 28-32 
WEEKS 
GESTATION 
AFTER 
DELIVERY 
BACKGROUND INFORMATION       
Demographic Information X     
Health History Survey X X   
PRIOR LIFE ADVERSITY       
Childhood Trauma Questionnaire X     
Household Dysfunction X     
MacArthur Subjective Social Status 
Scale (MSS) X     
MODERATING VARIABLES       
Social Provisions Assessment (SPA) X X   
PSYCHOLOGICAL DATA       
Perceived Stress Scale (PSS) X X   
Pregnancy Related Anxiety (PA) X X   
State Trait Anxiety (STAI) X X   
Edinburgh Depression Scale (EDS) X X   
Depressive Symptoms (CES-D) X X   
Mood Disturbance (POMS-65) X X   
Pregnancy Experience Scale (PES-
Brief) X X   
Tilburg Pregnancy Distress Scale 
(TPDS) X X   
The Pittsburg Sleep Quality Index 
(PSQI) X X   
NEUROENDOCRINE DATA       
Hair cortisol (cutting hair) X X   
IMMUNE DATA        
IL-6 (blood draw) X X   
TNF alpha (blood draw) X X  
NEONATAL OUTCOMES       
Birthweight (grams)     X 
Gestational Age (weeks gestation)     X 
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